PROCESS FOR PRODUCING ANTIBIOTIC COMPOUNDS DERIVED FROM CEPHALOSPORINS
The present invention relates to antibiotic compounds derived from cephalosporins, processes for the production 5 thereof and pharmaceutical compositions containing the same. These compounds correspond to the formula: . the COOA group at the 4 position is an acid radical, or an alkaline or alkaline-earth salt or an amino acid or amine salt, for example triethylamine or ethanolamines, or an easily hydrolyzable or metabolically labile and 20 pharmaceutically acceptable ester radical; . X denotes an oxygen atom or a sulfur atom; . n is zero or 1; . Ri and R2 each denote independently hydrogen or a lower alkyl group, preferably a methyl group; or 25 . Ri and R2 taken together with the carbon atom to which they are linked form a cyclobutyl or cyclopentyl nucleus; . B is the rèsidue of a primary or secondary amine selected from the following groups: - Z-NH-R where Z is an alkylene group with a sttàight or 30 branched chain alkylene group having from 2 to 7 carbon atoms, optionally interrupted by a sulfur atom and optionally substituted by a hydroxyl, thiol, methylthio, amino, acetamido, carbamoyl, phenyl, hydroxyphenyl or imidazolyl group, Z can also be a σyclopentylidene or cyclohexylidene 35 group, and R represents a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms, - Z R is as defined above, - R' Y denotes an alkyl group (CH2)m in which m = 0,1,2,3 or 4, a branched alkyl group having 2 or 3 carbon atoms 10 or also Y with NH-R" constitutes a ring R' and R", identical or different, have the same meaning as that given for R above, 15 -− Z"-NH~R where Z" is a 1,3-cyclohexylene or 1,4cyclohexylene group and R is as previously defined, R3i f Jl (NH-C)n - Aik -NH-R where R3 represents a s ό hydrogen atom or a methyl group, 20 n ≈ 0 or 1 and Aik and R are as previously defined, 1 -s (NH-C)n - Aik 6 NH-R where n ≈ 0 or 1 and Aik and R are as previously defined, 25 - a 2-piperidyl, 3-piperidyl or 4-piperidyl group optionally substituted on the nitrogen atom by a -C0-Alk-NH2 group or Thfer-Salts that the compounds of Formula (I) are 30 capable of giving with the pharmaceutically acceptable acids form an integral part of the invention. Consequent on the presence in the formula of an oxime group, the compounds (I) exist in 2 isomeric forms syn and anti. The syn isomers whose therapeutic activity is higher 35 are the preferred compounds. It is understood that the compounds (I) indicated above can exist: - either in the form indicated in Formula (I), - or in tautomeric form (I'): According to the reaction diagram below, the process of the invention consists of first acylating 4-tertiobutyl-l-S-oxide 7-amino-3-bromomethyl-3-cepheme carboxylate (II) with 15 the acid (III) to obtain the compound (IV) described in European patent application number 60,745. To the compound IV, is then added the acid B - (CH2)n - COOH or the thioacid B(CH2)n COSH whose amine function must be previously protected, according to a known method, by a protective group 20 like tertiobutoxycarbonyl or trichlorethoxycarbonyl, for example, B' then represents the group B in which the amine function is protected. The addition of the sodium or potassium salt of the acid B' - (CH2)nC00H to the compound (IV) is preferably done 25 in an aprotic polar solvent, for example dimethylformamide, whilst the addition of the sodium or potassium salt of the thioacid B# - (CH2)nC0SH σan be done in an apolar solvent like tetrahydrofuran. The compound (V) is obtained. In the case of the thioacids, to prepare the compounds 30 (V), it is possible to use the thioacid itself instead of an alkali salt. The operation is then in anhydrous acetone in the presence of potassium bicarbonate and sodium iodide. Finally, to end with the compound (I) , the protective groups on the amines and the tertiσbutyl esters are removed by a known process, in particular by hydrolysis in an acid medium by using, for example, trifluoracetic acid or a mixture of formic acid and hydrochloric acid. (IV) + B'-CCH2)jj- C - XH 0 -> CV) (V) + H+ CD Tr represents trityl> tBü tertiobutyl> X, Rj, R2>n> B' and B have the previously indicated meanings. The compounds (I) of the invention in which A is other than H are obtained from compounds (I) in which A is H by reactions known in themselves. 5 Thus the inorganic salts are obtained by the action on compounds (I), in which A is H, of an inorganic base such as soda or potash or sodium bicarbonate in an equimolecular amount; the salification reaction is carried in a solvent such as 10 water or ethanol and the salt obtained is isolated by evaporation of the solution. The salts of organic bases are obtained by the action on a solution of the acid I (A = H), in a solvent or a mixture of suitable solvents, of an equimolecular 15 amount of the organic base. The salt is isolated by precipitation with ether. The esters are obtained by known esterification processes; for example there will advantageously be used the action of a halogen 20 derivative on a salt such as the sodium salt of the acid; preferably the reaction will be carried out in a solvent capable of dissolving the starting acid derivative, for example in dimethyl-formamide. The syn and anti form isomers are obtained by 25 a suitable choice of reagents. The following examples enable the scope of the invention to be further understood without however limiting it. Thus as is usual in this family of compounds, 30 the products according to the invention do not have a distinct melting point but only points of decomposition which do not permit them to be characterized. The products will therefore be characterized by their nuclear magnetic resonance spectrum recorded at 35 60 MUz or at 250 MHz, the internal standard being hexamethyldisiloxane. The spectra are recorded in deuteriated dimethylsulfoxide with the exceptions indicated in the description of the spectrum; 50 mg of product in 0.5 ml of solvent at 60 MHz and 10 mg in 0.5 ml at 250 MHz. The chemical displacements are measured at ± 0.01 ppm and the coupling constants at 5 ± 0.5 Hz. The following abbreviations^ will be used: - S : singlet - D : doublet - D of D : doublet of doublet 10 - S. e. : widened singlet - M : multiplet - Q : quadruplet - AB : AB system - J : represents the coupling constant. 15 In addition elementary microanalyses were carried out in each case and are in agreement with the formulae indicated. The infra-red spectra also serve to characterize the products obtained. They were recorded 20 between 4,000 cm”1 and 600 cm”1 from a preparation constituted by a potassium bromide tablet containing the product at a concentration of about 2%; when the spectrum is recorded in solution at 1% in a chlorinated solvent, the nature of the latter is mentioned. The 25 elongation vibration frequency of the carbonyl groups of the molecule is noted ( £) CO). EXMSM--i 7-f2~(2-Amino 4-thiazolvli 2-(2-carboxv 2-propvl oxvimino) acetamidol 3 -f 4 30 pjperidinvlΐcarbonvl oxvmethvl 3-cepheme 4carboxvlic 1-β-S-oxide acid trifluoroaσetate svn isomer. SR 41 862. a) 7 - r 2- 2- S-oxide carboxvlate of Tertiobutvl: svn isomer. tBu and T have the previously indicated meanings, Boc denotes the tertiobutoxycarbonyl group. To a solution of 1.38 of 4-tertiobutyl 1-β-S-oxide 7-[2-(2-tritylamino 4-thiazolyl) 2-(2tertiobutoxycarbonyl 2-propyl oxyimino) acetamido] 3-bromomethyl 3-cepheme carboxylate syn isomer, in 20 ml of anhydrous dimethylformamide, are added 1 g of l-tertiobutyloxycarbonyl 4-piperidinyl carboxylic acid and 1.5 of potassium bicarbonate. After 17 hours of stirring at ambient temperature (20-25"C) the reaction mixture is poured on to 200 ml of ice water. After vigorous stirring, the crystals were filtered and washed with water. They are then taken up with 70 ml of dichloromethane. The organic phase is then washed with a saturated solution of sodium chloride, dried over magnesium sulfate and evaporated. The lacquer obtained is chromatographed on a column of 50 g of silica. It is eluted with a dichloromethane-ethyl acetate mixture 90-10 (vol/vol). After evaporation of the fractions containing the compound and trituration in hexane, 1.3 g of the expected compound is obtained. IR Spectrum; 9 CO . 1805 cm1: C ≈ 0 at 8 of the β lactame -1 . 1735 cm : C = 0 of the tertiobutyl esters and of the ester at the 3 position -I . 1695 cm : C = 0 of the tertiobutoxycarbonyl protecting group of the piperidine. NMR Spectrum at 250 MHz. 1H at 8.75 ppm (S, NH Tr) - 1H at 8.10 ppm (D, J=9 Hz, CONH) - 15 H at 7.25 ppm (M, H aromatics) - 1H at 6.73 ppm (S, H thiazole) - 1H at 5.81 ppm (M, Hj) - 1H at 5.25 ppm (D, J≈13 Hz, CH^ 0C0) - 1H at 4.94 ppm (D, J=4 Hz, Hβ) - 1H at 4.55 ppm (D, J=13 Hz, CH2 OCO) - 1H at 3.90 ppm (D, J=17 Hz, CH2SO) - 2H at 3.79 ppm (D, J=12 Hz, gCN Boc equatorials) - 1H at 3.53 ppm (D, J=17 Hz, CH2 SO) - 2H at 2.75 ppm (M, HCH Boc arials) - 1H at 2.50 ppm (M, acco2) - 2H at 1.75 ppm (D, J=12 Hz, HCHC02 equatorials) - 9H at 1.46 ppm (S, C02, tBU) - 2H at 1.40 ppm (M, HCCHC02 axials) - 6H at 1.39 ppm (S, (CH3)2C) - 9H at 1.36 ppm (S, C02tBU - 9H at 1.29 ppm <sΠS& N) . b) SR 41 862. 0.8 g of the compound obtained above was dissolved in 10 ml of trifluoroacetic acid. After 45 minutes at 23 °C the acid was evaporated under vacuum without heating and the oily residue was crystallized by the addition of 50 ml of isopropyl ether. The crystals were filtered and washed with isopropyl ether and then with hexane. They were then dried under vacuum over phosphoric anhydride. 0.66 g of the expected products was obtained. IR Spectrum; 3 CO . 1795 cm”1: C ≈ 0 at 8 of the β lactam . 1735 cm”1: C = 0 of the ester at 3 . 1680 cm”1 wide band: C = 0 of the acids of the molecule, of the amide at 7, of the ions CF3CO2- . NMR Spectrum at 250 MHz. 5 2H at 8.60 ppm (S.e., NH2+) - 1H at 8.50 ppm (D, J+9 Hz, CONH) - 3H at 8.40 ppm (S.e., NH3+) - 1H at 6.68 ppm (S, H thiazole) - 1H at 6.0 ppm (D of D, J3 = 9 Hz, J2=4 Hz, H2) “ 1H at 5.16 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.97 ppm (D, J=4 Hz, Hg) - 1H at 4.60 ppm (D, J=13 Hz, 10 CH^OCO) - 1H at 3.90 ppm (D, J=17 Hz, CH^SO) - 1H at 3.55 ppm (D, J=17 Hz, CHgSO) - 2H at 3.25 ppm (M, CHgNH) - 2H at 2.90 ppm (M, CHgNH) - 1H at 2.66 ppm (M, CHC02) - 2H at 1.90 ppm (M, CH^CH) - 2H at 1.70 ppm (M, CH2CH) - 6H at 1.44 ppm (2S, CH3)2C). 15 EXAMPLE 2 7-f 2 -(2-amino 4-thiazolvl) 2-(2-carboxv 2-propvl oxyΐmino) acetanidol (3-amino propionvll 3-thio-mβthvl 3-c℮pheme 4carboxvlic β 1-s-oxide acid trifluoracetate 20 svn isomer SR 41884. a) Tertiobutoxvcarbonvl 3-amino thiopropionic acid. 1.8 g of tert iobutoxycarbonyl 3-aminσ propionic acid was solubilized in 50 ml of anhydrous 25 dichloromethane. The triple-neck flask was provided with a calcium chloride trap and cooled in a bath of water and ice. In order, there were added 1.4 ml of triethylamine and 1.3 ml of isobutyl chloroformate. After 20 minutes stirring 30 in the cold, 1.5 ml of triethylamine was added and a light current of hydrogen sulfide was bubbled through for 15 minutes. Then the mixture was stirred in the cold for 45 minutes before being evaporated to dryness. 150 ml of sulfate buffer (pH 2) were added and the 35 thioacid was extracted twice with 70 ml of dichloromethane. The combined organic phases were dried over magnesium sulfate and evaporated. The oily product obtained was used as such. b) 7- r2- To a solution of 0.46 g of 4-Tertiobutyl 1 β S-oxide 7-[2-(2-tritylamino 4-thiazolyl) 2- (210 tertiobutoxy-carbonyl 2-propyl oxyimino) acetamido] 3-bromomethyl 3-cepheme carboxylate syn isomer, in 10 ml of tetrahydrofurane, were added 0.4 g of the thioacid described above as well as 0.6 g of potassium bicarbonate. After 4 hours stirring at ambient 15 temperature the solvent was evaporated and the residue taXen up again with 100 ml of water and 50 ml of dichloromethane. After decantation the aqueous phase was extracted with 50 ml of dichloromethane. The organic phases were combined, dried over magnesium 20 sulfate and evaporated. The lacquer so obtained was chromatographed on a column of silica (40 g), it was eluted with a mixture of dichloromethane-ethyl acetate 90-10 (vol/vol). IR spectrum; 25 . 1805 cm : C = 0 at 8 of the β lactame . 1720 cm : C = 0 of the tertiobutylic esters . 1690 cm : C == 0 of the amide at 7, of the thioester at 3 and of the 30 tertiobutoxy carbonyl protecting the amine. N M R Spectrum at 250 MHz fCD CL3ΐ. 1H at 7.75 ppm (D, J≈9 Hz, CONH) - 15H at 7.27 ppm (M, H ar Trit) - 1H at 6.95 ppm (S.e., NH-Trit) - 1H at 6.63 35 ppm (S, H thiazole) - 1H at 6.21 ppm (D of D, C) SR 41 884 The whole of the compound obtained above was solubilized in 10 ml of trifluoroacetic acid. After 45 minutes at 23“C the acid was evaporated under vacuum 10 without heating, and the oily residue was crystallized by the addition of 50 ml of isopropyl ether. The crystals were filtered and washed with isopropyl ether and then with hexane. They were then dried under vacuum over phosphoric anhydride. 15 0.37 g of the expected product was obtained. IR Spectrum: . 1785 cm "*■: C = 0 at 8 of the β lactam . 1680 cm1 wide band: C = O of the acids of the molecule, of the amide 20 at 7, of the thioester, of the CF3CO;}” ions. NMR Spectrum at 250 MHz. 1H at 8.40 ppm (D, J==9 Hz, CONH)- 3H at 7.80 ppm (S.e., NH3) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.78 ppm (S, 25 H, thiazole) - 1H at 5.95 ppm (D of D, Jα=9 Hz, J2=4 HZ, Hj) - 1H at 4.92 ppm (D, J≈4 Hz, H6) - 1H at 4.18 ppm (D, J=13 Hz, CH^S CO) - 1H at 3.79 ppm (D, J=13 Hz, CH2 S CO) - 2H at 3.66 ppm (S, CH2 SO) - 2H at 3.0 ppm 30 ppm (S, (CHj )2 C). ~ (M, CHg NH) - 2H at 2.92 ppm (M, CH2 COS) - 6H at 1.44 EXAMPLE 3 Trifluoroacetate of To 0.46 g of 4-Tertiobutyl 1 β-S-oxide 7-[2(2-tritylamino 4-thiazolyl) 2-(2-tertiobutoxy carboxylamino 2-propyl oxyimino) acetamido] 3-bromomethyl 310 cepheme carboxylate syn isomer in 10 ml of anhydrous acetone, were added 0.4 of 3-tertiobutoxycarbonylamino thio-propionic acid, 0.6 g of potassium bicarbonate and 0.25 g of sodium iodide. After 2 hours stirring at room temperature, 15 the solvent was evaporated to dryness. The residue was taken up again in 100 ml of water and extracted with 50 ml of dichloromethane. The organic phase is separated and the aqueous phase reextracted with 50 ml of dichloromethane. The organic extracts were combined, 20 dried over magnesium sulfate and evaporated to dryness. The product obtained was chromatographed on a silica column by eluting with a dichloromethane-ethyl acetate mixture 90-10 (vol/vol). An identical product (IR spectrum and NMR 25 spectrum) to the product of Example 2 b) was obtained. b) SR_41-9M. The deprotection was carried out as indicated in Example 2 c). By operating as in Example 1, the compounds 30 according to the invention were prepared in the form of trifluoroacetate, described in Table I below. 0- C -(·CH9) B, TFA ii These compounds are identified by a reference number. For each among them the values of Rlf R2, B and n and the NMR spectrum are given. The acid B' - (CH2)n -COOH which reacts on 15 (IV) to give (V) is an aminoacid of the L series or of the D series or racemic; the corresponding indication appears in Table I, at column B. The chromatographic eluant is also given which serves to isolate (V) : the last intermediate 20 product before deblocking the acid and amine functions of the molecule. This intermediate V is characterized by its infra-red spectrum, the wavelengths indicated in - 1 cm correspond in order to the elongation vibration frequencies of the carbonyl at the 8 position of the 25 beta lactam, the tertiobutylic esters and the ester at the 3 position, the amide at the 7 position and the carbamate protecting the amine. When 2 wavelengths only are indicated, the second corresponds to a wide band which covers the elongation vibration frequencies 30 both of the esters, of the amide and of the protective carbamate of the amine. The list of NMR spectra of the compounds mentioned in Table I is given following this table. 41 807 A ch3 ch3 © CH - NH2 ch3 - CH2-C0-NH2 CH2 Cl2 50 Ac 1805 1735 1680 41 810 ■CH - NH2 © CH20H CH2 Cl2 80 AcEt 20 1805 1725 41 354 ·<ch2>3NH2 ■(ch2)5nh2 CH2 Cl2 90 AcEt 10 1805 1725 41 855 CH2 Cl2 90 1805 1725 1690 41 855 (ch2)7nh2 CHj Clg 90 AcEt 10 1805 1725 1595 10 41 857 -CH - NH, © I2 CH2S - CH2NHCOCH3 CH2 Cl2 100 Ha 1.5 1805 1725 1630 11 41 858 ch3 - C - NH, £h 3 CH2 Cl2 90 AcEt 10 1805 1725 12 41 859 “pH* nh2 © CH2 Clg 92.5 AcEt 7.5 1810 1725 13 41 860 Cl, 92.5 AcEt 7.5 1805 1725 14 -a - 18 - -a S o KMK SPECTRAi The spectra are recorded at 60 Mtlz, indicated by (a) or at 2.50 MHz, indicated by (b); when there exist two dinsteroo-isomers in a molecule, the split signals are indicated by NMR n° 1 - ftp ; 1H at 8.44 ppm (D, J=9 Hz, CONH) - 3H at 7.90 ppm (S.e., NHj) ~ 3H at 7.50 ppm NH^) - 1H at 6.78 ppm (S, H 5 thiazol) - 1H at 5.97 ppm (D of D, Jx = 9 Hz, J2=4 Hz, H7) - 1H at 5.18 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.94 ppm (D, J=4 Hz, H5) - 1H at 4.64 ppm (D, J=13 Hz, CH2OCO) - 1H at 3.90 ppm (D, J=17 Hz, CH2 SO) - 1H at 3.58 ppm (D, J=17 Hz, CH2 SO) - 2H at 3.00 ppm (M, 10 CH2NH2) - 2H at 2.61 ppm (M, CH2 C02) - 6H at 1.44 ppm (S~ («13)2 C). ~~ NMR n' 2 - fb): 4H at 8.45 ppm (M, NH3,CONH) - 3H at 7.35 ppm (S.e., NH^) - 5H at 7.25 ppm (M, H aromatics - 1H at 6.82 ppm 15 (S, H thiazol) - 1H at 6.0 ppm (D of D, Jx=9 Hz, J2=4 Hz, H7) - 1H at 5.20 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.92 ppm (D, J≈4 Hz, H6) - 1H at 4.81 ppitT (D, J=13 Hz, CH20C0) - 1H at 4.31 ppm (S.e., CH NH2) - 1H at 3.50 ppm (D, J=17 Hz, CH2 SO) - 1H at 3.30 ppm (D, J=17 Hz, CH^ 20 SO) - 2H at 3.10 ppm (M, CH2C6H5) - 6H at 1.44 ppm (2 S, (CH3)2 C). ~ NMR n· 3 - fbΐ : 5H at, 8.45 ppm (S.e., NH2, OH, CONH) “ 3H at 7.50 ppm (S.e., NH3)- 2H at 6.95 ppm (D, J=8 Hz, H meta OH) - 1H 25 at 6.78 ppm (S, H thiazol) - 2H at 6.68 ppm (D, J=8 Hz, H ortho OH) - 1H at 6.0 ppm (D of D, Jx=9 Hz, J2=4 Hz, H7) - 1H at 5.16 ppm (D, J≈13 Hz, CH^OCO) - 1H at 4.92 ppm (D, J≈>4 Hz, Hg) - 1H at 4.74 ppm (D, J=13 Hz, CHa 0C0) - 1H at 4.19 ppm (M, CHNH2) - 1H at 3.66 ppm (D, 30 J=>17 Hz, (CHgSO) - 1H at 3.34 ppm (D, J=17 Hz, CH^SO) 2H at 2.93 ppm (M, CH2 - CH - NH2) - 6H at 1.44 ppm (2 S, (CH3)2 C). “ NMR n" 4 - fb): 1H at 8.50 ppm (D, J=9 Hz, CONH) - 3H at 8.40 ppm (S.e. 35 NH3) - 3H at 7.60 ppm (S.e. NH3) - 1H at 6.79 ppm (S, H thiazol) - 1H at 6.00 ppm (D of D, J3=9 Hz, J2=4 Hz, H7) - 1H at 5.45 ppm (D, J=13 Hz, CHsOCO) - 1H at 4.97 ppm (D, J=4 Hz, Hg) - 1H at 4.80 ppm (D, J=13 Hz, CHgOCO) - 1H at 4.08 ppm (M, CHNH2) - 1H at 3.92 ppm (D, J=17 Hz, CHjgSO) - 1H at 3.58 ppm (D, J=17 Hz, CH2SO) - 6H at 1.44 ppm (S, (CH3)2C) - 3H at 1.34 ppm (D, J=7 5 Hz, CH3CH). NMR n° 5 - : 1H at 8.45 ppm (D, J=9 Hz, CO NH) - 3H at 8.40 ppm (S.e., NHg) - 3H at 7.60 ppm (S.e., Sh^) - 1H at 6.78 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jj=9 Hz, 10 J2=4 Hzn H7) - 1H at 5.25 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.95 ppm (D, J≈4 Hz, H6) - 1H at 4.82 ppm (D, J=13 Hz, CH2OCO) - 2H at 3.92 ppm (M, CH NH2 and CH2SO) 1H at 3.56 ppm (D, J=17 Hz, CH^SO) - 1H at 2.11 ppm (M, CH (CH3)2) - 6H at 1.44 ppm (2 S, (CH3)2 C) - 6H at 0.9 15 ppm (D, J=7 Hz, (CH3)2 CH). NMR n" 6 - (bï: 1H at 8.45 ppm (D, J=9 Hz, CONH) - 3H at 8.35 ppm (S.e., NH3) - 4H at 7.40 ppm (S.e., CONH2, &H3) - 1H at 6.92 ppm (S.e., CONH2) - 1H at 6.76 ppm (S, H thiazol) - 1H 20 at 6.0 ppm (D of D, Jχ=9 Hz, J2=4 Hz, Hj) - 1H at 5.25 ppm (D, J=13 HZ, CHgOCO) - 1H at 5.00 ppm (D, J=4 Hz, Hg) - 1H at 4.82 ppm (D, J=13 Hz, CH3OCO) - 1H at 4.00 ppm (M, CH NH2) - 1H at 3.95 ppm (D, J=17 Hz, ClfgSO) 1H at 3.56 ppm (D, J≈17 Hz, CH2SO) - 2H at 2.20 ppm (M, 25 CH2-CONH2) - 2H at 1.95 ppm (M, CH2-CH) - 6H at 1.44 ppm (2~S, (CH3)2C). ~ MMBL. nα .7 - (b) Î 1H at 8.50 ppm (D, - 1H at 5.25 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.92 ppm (D, J=4 Hz, H6) - 1H at 4.82 ppm (D, J=13 Hz, CH2OCO) 1H at 4.16 ppm (M, CHNH2) - 1H at 3.95 ppm (D, J=17 Hz, CHgSO) - 1H at 3.81 ppm (A of AB, JAβ=13 Hz, CHgOH) 35 1H at 3.69 ppm (B of AB, JAB=13 Hz, CHgOH) - 1H at 3.55 ppm (D, J=17 Hz, CHg SO) - 6H at 1.44 ppm (2 S, (CH3)2 C). ~ NMR n” 8 - (aï : 8H between 5.5 and 8.5 ppm (widened signal, NH2, C02H, TFA) - 1H at 8.40 ppm (D, J=9 Hz, CONH) - 1H at 6.82 ppm 5 (S, H thiazol) - 1H at 6.0 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H^) - 1H at 5.15 ppm (A of AB, Jab~13 Hz» CH20C0) 1H at 5.0 ppm (D, J=4 Hz, H6) - 1H at 4.67 ppm (B of AB, J=13 Hz, CH^OCO) - 1H at 3.85 ppm (A of AB, J=17 Hz: CH2S0) - 1H at 3.62 ppm (B of AB, J=17 Hz, CH2SO) - 2H 10 at 2.80 ppm (M, CH2NH2) - 2H at 2.40 ppm (M, CH2C02) 2H at 1.80 (M, CH2CH2CH2) - 6H at 1.43 ppm (S, (CH3)2C). ~ NMR n’ 9 - faΐ: 8H between 5.5 and 8.7 ppm (wide signal, C02H, NH2, TFA) 15 - 1H at 8.40 ppm (D, J=9 Hz, CONH) - 1H at 6.87 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, J3=9 Hz, J2 = 4 Hz, H7) - 1H at 5.15 ppm (A of AB, J=13 Hz, CH2OCO) - 1H at 5.0 ppm (D, J=4 Hz, H6) - 1H at 4.60 ppm (B of AB, J=13 Hz, CH2OCO) - 1H at 3.85 ppm (A of AB, J=17 Hz, CH2SO)20 1H at 3.60 ppm (B of AB, J=17 Hz, CH2S0) - 2H at 2.80 ppm (M, CH2NH2) - 2H at 2.30 ppm (M, CH2CO) - 12 H at 1.45 ppm (S.e., (CH3)2C and CH2(CH^)3CH2). NMR n* 10 - fa): 8H between 5.5 and 8.0 ppm (wide signal, NH2, C02H, TFA) 25 - 1H at 8.45 ppm (D, J==9 Hz, CONH) - 1H at 6.87 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jx≈9 Hz, J2=4 Hz, H7) - 1H at 5.15 ppm (A of AB, J=13 Hz, CH20C0) - 1H at 5.0 ppm (D, J=4 Hz, H^) - 1H at 4.65 ppm (B of AB, J≈13 Hz, CHgOCO) - 1H at 3.85 ppm (A of AB, J=17 Hz, CHgSO) 30 1H at 3.62 ppm (B of AB, J=17 Hz, CH2S0) - 2H at 2.80 ppm (M, ℮H2NH2) - 2H at 2.30 ppm (M, CH^CO^ - 6H at 1.45 ppm (S, (CH3)2C) - 10H at 1.35 ppm (S.e., CH2(CH2)5CH2). NMR n“ 11 - 35 2H at 8.40 ppm (M, CONH, CH3CONH) - 8H at 7.50 ppm (S.e., Sh3, C02H) - 1H at 6.90 ppm (S, H thiazol) - 1H at 6.05 ppm (D of D, J!=9 Hz, J2=4 Hz, H7) - 1H at 5.40 CONH, CH3CONH) - 8H at 7.50 ppm 1H at 6.90 ppm (S, H thiazol) - 1H J!=9 Hz, J2=4 Hz, H7) - 1H at 5.40 ppm (A of AB, J==13 Hz, CH2OCO) - 1H at 4.98 ppm (D, J=4 Hz, Hg) - 1H at 4.90 ppm" (B of AB, J=13 Hz, CH20C0) 3H at 4.30 ppm (M, CH·^NHCOCH;j,CHNH2) - 1H at 4.00 ppm (A 5 of AB, Jab=17 Hz» CH2SO) - 1H at 3.65 ppm (B of AB,JAB=17 Hz, CH2SO) - 2H at 3.00 ppm (M, CHgS) - 3H at 1.80 ppm (S, CH3CONH), - 6H at 1.45 ppm (S,(CH3)2C). NMR n° 12 - fa^; 8H between 6.5 and 9 ppm (wide signal, C02H, TFA, NH2) 10 - 1H at 8.5 ppm (D, J=9 Hz, CONH) “ 1H at 6.90 ppm (S~H thiazol) - 1H at 6.0 ppm (D of D, J^-9 Hz, J2=4 Hz, H^) - 1H at 5.30 ppm (A of AB, J=13 Hz, CH20C0) -- 1H at 5.0 ppm (D, J=4 Hz, H^) - 1H at 4.80 ppm (B of AB, J=13 Hz, CH2OCO) - 1H at 3.92 ppm (A of AB, J=17 Hz, CHg SO) - 1H 15 at 3.67 ppm (B of AB, J=17 Hz, CH2SO) - 12H at 1.45 ppm (S, (CH3)2C-C02H, (CH3)2CNH2). NMR n· 13 - (aï : 8H between 6.5 and 9.5 ppm (wide signal, C02H» NH2, TFA) - 1H 8.5 ppm (D, J=9 Hz, CONH) - 1H at 6.90 ppm (S, H 20 thiazol) - 1H at 6.05 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7) - 1H at 5.30 ppm (A of AB, J≈13 Hz, CHgOCO) - 1H at 5.05 ppm (D, J=4 Hz, Hg) - 1H at 4.90 ppm (B of AB, J=13 Hz, CH20C0) - 3H at 3.80 ppm (M, CHNH2 and CH2S0) - 3H at 1.50 ppm (M, CH2-CH) - 6H at 1.45 ppm (S, 7ch3)2C) 25 6H at 0.85 ppm (D, J=7 Hz, (CH^CH). NMR n‘ 14 - (a) : 8H between 7 and 9 ppm (wide signal, NH2, C02H, TFA) 1H at 8.50 ppm (D, J=9 Hz, CONH) - 1H at 6.90 ppm (S, H thiazol) - 1H 6.08 ppm (D of D, Jx=9 Hz, J2≈4 Hz, H7) 30 1H at 5.30 ppm (A of AB, Jab≈13 Hz' CH2OCO) - 1H at 5.05 ppm (D, J=4 Hz, Hg) - 1H at 4.49 ppm (B of AB, Jab=13 HZ, CHgOCO) - 3H at 3.90 ppm (M, CH2SO and CH CH2) - 1H at 1.80 ppm (M, CH CH3) - 6H at 1.45 ppm (S, (CH^)2C) 2H at 1.30 ppm (M, CH2 CH3) - 6H at 0.88 ppm (M, CH^ CH2 35 and CH^CH). NMR n° 15 - : 1H at 8.5 ppm (D, J=9 Hz, CONH) - 3H at 8.30 ppm (S.e., NHS) - 3H at 7.40 ppm (S.e., &H3) - 1H at 6.76 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7) - 1H at 5.24 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.92 ppm (D, J=4 Hz, Hg) - 1H at 4.84 ppm (D, J=13 Hz, CH^OCO) 5 1H at 4.10 ppm (M, CH-NH2) - 1H at 3.97 ppm (M, CH-OH) 1H at 3.94 ppm (D, J=17 Hz, CH^SO) - 1H at 3.55 ppm (D, J =17 Hz, CH^SO) - 6H at 1.44 ppm (S, (CHg^C) - 3H at 1.14 ppm (D, J=7 Hz, CHjCH). NMR n° 16 - (b): 10 1H at 8.5 ppm (D, J=9 Hz, CONH) - 3H at 8.40 ppm (S.e., Ntfj) - 1H at 7.66 ppm (S, CONH2) - 3H at 7.50 ppm (S.e., NH3) - 1H at 7.22 ppm (S, CO NH2) - 1H at 6.78 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, - 1H at 5.29 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.92 ppm 15 (D, J≈4 Hz, Hg) - 1H at 4.79 ppm (D, J=13 Hz, CH2OCO) 1H at 4.26 ppm (M, CHNH2) - 1H at 3.92 ppm (D, J=17 Hz, CH2 SO) - 1H at 3.52 ppm (D, J=17 Hz, CH2SO) - 2H at 2.71 ppm (M, CH2CONH2) - 6H at 1.44 ppm (S,(CH3)2C). NMR n0 17-fbi; 20 1H at 8.50 ppm (D, J≈9 Hz, CONH) “ 3H at 8.45 ppm (S.e., iiWj) - 3H at 7.45 ppm (S.e., NH3) - 1H at 6.78 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7) - 1H at 5.24 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.98 ppm (D, J≈4 Hz, Hg) - 1H at 4.82 ppm (D, J=13 Hz, CH2OCO) 25 1H at 4.13 ppm (M, CHNH2) - 1H at 3.92 ppm (D, ~J≈17 Hz, CH2S0) - 1H at 3.10 ppm (D, J=17 Hz, CH2S0) - 1H at 2.1θ ppm (M, CH2S) - 5H at 2.0 ppm (M, CH3S~ and CH2-CH2-S) - 6H at 1.44 ppm (S, (CH3)2C). NMR n* 13 - (hi 30 4H at 8.50 ppm (M, CONH, NH3) - 3H at 7.80 ppm (S.e., NH^) - 3H at 7.50 ppm (S.e.,”!^) - 1H at 6.79 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jx=9 Hz, J2=4 Hz, H7) - 1H at 5.24 ppm (D, J=13 Hz, CHgOCO) - 1H at 4.97 ppm (D, J=4 Hz, Hg) - 1H at 4.82 ppm (D, J≈13 Hz, CH2OCO)35 1H at 3.97 ppm (M, CHNH2) - 1H at 3.92 ppm (D, J^Ï7 Hz, CH2SO) - 1H at 3.60 ppm (D, J=17 Hz, CH2SO) - 2H at 2.75 ppm (M, CH2NH2, - 1H at 1.75 ppm (M CH^CH) - 11H at 1.40 ppm (S.e. TfCH^C, (CH2)3CH2NH2). NMR n· 19- fb): , , + 1H at 9 ppm (S, H2 îmidazol) - 3H at 8.6 ppm (S.e., NH3) - 1H at 8.5 ppm (D, J=9 Hz, CONH) - 1H at 7.40 ppm (S, 5 H4 imidazol) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.79 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, J^=9 Hz, J2=4 Hz, H7) - 1H at 5.22 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.97 ppm (D, J=4 Hz, H6) - 1H at 4.90 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.40 ppm (M, CHNH2) - 1H at 3.89 ppm 10 (D, J=17 Hz, CH2SO) - 1H at 3.52 ppm (D, J=17 Hz, CH2SO) - 2H at 3.20 ppm (M, CH2CH) - 6H at 1.44 ppm (S, (CH3)2 C) . NMR n‘ 20 -fbΐ: 1H at 8.50 ppm (D, J=9 Hz, CONH) - 3H at 8.40 ppm (S.e., 15 NH^) - 3H at 7.40 ppm (S.e., NH3) - 1H at 6.77 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7) - 1H at 5.76 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 1H at 4.81 ppm (D, J=13 Hz, CH^OCO)1H at 4.06 ppm (M, CHNH2) - 1H at 3.95 ppm (D, J=17 Hz, 20 CH^SO) - 1H at 3.63 ppm (D, J=17 Hz, CHgSO) - 6H at 1.44 ppm (S, (CHj^C) - 3H at 1.36 ppm (D, J=7 Hz, CH3CH). NMR n‘ 21 - (a^; 8H between 6.5 and 9 ppm (widened signal, NH2, C02H, TFA) - 1H at 8.35 ppm (D, J=9 Hz, CONH) - 1H at 6.80 ppm 25 (S, H thiazol) - 1H at 6.0 ppm (D of D, Jx=9 Hz, J2=4 HZ, Hjz) - 1H at 5.15 ppm (A of AB, JAB=13 Hz, CHjOCO)1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.65 ppm (B of AB, JAB≈13 HZ, CH20C0) - 1H at 3.95 ppm (A of AB, JAB=17 Hz, CH2SO) - 1H at 3.65 ppm (B of AB, JAB≈17 Hz, CH2SO) - 2H 30 at 2.80 ppm (M, CH2NH2) - 2H at 2.35 ppm (M, CH^CO)10H at 1.45 ppm (S.e., (CH3)2C + CH2(CH2)2CH2). NMR n' 22 - 8H between 6 and 9 ppm (wide signal, TFA, NH2, C02H)1H at 8.42 ppm (D, J=9 Hz, CONH) - 1H at 6.85 ppm (S, H 35 thiazol) - 1H at 6.05 ppm (D of D, - 1H at 5.30 ppm (A of AB, J=13 Hz, CH^OCO) - 1H at 5.05 ppm (D, J=4 Hz, Hg) - 1H at 4.68 ppm (B of AB, JAB=13 Hz, CH20C0) - 1H at 4.0 ppm (A of AB, JAB=17 Hz, CH2S0) - 1H at 3.65 ppm (B of AB, JAb=17 Hz> CH2SO) - 8H at 1.75 ppm (M, H, cyclopentane) - 6H at 1.45 ppm (S, (CH3)2C). 5 NMR n· 23 - 8H between 7 and 10 ppm (wide signal, TFA, NH2, C02H) 1H at 8.50 ppm (D, J=9 Hz, CONH) - 1H at 6.92 "ppm (S, H thiazol) - 1H at 6.10 ppm (D of D, J3=9 Hz, J2=≈4 Hz, H7) - 1H at 5.35 ppm (A of AB, J=13 Hz, CH2OCO) - 1H at 5.0 10 ppm (D, J=4 Hz, H6) - 1H at 4.75 ppm (B of AB, J=13 Hz, CH^OCO) ~ 1H at 4.0 ppm (A of AB, JAb=17 Hz, CH2SO) - 1H at 3.70 ppm (B of AB, JAb=17 Hz/ CH2SO) - 16H~between 1 and 2.3 ppm (M, (CH3)2C and cyclohexane). NMR n° 24 - 15 9H between 8 and 10 ppm (wide signal, NH2, OH, C02H, TFA) - 1H at 8.55 ppm (D, J=9 Hz, CONH) - 2H at 7.10 ppm (D, J=8 Hz, H meta OH) - 1H at 6.90 ppm (S, H thiazol)2H at 6.80 ppm (D, J=8 Hz, H ortho, OH) - 1H at 6.10 ppm (D of D, J3=9 Hz, J2=4 Hz, H7) - 1H at 5.80 ppm (A 20 of AB, J≈13 Hz, CH20C0) - 1H at 5.05 ppm (D, J==4 Hz, Hg) - 1H at 4.80 ppm (B of AB, J=13 Hz, CHj;OCO) - 1H at 4.30 ppm (M, CflNH2) - 2H at 3.70 ppm (M, CHgSO) - 2H at 3.0 ppm (M, CHg-CgH^OH - 6H at 1.46 ppm (S, (CMjJgC). MMR_.n° 25 - (a).ΐ 25 10H between 6.5 and 9.5 ppm (wide signal, NH2, C02H, TFA) - 1H at 8.40 ppm (D, J=9 Hz, CONH) " 1H at 6.85 ppm (S, h thiazol) - 1H at 6.05 ppm (D of D, Jx=9 Hz, J2=4 Hz, H7) - 1H at 5.30 ppm (A of AB, Jab313 Hz, CH20C0)1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.85 ppm (B of AB,30 JAB=13 Hz, CH20C0) - 1H at 4.20 ppm (M, CHNH2) - 2H 3.80 ppm (M, CH2S0) - 2H at 2.95 ppm (M, CH2NH2) - 2H at 2.20 ppm (M, CH2CH2NH2) - 6H at 1.45 ppm (S, (CH3)2C). NMR n° 26 - fb^: 3H at 8.60 ppm (S.e., NH3) - 1H at 8.44 ppm (D, J=9 Hz, 35 CONH) - 1H at 6.78 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, NMR n· 27 - (bi: -4* 3H at 8.50 ppm (S.e., NH3) - 1H at 8.44 ppm (D, J=9 Hz, CONH) - 3H at 7.80 ppm (S.e., NH^) - 3H at 7.30 ppm (S.e., NH^) - 1H at 6.78 ppm (S, H thiazol) - 1H at 6.0 10 ppm (D of D, Jχ=9 Hz, J2=4 Hz, Hy) - 1H at 5.26 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.97 ppm (D, J=4 Hz, Hg) - 1H at 4.84 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.08 ppm (M, ℮HC02) - 1H at 3.94 ppm (D, J=17 Hz, CH2SO) - 1H at 3.56 ppm (D, J=17 Hz, CH2S0) - 2H at 2.80~ppm (M, CH2NH2)15 4H at 1.60 ppm (M, 7cH2>2CH2 NH2) - 6H at 1.44 ppm (S, (CH3)2C) . NMR n° 28 - 1H at 8.37 ppm (D, J=9 Hz, CONH) - 3H at 7.90 (S.e., NΗ3) - 3H at 7.20 ppm (S.e., NH3) - 1H at 6.76 ppm (S, H 20 thiazol) - 1H at 6.0 ppm (D of”D, Jx==9 Hz, J2=4 Hz, Hy) - 1H at 5.16 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.97 ppm (D, J≈4 Hz, Hg) - 1H at 4.66 ppm (D, J=13 Hz, CH^OCO)1H at 3.92 ppm (D, J=17 Hz, CH2SO) - 1H at 3.58 ppm (D, J=17 Hz, CH2S0) - 1H at 3.50~ppm (M, CH NH2) - 2H at 25 2.56 ppm (M7 CH2|CHNH2) 6H at 1.44 ppm (S, (CH^C) - 3H at 1.16 ppm (D, J=6 Hz, CH3-CH). NMR n° 29 - (b): 1H at 8.44 ppm (D, J≈9 Hz, CONH) “ 3H at 7.95 ppm (S.e., fa^) - 3H at 7.50 ppm (S.e., NH3) - 1H at 6.78 ppm (S,H 30 thiazol) - 1H at 6.0 ppm (D of~D, Jx≈9 Hz, J2=4 Hz, Hy) 1H at 5.20 ppm (2D, J≈13 Hz, CH^jOCO) * ~ 1H at 4.95 ppm (M, Hg) - 1H at 4.62 ppm (2D, J=13 Hz, CH2OCO) * - 1H at 3.94 ppm (D, J=17 Hz, CH2SO) - 1H at 3.58 ppm (D, J=17 Hz, CH2SO) - 1H at 3.0 ppm (M, CHC02) - 2H at 2.75 ppm 35 (M, CH^NH2) - 6H at 1.44 ppm (M, (CH3)2 C) - 3H at 1.10 ppm (D, J≈7 Hz, CH3CH). NMR n’ 30 - (bΐ: 4" +■* 4H at 8.45 ppm (M, NH^, CONH) - 8H at 7.35 ppm (M, NH3, H aromatic) - 1H at 6.78 ppm (S, H thiazol) - 1H at 6.0 5 ppm (M, H7) - 1H at 5.05 ppm (2D, J=13 Hz, CH2OCO)* - 1H at 4.94 ppm (2D, J=4 Hz, H6)* - 1H at 4.60 ppm (M, CH NH2) - 1H at 3.66 ppm (2D, J=17 Hz, CH2SO)* - 1H at 3.40 ppm (2D, J=17 Hz, CH2SO)* - 2H at 3.0 ppm (M, CH2C02) 6H at 1.44 ppm (S, (CH3)2C). 10 NMR n' 31 -− ; 1H at 8.40 ppm (D, J=9 Hz, CONH) - 3H at 7.74 ppm (S.e., 4- -V NH3) - 3H at 7.40 ppm (S.e., NH3) - 1H at 6.81 ppm (S, H thiazol) - 1H at 6.0 ppm (D of~D, Hz, J2=4 Hz, H7) 1H at 5.13 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.97 ppm (D, 15 J=4 Hz, Hg) - 1H at 4.63 ppm (D, J=13 Hz, CH2OCO) - 1H at 3.90 ppm (D, J=17 Hz, CH2SO) - 1H at 3.55 ppm (D, J=17 Hz, CH^SO) - 1H at 3.16 ppm (M, CHNH2) - 2H at 2.40 ppm (M, CH2CO) -1H 1.77 ppm (M, CH2CHNH2) - 1H at 1.61 ppm (M, CH2CHNH2) - 6H at 1.44 ppm~(2S, (CH3)2C) - 1H at 20 1.1 ppm (D, J=7 Hz, CHβ-CH). NMR n* 32 - (a) : 7H between 7 and 9 ppm (NH, NH2, C02H, TFA) - 1H at 8.50 ppm (D, J≈9 Hz, CONH) - 1H at 6.90 ppm (S, H thiazol)1H at 6.05 ppm (D of D, Jχ=9 Hz, J2=4 Hz, ) - 1H at 25 5.15 ppm (A of AB, J=13 Hz, CHgOCO) - 1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.70 ppm (B of AB, J=13 Hz, CH2OCO) - 1H at 3.95 ppm (A of AB, JAB≈17 Hz, CH2S0) - 1H at 3.65 ppm (B Of AB, JAB =17 Hz, CHgSO) - 2H at 2.90 ppm (M, CH2NH) - 3H at 2.45 ppm (D, J=6 Hz, CHgNH) - 2H at 30 2.4 ppm (M, CH2C0) - 2H at 1.70 ppm (M, CH2CH2CH2) - 6H at 1.42 ppm (S, (CH3)2C). NMR n* 33 - (al: 7H between 7 and 9.5 ppm (NH2, NH, C02H, TFA) - 1H at 8.46 ppm (D, J=9 Hz, CONH) - 1H at 6.90 ppm (S, H 35 thiazol) - 1H at 6.05 ppm (D of D, Jχ=9 Hz, J2=4 Hz, Hj) - 1H at 5.15 ppm (A of AB, JAB=13 Hz, CH20C0) - 1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.70 ppm (B of AB,JAB=13 Hz' CH2OCO) - 1H at 3.90 ppm (A of AB, JAB=17 Hz, CH2SO) - 1H at 3.65 ppm (B of AB, JAB≈17 Hz, CH2SO) - 2H at 2.75 ppm (M, CH^ NH CH3) - 5H at 2.45 ppm (M, CH·jNH and CH2CO) - 10H at 1.45 ppm (S.e., (CH3)2C and CH2 5 (CH2)2CH2). NMR~n’ 34 -raΐ: 8H between 6 and 9 ppm (widened signal, NH2, TFA, OH, C02H) - 1H at 8.47 ppm (D, J=9 Hz, CONH) - 1H at 6.90 ppm (S, H thiazol) - 1H at 6.15 ppm (D of D, 15 NMR n‘ 35 - (bΐ: 1H at 8.50 ppm (D, J=9 Hz, CONH) - 3H at 8.35 ppm (S.e., NH3) - 2H at 7.94 ppm (D, J=8 Hz, H ortho CO) - 2H at 7.55ppm (D, J=8 Hz, H meta CO) - 1H at 6.84 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jx==9 Hz, J2=4 Hz, Hj) 20 - 1H at 5.44 ppm (D, J≈13 Hz, CH^OCO) - 1H at 4.99 ppm (D, J≈4 Hz, Rg) - 1H at 4.86 ppm (D, J=13 Hz, CH^OCO) 3H at 4.1 ppm (M, CH2NH2, CH^SO) - 1H at 3.72 ppm (D, J≈17 Hz, CH2SO) - 6H at 1.44 ppm (2S, (CH^C). NMR if 36 - (a): 25 3H at 9.30 ppm (S.e., NH3) - 1H at 8.55 ppm (D, J=9 Hz, CONH) “ 3H at 8.05 ppm (S.e., NH3) - 1H at 6.92 ppm (S, H thiazol) - 1H at 6.05 ppm (D of D, NMR n‘ 37 - (b): 35 8H between 6 and 9 ppm (wide signal, C02H, TFA, NH2)~ 1H at 8.50 ppm (D, J=9 Hz, CONH) - 1H at 6.90 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, J^=9 Hz, J2=4 Hz, H7) - 1H at 5.15 ppm (D, J=13 Hz, CH^OCO) - 1H at 5.0 ppm (D, J=4 Hz, H6) - 1H at 4.58 ppm (D, J=13 Hz, CH2OCO)1H at 3.9 ppm (D, J=17 Hz, CH2SO) - 1H at 3.54 ppm (D, J=17 HZ, CH2SO) - 2H at 2.6 ppm (M, CH2NH2) - 1H at 2.25 ppm (T, J=12 Hz, CH C02) - 4H at 1.84 ppm (M, CH^CHCO)6H at 1.45 ppm (S, (CH^C) - 3H at 1.25 ppm (M, CHCH2NH2 and CH2CHCH2NH2) - 2H at 0.95 ppm (M, CH2CHCH2NH2). NMR n‘ 38 - fb): 1H at 8.37 ppm (D, J=9 Hz, CONH) - 3H at 7.90 ppm (S.e., NH3) - 3H at 7.40 ppm (S.e., NH3) - 1H at 6.79 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, J3=9 Hz, J2=4 Hz, H7) - 1H at 5.11 ppm (2D, J=13 Hz, CH^OCO) * - 1H at 4.98 ppm (D, J=4 Hz, H6) - 1H at 4.61 ppm (2D, J=13 Hz, CH2OCO)* - 1H at 3.90 ppm (D, J=17 Hz, CH2SO) - 1H at 3."59 ppm (D, J=17 Hz, CHgSO) - 1H at 3.0 ppm (S.e., CHNH2) - 1H at 2.40 ppm (M, CHC02) - 1H at 2.10 ppm (M, CH2CHNH2) - 3H at 1.80 ppm (M, CH2CHNH2) - 6H at 1.44 ppm (2S, (CH3)2C) - 4H between 1 and 1.5 ppm (M, CH22CH^-CH-CO^ . 3_§..-_Cfel: 1H at 8.5 ppm (D, J=9 He, CONH) " 6H between 7 and 8 ppm (wide signal, NH2, TFA) - 1H at 6.81 ppm (S, H thiazol) - 1H at 6.0 ppm~(D of D, Jχ=9 Hz, J2≈4 Hz, NMR n° 40 - (a): 1H at 8.45 ppm (D, J=9 Hz, CONH) - 8H at 7.30 ppm (S.e., NHj, C02H) - 1H at 6.80 ppm S, H thiazol) - 1H at 6.0 ppm (M, H7) - 1H at 5.20 ppm (A of AB, Jab≈13 Hz' CHgOCO) - 1H at 4.90 ppm (B of AB, JAB=13 Hz, CH^OCO) 1H at 4.90 ppm (D, J=4 Hz, Hg) - 3H at 3.80 ppm (M, CH2SO, CHNH2) - 1H at 2.00 ppm (M, CH(CH3)2) - 6H at 1.45 ppm (S, (CH3)2C) - 6H at 0.95 ppm (2D, J=7 Hz, (CH3)2CH). NMR nα 41 - fa) : 5 2H at 8.50 ppm (S.e·, NHjg) - 1H at 8.45 ppm (D, J=9 Hz, CONH) - 3H at 7.30 ppm (S.e·, NH3) - 1H at 6.80 ppm (S, H thiazol) - 1H at 6.0 ppm (M, H7) - 1H at 5.15 ppm (A of AB, JAB=13Hz» CH2OCO) - 1H at 4.96 ppm (D, J=4 Hz, Hg) - 1H at 4.65 ppm (B of AB, 13 Hz, CH2OCO) - 1H at 10 3.90 ppm (A of AB, J=17 Hz, CH2SO) - 1H at 3.65 ppm (B of AB, J=17 HZ, CH^SO) - 2H at”3.00 ppm (M, CH_2NH) - 5H at 2.50 ppm (M, CH^NH, CH^CO^ - 6H at 1.42 ppm (S, (CH3)2C) . NMR n° 42 - faΐ; *+■ 4* 15 7H at 9.4 ppm (S.e·, NH3, NH2, C02H) - 1H at 8.45 ppm (D, J=9 Hz, CONH) - 1H "at 6.85 ppm (S, H thiazol) - 1H at 6.00 ppm (M, Hj) - 1H at 5.00 ppm (D, J=4 Hz, Hg) 1H at (A of AB, JAB=13 Hz, CH2OCO) - 1H at 4.65 ppm (B of AB, JAB=13 Hz, CH^OCO) - 1H at 3.85 ppm (A of AB, 20 JAB≈17 Hz, CHgSO) - 1H at 3.60 ppm (B of AB, JAB=17 Hz, CH^SO) - 4H at 2.85 ppm (M, CH2NHCH2) - 2H at 2.40 ppm (M, CHj| CO) - 2H at 1.80 ppm (M, CH2CH2CH2NH) - 6H at O 1.45 ppm (S, (CH3)2C) - 3H at 1.10 ppm (T, J=7 Hz, CH3 25 CH2NH). NMR-n.; 4,3 - (a) ; 2H at 8.50 ppm (S.e., NH2) - 1H at 8.40 ppm (D, J=9 Hz, CONH) - 3H at 7.00 ppm (S.e., NH3) - 1H at 6.76 ppm (S, H thiazol) - 1H at 5.95 ppm (M, "H7) - 1H at 5.10 ppm (A 30 of AB, JAB =13 Hz, CHjjOCÔ) - 1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.65 ppm (B of AB, JAB=13 Hz, CI^OCO) - 1H at 3.85 ppm (A of AB, JAB=17 Hz, CH2S0) - 1H at 3.50 ppm, B of AB, JAB=17 Hz, CH^SO) - 1H at 3.30 ppm (M, CHNH) “ 5H at 2.45 ppm (M, CH3NH and CHg CO) - 2H at 35 O 1.80 ppm (M, CH2CH2 CO) - 6H at 1.45 ppm (S, (CH3)2C) o 3H at 1.10 ppm (D, J=7 Hz, CH3CH). NMR n· 44 - 1H at 8.40 ppm (D, J=9 Hz, CONH) - 7H at 7.80 ppm (S.e., NH/j, NH2, C02H) - 1H at 6.80 ppm (S, H thiazol) - 1H at 5 6.00 ppm (M, Hy) - 1H at 5.00 (M, H6) - 1H at 5.00 ppm (A Of AB, Jab=13 Hz/ CH2OCO) - 1H at 4.65 ppm (B of AB, Jab=13 Hz, CH2OCO) - 1H at 3.85 ppm (A of AB, Jab=17 Hz' CH^SO) - 1H at 3.55 ppm (B of AB, JAB=17 NMR n· 45 - (b): 1H at 8.75 ppm (D, J=9 Hz, CONH) - 1H at 8.60 ppm (S.e., NH2) - 1H at 8.40 ppm (S.e., NH2) - 3H at 7.30 ppm 15 (sTe., NH^) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.91 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7) - 1H at 5.13 ppm (D, J=13 HZ, CH2OCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 1H at 4.61 ppm (D, J=13 Hz, CH2OCO) - 2H at 4.55 ppm (S, CHjjON) - 1H at 3.84 ppm (A of AB, Jab=17 NMR n1 46 - (b): 25 1H at 8.75 ppm (D, J=9 Hz, CONH) - 1H at 8.60 ppm (S.e., NH2) - 1H at 8.40 ppm (S.e., NH2) - 3H at 7.30 ppm (S.e., [3) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.94 ppm (D of D, J]_≈9 Hz, J2≈4 Hz, Hy) - 1H at 5.13 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.95 ppm (D, J≈4 Hz, Hg) - 1H 30 at 4.61 ppm (D, J=13 Hz, CH2OCO) - 1H at 3.90 ppm (A of AB, J=17 Hz, CHjSO) - 1H at"3.55 ppm (B of AB, J=17 Hz, CHjjSO) - 2H at 3.20 ppm (M, CH2 NH) - 2H at 2.90 ppm (M, CH2NH) - 1H at 2.64 ppm (M, Cfl) C02) - 4H at 2.40 ppm O 35 (M, CHg-I C02H) - 6H between 1.5 and 2 ppm CHj ^CH2 (CH2 /Kr CH2-CH2NH) . x ch2 co2h 5 NMR n· 47 - (to : 1H at 8.79 ppm (D, J=9 Hz, CONH) - 3H at 8.30 ppm (S.e., NH^) - 2H at 7.97 ppm (D, J=8 Hz, H ortho CO) - 2H at 7.55 ppm (D, J=8 Hz, H meta CO) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.84 ppm (S, H thiazol) - 1H at 5.92 ppm (D 10 of D, Ji=9 Hz, J2=4 Hz, H7) - 1H at 5.40 ppm (D, J=13 Hz, CIPgOCO) - 1H at 4.95 ppm (D, J=4 Hz, H5) - 1H at 4.84 ppm (D, J=13 Hz, CHgOCO) - 2H at 4.56 ppm (S, CHjON) - 1H at 4.08 ppm (M, CH2NH2) - 1H at 4.00 ppm (A of AB, Jab≈17 Hz' CH^SO) - 1H at 3.71 ppm (B of AB,15 JAB=17 Hz, CH2S0). NMR n° 48 - (b): 1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 8.30 ppm (S.e., Î1H3) - 2H at 7.95 ppm (D, J=8 Hz, H ortho CO) - 2H at 7.55 ppm (D, J=8 Hz, H meta CO) - 3H at 7.30 ppm (S.e., 20 NH3) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.95 ppm (D of" D, 0 1 2.40 ppm (M, CH2- c C02H) - 2H at 1.85 ppm CH2 CH2 O 30 (M, nch2 co2h NMR n· 49 - (bΐ: 1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.70 ppm (S.e., NH3) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.82 ppm (S, H 35 thiazol) - 1H at 5.90 ppm (D of D, - 1H at 5.10 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 1H at 4.56 ppm (D, J=13 Hz, CH2OCO)2H at 4.53 ppm (S, CH20N) - 1H at 3.84 ppm (A of AB, 44 5 NMR n· 50 - fbΐ: 10 (D, J==4 Hz, Hg) - 1H at 4.63 ppm (D, J=13 Hz, CH2OCO)15 CH2 20 1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.60 ppm (S.e., 25 CH2OCO) - 2H at 4.57 ppm (S, CH^ON) - 1H at 3.81 ppm (A 30 1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.70 ppm (S.e., Jab=17 Hz, CH2SO) - 1H at 3.55 ppm (B of AB, JAB=17 Hz, CH^SO) - 2H at 2.76 ppm (M, CH2NH2) - 2H at 2.40 ppm (M, CH^CC^) - 2H at 1.72 ppm (M, CH2CH2CH2NH2). NMR n· 50 - fbΐ: 1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.75 ppm (S.e., NH3) - 3H at 7.25 ppm (S.e., NH3) - 1H at 6.77 ppm (S, H thiazσl) - 1H at 5.94 ppm (D of D, Jj=9 Hz, J2=4 Hz, H7) - 1H at 5.11 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.95 ppm (D, J==4 Hz, Hg) - 1H at 4.63 ppm (D, J=13 Hz, CH2OCO)1H at 3.89 ppm (A of AB, J=17 Hz, CH2SO) - 1H at 3.55 ppm (B of AB, J≈17 Hz, CH^SO) - 2H atH.78 ppm (M, O CH2NH2) - 6H at 2.40 ppm (M, CH2 -4 C02H, CH2C02) - 4H 4H at 1.85 ppm (M, CH2CH2NH2, CH2 ). CH2 ch2 ch2 COoH COoH ). NMR n" 51 - 1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.60 ppm (S.e., NH3) -− 3H at 7.30 ppm (S.e., NKh|) - 1H at 6.82 ppm (S, H thiazol) - 1H at 5.87 ppm (D of D, Jx=9 Hz, J2=4 Hz, Hj) - 1H at 5.61 ppm (D, J=13 Hz, CHgOCO) - 1H at 4.92 ppm (D, J=4 Hz, H^) - 1H at 4.58 ppm (D, J=13 Hz, CH2OCO) - 2H at 4.57 ppm (S, CH^ON) - 1H at 3.81 ppm (A of AB, J≈13 Hz, CH2S0) - 1H at 3.55 ppm (B of AB, J=13 Hz, CHgSO) - 2H at 2.75 ppm (M, CH^NH;j) - 2H at 2.31 ppm (M, CH2CO2) - 4H at 1.50 ppm (M, CH^(CH2)2CH2N)· 1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.70 ppm (S.e., NH3) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.92 ppm (D of D, - 1H at 5.13 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 1H at 4.58 ppm (D, J=13 Hz, CH2OCO) 1H at 3.86 ppm (A of AB, J≈17 Hz, CH^SO) - 1H at 3.55 ppm (B of AB, J=17 HZ, CH2SO) - 2H at 2.74 ppm (M, 35 1H at 3.86 ppm (A of AB, J≈17 Hz, CH^SO) - 1H at 3.55 5 10 15 20 25 30 35 CH2NH2) - 6H at 2.40 ppm (M, CH2 C02 + CH2-j C02H) “ CH2 / ch2 o 2H at 1.85 ppm (M, CH2 />^ ) - 4H at 1.50 ppm (M, CH2 co2h ch2ch2ch2co2). NMR n° 53 - fbΐ: 1H at 8.80 ppm (D, J=9 Hz, CONH) - 3H at 8.40 ppm (S.e., NH3) - 3H at 7.40 ppm (S.e., NH3) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.95 ppm (D ofD, Jx=9 Hz, J2=4 Hz, H7) - 1H at 5.25 ppm (D, J=13 Hz, CHgOCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 1H at 4.78 ppm (D, J=13 Hz, CH2OCO) ~ 1H at 4.08 ppm (M, CHNH2) - 1H at 3.95 ppm (A "of AB, J=17 HZ, CH2SO) - 1H at 3.60 ppm (B of AB, J=17 Hz, O CH2SO) - 4H at 2.40 ppm (M, CHa -j C02H) - 2H at 1.80 ' CH2 ch2 o ppm (M, CHg ) - 3H at 1.36 ppm (D, J≈7 Hz,nch2 co2h CH3CH). NMR Π * ■■ ■5 4 - (M: 1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.87 ppm (S.e., NHg) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.95 ppm (D of D, Hz, J2≈4 Hz, Hy) - 1H at 5.19 ppm (2D, J=>13 Hz, CH^OCO) * - 1H at 4.95 ppm (D, J=>4 Hz, H6) - 1H at 4.64 ppm (2D, J=13 Hz, CHgOCO) * - 1H at 3.92 ppm (A of AB, J=17 Hz, CH2SO) - 1H at 3.55 ppm (B of AB, J≈17 Hz, CH2SO) - 1H at 3.0 ppm (M, CHC02) - 2H at 2.80 ppm (M, CH2NH2) - 4H at 2.40 ppm (M, 0 0 CIÎ2-|C02h) "2H at 1·80 PPm (M, CH2 ) C02H 3H at 1.08 ppm (D, J=7 Hz, CH^CH). NMR n° 55 - (bï: 1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.80 ppm (S.e., NHjj) - 3H at 7.30 ppm (S.e., NH^) - 1H at 6.80 ppm (S, H 5 thiazol) - 1H at 5.95 ppm (M, H7) - 1H at 5.20 ppm (D, J=13 Hz, CHpOCO) - 1H at 4.95 ppm (S.e., H6) - 1H at 4.63 pprn (D, J=13 Hz, CH2OCO) - 1H at 3.90 ppm (A of AB, J=17 Hz, CH^SO) - 1H at 3.58 ppm (B of AB, J=17 Hz, CH2SO) 2H at 2.93 ppm (M, CH2NH2) - 4H at 2.40 ppm (M, 10 0 O CH2 j C02H) - 2H at 1.90 ppm (M, CH2 1 C02H) CH_2 CHj - CH2 -6H at 1.14 ppm (S, (CH3)2C). NMR n° 56 - (bl: 15 1H at 8.75 ppm (D, J=9 HZ, CONH) - 3H at 7.75 ppm (S.e., NH3) - 3H at 7.35 ppm (S.e., NH3) - 1H at 6.80 ppm (S, H thiazol) - 1H at 5.95 ppm (D of D, Jx=9 Hz, J2=4 Hz, H7) - 1H at 5.15 ppm (2D, J=13 Hz, CH^OCO)* - 1H at 4.95 ppm (D, J=4 Hz, H6) - 1H at 4.60 ppm (2D, J=13 Hz, CH2OCO) * 20 - 1H at 3.90 ppm (A of AB, J=17 Hz, CH2S0) - 1H at 3.56 ppm (B of AB, J=17 Hz, CH2SO) - 2H at 2.74 ppm (M, CH^NH;j) - 1H at 2.50 (M, CHC02) - 4H at 2.40 ppm (M, O O CH2-I C02H) - 3H at 1.90 ppm (M, CH2 I-C02H and 25 CH2 CH-2 · CH2 CH3CH2NH2) - 1H at 1.55 ppm (M, CH2CH2NH2) - 3H at 1.08 ppm (D, J=>7 Hz, CH3CH) . m-n:.-S.7,_r- 1H at 8.80 ppm (D, H≈9 Hz, CONH) - 3H at 8.40 ppm (S.e., 30 NH3) - 3H at 7.40 ppm (sie., NH^) - 1H at 6.79 ppm (S H thiazol) - 1H at 5.95 ppm (D of D, Hz, J2=4 Hz, Hj) - 1H at 5.28 ppm (D, J=13 Hz, CHgOCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 1H at 4.75 ppm (D, J=13 Hz, CH2OCO)1H at 3.95 ppm (A of AB, J=17 Hz, CH^SO) - 1H at 3.61 35 ppm (B of AB, J=17 Hz, CHgSO) - 4H at 2.40 ppm (M, Ch2-| C02H) - 2H at 2.10 ppm (M, CH2 cyclopentane)~ GH2 O 2H at 1.90 (M, CH2 |\ ) - 6H at 1.80 ppm (M, CHg ch2 ch2 ~ cyclopentane). NMR n° 58 - fb\ : 1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 2.70 ppm (S.e., ÜHj) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.84 ppm (S, H thiazol) - 1H at 5.89 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7) - 1H at 5.13 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 3H at 4.55 ppm (M, CH2ON and CH20C0) - 1H at 3.82 ppm (A of AB, J=17 Hz, CH2SO) - 1H at 3.55 ppm (B of AB, J=17 Hz, CH2SO) - 2H at 2.60 ppm (M, CH2NH2) - 1H at 2.21 ppm (M, CH C02) - 4H at 1.80 ppm, (M, CH2 cyclohexane) - 1H at 1.45 ppm (M, CHCH2NH2) - 2H at 1.25 ppm (M, CH2 cyclohexane) - 2H at 0.90 ppm (M, CH2 cyclohexane). NMR n° 59 - (bΐ; 1H at 8.67 ppm (D, J≈9 Hz, CONH) - 3H at 7.70 ppm (S.e., ΐfHg) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.82 ppm (S, H thiazol) - 1H at 5.94 ppm (D of D, Jx=9 Hz, J2≈4 Hz, Hy) - 1H at 5.13 ppm (D, J=13 Hz, CHgOCO) - 1H at 4.95 ppm (D, J=4 Hz, H6) - 1H at 4.56 ppm (D, J=13 Hz, CH2OCO)1H at 3.87 ppm (A Of AB, J≈17 Hz, CH2SO) - 2H at 3.55 ppm (B of AB, J≈17 Hz, CHjjSO) - 2H at 2.60 ppm (M, CH2NH2) - 5H between 2.0 and 2.5 ppm, 6H between 1.6 and 2.0 ppm, 3H at 1.1 and 1.6 ppm, 2H at 0.90 ppm (M, CH2 X co2h and u CH,CH, - \ rH2 XX"- CH2CH2 NMR na 60 -fb>: CONH)* - 3H at 7.70 ppm 1H at 6.82 ppm (2S, H thiazol)* - 1H at 5.95 ppm (D of D, (S.e, NH3) - 3H at 7.30 ppm (S.e., NH3) 5 10 15 20 25 30 35 Hz, H7) - 1H at 5.13 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.95 ppm (2D, Hg)* - 2H at 4.60 ppm (M, CH2OCO + CHON)1H at 3.86 ppm (2D, J=17 Hz, CH^SO)* - 1H at 3.56 ppm (2D, J=17 Hz, CHgSO)* ■- 2H at 2.75 ppm (M, CH2NH2) - 2H at 2.40 ppm (T, J=7 Hz, CH2C02) - 2H at 1.75 ppm (M, CH2CH2CH2NH2) - 3H at 1.39 ppm (D, J==7 Hz, CH3CH) . NMR n· 61 - fbï: ~ 1H at 8.70 ppm (2D, J=9 Hz, CONH)* - 3H at 7.70 ppm (S.e., NH3) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.82 ppm (2S, H thiazol)* - 1H at 5.95 ppm (D of D, Ji=9 Hz, J2≈4 Hz, H7) - 1H at 5.12 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.94 ppm (2D, Hg)* - 2H at 4.60 ppm (M, HCON, and CH2OCO) - 1H at 3.86 ppm (A of AB, J=17 Hz, CÎ^SO) - 1H at 3.55 ppm (B of AB, J=17 Hz, CH2SO) - 2H at 2.75 ppm (M, CH2NH2) - 2H at 2.31 ppm (M,~CH2C02) - 4H at 1.50 ppm (M, CH2CH2CH2CH2NH2) - 3H at 1.45 ppm (D, J=7 Hz, CH^CH). NMR n" 62 - (bï: 2H at 8.60 ppm (M, CONH, NH3) - 1H at 8.40 ppm (S.e., NHj*) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.82 ppm (2S, H thiazol)* - 1H at 5.95 ppm (D of D, Jx≈9 Hz, J2=4 Hz, H7) - 1H at 5.14 ppm (D, J≈13 Hz, CHgOCO) - 1H at 4.95 ppm (2D, Hg)* - 2H at 4.60 ppm (M, CH-ON, and CH2OCO)1H at 3.88~ ppm (2D, J=17 Hz, CH2SO) - 1H at 3/55 ppm (D, J=17 Hz, CHgSO) - 2H at 3.20 ppm and 2H at 2.95 ppm (M, CH2NH ) - 1H at 2.66 ppm (M, CHC02) - 2H at 1.95 ppm CH2_ and 2H at 1.70 ppm CHg (M, 02C 3H at 1.45 ppm (D, J≈7 Hz, CH^CH). NMR n° 63 - : 1H at 8.70 ppm (2D, J=9 Hz, CONH)* - 3H at 8.20 ppm (S.e., NIPj) - 2H at 7.95 ppm (D, J= Hz, H ortho C02)2H at 7.55 ppm (D, J=8 Hz, H meta C02) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.82 ppm (2S, H thiazol)* - 1H at 5.95 ppm °f NMR n° 64 - fb): 1H at 8.60 ppm (2D, J=9 Hz, CONH)* - 3H at 7.70 ppm (S.e·, NH3) - 1H at 6.80 ppm (2S, H thiazol)* -■ 1H at 10 5.95 ppm (D of D, J3=9 Hz, J2=4 Hz, H7) - 5H between 4 and 6 ppm (S.e., NH3 C02H) - 1H at 5.13 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.95 ppm (2D, Hg) * - 2H at 4.60 ppm (M, CHgOCO and CHON) - 1H at 3.86 ppm (A of AB, J=17 Hz, CHgSO) - 1H at 3.55 ppm (B Of AB, J=17 Hz, CH2SO) - 2H 15 at 2.61 ppm (M, CH2NH2) - 1H at 2.21 ppm (M, CHC02) - 4H at 1.80 ppm (M,\ Hz, CH3CH) - 2H at 1.25 ppm and 2H at 0.90 ppm NMR n° 67 - (bl; 3H at 8.50 ppm (M, N%2 and CO NH) - 2H at 7.50 ppm 10 (Se., NH2 thiazol) - 1H at 6.79 ppm (S, H thiazol) - 1H at 5.99 ppm (D of D, J3 ≈ 9 Hz, J2 = 4 Hz, H7) - 1H at 5.16ppm (2D, J = 13 Hz, CH2 O CO) - 1H at 4.95 ppm (D, J = 4 Hz Hg) - 1H at 4.66 ppm (D, J = 13 Hz, O CO) - 1H at 3.92 ppm (D, J = 17 Hz, CH2 SO) - 1H at 3.58 ppm (D, 15 J = 17 Hz, CH2 so) - 1H at 3.36 ppm (M, Cî^T H2) - 1H at 3.25 ppm (M, CH2 Ï®H2) - 1H at 2.95 ppm (M, CH2cX 1$H2) - 2H at 2.60 ppm (2D superposed CH2 C02) - 3H at 1.70 ppm (M, H piperidine) - 6H at 1.48 ppm (2S (CH3)2 C) 3H at 1.45 ppm (M, H piperidine). 20 NMR n° 68 - fbl: 1H at 8.60 ppm (Se., N®k2 piperidine) - 1H at 8.45 ppm (Se., NH^jp piperidine) - 1H at 8.45 ppm (D, J = 9 Hz, CO NH) - 1H at 7.50 ppm (Se., NH2 thiazol) - 1H at 6.70 ppm (S, H thiazol) - 1H at 5.97 ppm (D of D, Jx = 9 Hz, J2 = 25 4 Hz, H7) - 1H at 5.10 ppm (D, J ≈ 13 Hz, CH2 O CO) - 1H at 4.97 ppm (D, J =■ 4 Hz, Hg) - 1H at 4.63~ppm (D, J = 13 HZ, CH2 o CO) - 1H at 3.90 ppm (D, J = 17 Hz, CH2 SO) - 1H at 3T57 ppm (D, J ≈ 17 Hz, CHg SO) - 2H at 3.20 ppm (M, CHj (X *®H2) "2H at 2·70 PPm (M, CH2o4 N®^2) "2H at 30 2.30 ppm (D, J ≈ 7 Hz, CH2 C02) - 1H at 2.05 ppm (M, CH CH2 C02) - 3H at 1.55 ppm (M, CH2 piperidine) - 6H at lT48 ppm (2 S, (CH3)2 C) - 1H at 1.20 ppm (M, CH2 piperidine). NMR n' 69 - (bl; 35 1H at 10.9 ppm (Se., Ar NH CO) - 1H at 8.45 ppm (D, J = 9 Hz, CO NH) - 4H at 8.15 ppm (2 S, CH2 and CH2 SO) - 6H at 1.47 ppm (2 S, (CH3)2 C). 10 NMR n1 70 - ; 1H at 8.70 ppm (D, J = 9 Hz, CO NH) - 3H at 8.50 ppm (Se., CH2~Î^H3) - 1H at 8.05 ppm (S, H Ar NMR n* 71 - (bΐ; 1H at 8.70 ppm (D, J ≈ 9 Hz, CO NH) - 9H at 8.50 ppm (Sθ·, CH2 ï$H3) - 2H at 7.78 ppm (M, B Ar 2', 6') - 1H at 7.50 ppm (D, J ≈ 7 Hz, H Ar 5') - 1H at 6.92 ppm (S, 25 H thiazol) - 1H at 6.00 ppm (D of D, Jx ≈ 9 Hz, J2 = 4 Hz, H7) - 1H of 5.45 ppm (D, J ≈ 13 HZ, CH2 O CO) - 1H of 5.00 ppm (D, J = 4 Hz, Hg) - 1H at 4.81 ppm (D, J =13 Hz, CH2 0 CO) - 3H at 4.05 ppm (M, Ar CH2 Ï$H3 CHg SO)1H at 3.75 ppm (D, J ≈ 17 Hz, CHg SO) ~ 3H at 2.36 ppm 30 (S, CHg Ar) - 6H at 1.47 ppm (2 S, (CH3)2 C). NMR n° 72 - ; ~ 1H at 8.70 ppm (D, J = 9 Hz, CO NH) - 2H at 7.95 ppm (D, J ≈ 8 Hz, H Ar 2', 6') - 2H at 7.67 ppm (D, J = 8 Hz, H Ar 3', 5') - 1H at 6.95 ppm (S, H thiazol) - 1H at 6.00 35 ppm (D of D, Jx = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.45 ppm (D, J = 13 Hz, CHg 0 CO) - 1H at 5.00 ppm (D, J = 4 Hz, H6) - 1H at 4.82 ppm (D, J = 13 Hz, CH2 O CO) - 2H at 4.16ppm (M, Ar CH2 NHCH3) - 1H at 4.08 ppm (D, J = 17 Hz, CH2 SO) - 1H at 3.78 ppm (D, J = 17 Hz, CH2 SO) 3H at 2.43 ppm (S, CH3 N) - 6H at 1.48 ppm (2 S, (CH3)2 C) . 5 NMR n° 73 - fb): 1H at 8.70 ppm (D, J = 9 Hz, CO NH) - 2H at 7.95 ppm (D, J = 8 Hz, H Ar 2', 6') - 2H at 7.67 ppm (D, J = 8 Hz, H Ar 3', 5') - 1H at 6.92 ppm (S, H thiazol) - 1H at 6.00 ppm (D of D, J·L = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.43 ppm 10 (D, J = 13 HZ, CH2 O CO) - 1H at 5.00 ppm (D, J = 4 Hz, H6) - 1H at 4.82 ppm (D, J = 13 Hz, CH2 O CO) - 2H at 4.18 ppm (M, CH^ Ar) - 1H at 4.10 ppm (d7 J = 17 Hz, CHg SO) - 1H at 3.76 ppm (D, J = 17 Hz, CH2 SO) - 2H at 2.90 ppm (M, CH3 CH^ NH) - 6H at 1.47 ppm (2 S, (CH3)2 C)15 3H at 1.16 ppm (T, J = 7 Hz, CH3 CH2). ~ NMR n* 74 - fbΐ: 1H at 8.70 ppm (D, J = 9 Hz, CO NH) - 2H at 7.95 ppm (D, J = 8 Hz, H Ar 2', 6') - 2H at 7.67 ppm (D, J = 8 Hz, H Ar 3', 5') - 1H at 6.95 ppm (S, H thiazol) - 1H at 6.00 20 ppm (D of D, = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.45 ppm (D, J = 13 Hz, CHg O CO) - 1H at 5.00 ppm (D, J = 4 Hz, Hg) - 1H at 4.82 ppm (D, J ≈ 14 Hz, CH2 O CO) - 2H at 4.16ppm (M, Ar CH2 N Pr) - 1H at 4.08~ ppm (D, J = 17 Hz, CH2 SO) - 1H at” 3.78 ppm (D, J ≈ 17 Hz, CH2 SO) 25 1H at 3.20 ppm (M, NH-CJJ (CH3)2) - 6H at 1.41 ppm (2S, (CH3)2 C) - 6H at 1.26 ppm (57 J = 7 Hz, (CH3)2 CH). NMR~n° 75 r (b) : 1H at 8.62 ppm (D, J ≈ 9 Hz, CO NH) - 3H at 8.10 ppm (Sa., CH2 t®K3) - 1H at 7.68 ppm (D, J = 7 Hz, H Ar 6') 30 - 1H at 7.55 ppm (D, J ≈ 7 Hz, H Ar 4') - 1H at 7.34 ppm (T, J ≈ 7 Hz, H Ar 5#) - 1H at 6.92 ppm (S, H thiazol)1H at 6.00 ppm (D of D, ≈ 9 Hz, J2 = 4 Hz, H7) - 1H at 5.37 ppm (D, J ≈ 13 Hz, CH2 0 CO) - 1H at 5.00 ppm (D, J = 4 Hz, H6) - 1H at 4.84 ppm (D, J = 13 Hz, CH2 O 35 CO) - 3H at 4.10 ppm (M, CH2 *Aï3 et CH2 SO) - 1H at 3.75 ppm (D, J = 17 Hz, CH2 SO) - 3H at 2.40 ppm (S, CH3 Ar) - 6H at 1.47 ppm (2S, TcH3)2 C). NMR n° 76 - (b3: 1H at 8.62 ppm (D, J = 9 Hz, CO NH) - 3H at 8.00 ppm (Se., CH2 - 1H at 7.31 ppm (D, J ≈ 7 Hz, H Ar 4') 5 - 1H at 7.14 ppm (D, J ≈ 7 Hz, H Ar 5') - 1H at 6.90 ppm (S, H thiazol) - 1H at 6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, Hy) - 1H at 5.27 ppm (D, J = 13 Hz, CH2 O CO) - 1H at 5.00 ppm (D, J = 4 Hz, H6) - 1H at 4.92 ppm (D, J = 13 Hz, CH2 O CO) ~ 3H at 4.00 ppm (M, CH2 lfàï3 et CH2 10 SO) - 1H at 3.64 ppm (D, J = 17 Hz, CH2 SO) - 6H at 2.18 ppm (S, CH3 - Ar) - 6H at 1.48 ppm (2 S, (CH3)2 C). NMR n° 77 (b3: 1H at 8.65 ppm (D, J = 9 Hz, CO NH) - 3H at 7.90 ppm (Se. , CH2 îAî^) - 1H at 7.00 ppm (S, H Ar) - 1H at 6.90 15 ppm (S, H thiazol) - 1H at 6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.25 ppm (D, J = 13 Hz, CH2 O CO) - 1H at 5.00 ppm (D, J - 4 Hz, Hg) - 1H at 4.92 ppm (D, J = 13 Hz, CH2 O CO) - 3H at 4.00 ppm (M, Ar CH2 *Φh3 and CH2 SO) - 1H at 3.65 ppm (D, J = 17 Hz, CH2 SO) - 3H 20 at 2.31 ppm (S, CH3 Ar) - 3H at 2.25 ppm (sT CH3 Ar)3H at 2.14 ppm (S, CH3 Ar) 6H at 1.45 ppm (2S, (CH3)2 C) . “ 7.8_,.r_(.b,).: 1H at 8.70 ppm (D, J =< 9 Hz, CO NH) - 3H at 8.00 ppm 25 (Se., CH2 N+H3) - 1H at 7.45 ppm (D, J ≈ 7 Hz, H Ar 4') - 2H at 6.92 ppm (M, H thiazol and g Ar 5') - 1H at 6.00 ppm (D of D, NMK n° 79 - (b) : 1H at8.62 ppm (D, J = 9 Hz, CO NH) - 5H at8,00 ppm (M, CH^ i^r^and H Ar 2', 6')1H at 7.20 ppm (D, J = 7 Hz, H Ar 51) - 1H at6.95 ppm (S, H thiazol ) - 1H at 6,00 ppm (D of D, Jj = 9 Hz, J2 = 4 Hz, H?) - l·H at 5.45 ppm (0, J = 13 Hz 5 CH2 0 CO) - 1H at 5 00 ppm (D, J = 4 Hz, Hg) - lHat4.82 ppm (D, J =» 13 Hz, CH2 0 CO) - 3H at 4.00 ppm (M, CH2 N^and CH2 SO) - 3H at 3 .88 ppm (S, 0 CH3) 1H at3.72 ppm (D, J = 17 Hz, CH2 SO) - 3Hat 1.48 ppm (S, (CH3)2 C) - 3H at 1.47 ppm (S, (CH^)2 C) NMR n° 80 - (B) : 10 1H at 8.66 ppm (D, J = 9 Hz, CO NH) - 3H ats.05 ppm (Se., CH2 N®H3) - 3H at 7,50 ppm (M, ji Ar) - 1H at 6.95 ppm (S, H thiazol) - 1H at 6,00 ppm (D of D = 9 Hz, J2 = 4 Hz, H?) - 1H at5.45 ppm (D, J = 13 Hz, CH2 0 CO) 1H atδ.OO ppm (D, J = 4 Hz, Hg) - lHat 4.84 ppm (D, J ≈ 13 Hz, CH2 0 CO) 3H at4.00 ppm (M, CH2 et CH2 SO) - 3H at3,86 ppm (S, CH30 - Ar) ~ IS 1H at3.75 ppm (D, J = 17 Hz, Cli, SO) - 3H at 1,48 ppm (S, (CH3)2 C) - 3H at 1.47 ppm (S, (CH3)2 C) 20 25 NMR n° 81 - (b) : 1H at 8.82 ppm (D, J ≈ 9 Hz, CO NH) - 3H at 8.20 ppm (Se., CH℮ N^3) - 1H at 8.13 ppm (Se., H Ar 2') - 1H at7.95 ppm (D, 0 = 7 Hz, H Ar 6') - 1H at7.69 ppm (D, J = 7 Hz, H Ar 4') - 1H at 7.55 ppm. (T, J = 7 Hz, H Ar 5') 1H at 6.95 ppm (S, H_ thiazol) - 1H à 6.00 ppm (D of D, ≈ 9 Hz, J2 = 4 Hz, Hy) - 1H at 5.48 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at 5.00 ppm (D, J = 4 Hz, Hg) 1H at 4.86 ppm (D, J = 13 Hz, CH℮ 0 CO) - 3Hat4.05 ppm (M, CH2 N®H3 and CH2 SO) - 1H at 3.75 ppm (D, 0 ≈ 17 Hz, CH2 SO) - 4H at 2.40 ppm • CH, (M, CH; ■ 0) cΐn 2H at 1.90 ppm (M, t-j 0) CO 10 15 20 1H at 8.82 ppm (D, J = 9 Hz, CO NJJ) - 3Hat8.20 ppm (Se., CH2 ^3) - 2H at 7.80 ppm (M, H Ar 2' , 6') - lHat 7.45ppm (D, J ≈ 7 Hz, H Ar 5') - 1H at 6.92 ppm (S, H thiazol) - 1H à 5.97 ppm (D of D, J1 = 9 Hz, J2 = 4 Hz, H?) - 1H at 5.45 ppm (0, J ≈ 13 Hz, CH2 0 CO) - 1H at 5.00 ppm (D, J = 4 Hz, Hg) 1H at 4 .82 ppm (D, J = 13 Hz, CH2 0 CO) - 3Hat 4.05 ppm (M, CH2 fF^and CH2 SO) - |-CH2 1H at3.75 ppm (0, J = 17 Hz, CH2 SO) - 4H at2·40 ppm (M, CH2-j-- 0) " “ “CO ch2- 3H at2 .34 ppm (S, CH^ Ar) - 2H at 1,90 ppm (M, t 0) “ CO NMRΠ° 83 - (b) : 1H at8.97 ppm (D, 0 ≈ 9 Hz, CO NH) - 2Hat 8.79 ppm (Se., CH2 N^2) - 2H atδ.OO ppm (D, J = 8 Hz, JJ.Ar 2' , 5') - 2Hat 7.58 ppm (D, J = 8 Hz, JH Ar 3', 5') - 1H at6 95 ppm (S, JJ thiazol) - lHat 5.97 ppm (D of D, J1 = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.45 ppm (D, J ≈ 13 Hz, CH2 0 CO) - 1H atδ.OO ppm (D, J = 4 Hz, Hg) - lHat 4.84 ppm (0, J = 13 Hz, CH2 0 CO) - 2H at 4,19 ppm' (M, CH2 CH, 4H at 2.40 ppm (M, CHg ■ NMRn0 84 (b) : 0) - '2Hat 1.90 ppm (M, Cl-L- .0) CO CO 25 1Hat 10.7 ppm (S, CO NH Ar) - 1H atδ.60 ppm (D, J = 9 Hz, CO NJJ) - 1H at 8.20 ppm (S, H Ar 2') - 1H at 7.80 ppm (D,J≈8Hz,HAr6')~ 3 “ 3H at 7.65 ppm (Se., CH2 N+H ) - 1H at7.60 ppm (D, J = 8 Hz, JJ Ar 41) - lHat 7.45 ppm (T, J = 8 Hz, JJ Ar 51) - 1H at℮.92 ppm (S, JJ thiazol) - lHat 6,00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H?) - lHat 5.45 ppm (D, J = 13 Hz, 30 CH2 0 CO) - lHat 5,00 ppm (D, J = 4 Hz, Hg) - lHat 4.84 ppm (0, J = 13 Hz, CH2 0 CO) - 1H at 4.00 ppm (D, J = 17 Hz, CH2 SO) - lHat 3.75 ppm (D, J = 17 Hz, CH2 SO) - 2H at 3.05 ppm (Q, J = 7 Hz, CH2 CH2 N^3) - 2Hat2.70 ppm (T, J = 7 Hz, CH2 CH2 f^H3) - 6H at 1,47 ppm (2 S, (CH3)2 C) S 1H at 4.98 ppm (D, J ≈ 4 Hz, Hg) - 1H at 4.78ppm (D, J = 13 Hz, CH2 0 CO) - 10 3H at 8.07 ppm (Se., CH2 I'ftg) - 2Hat 7.94 ppm (0, J = 8 Hz, H Ar 2' 6') - 15 and CHg ^H3) - 6H at 1.48 ppm (2 S, (CH3)2 C) 20 25 5H at 1,85 ppm (M, 3H^ of the piperidine εnd 0) - 30 3H at 1.45 nnm (M, 3H piperidine) 5 10 IS 20 25 îJMR ∩° 88 - (b) : lHat 8,80 ppm (D, J = 9 Hz, CO N_H) - 1H at 8.60 ppm (Se., ΐ^l2 P “· pé>”i dine) 1H at 8.45 ppm (Se., I^2 piperidine) - 2Hat7.25 ppm (Se., NH2 thiazol ) 1H at 6,79 ppm (S, H thiazol) - 1H at 6.00 ppm (Dot D, = 9 Hz, J2 ≈ 4 Hz, Hy) - 1H at 5.16 ppm (D, J = 13 Hz, CH2 0 CO) - lHat 5.00 ppm (D, J = 4 Hz, Hg) - 1H at 4.69 ppm (D, 0 = 13 Hz, CH2 0 CO) - lHat 3.90 ppm (D, J = 17 Hz, CH2 SO) - 1H at3.60 ppm (D, J * 17 Hz, CH2 SO) - 2Hat 3.24 ppm (M, CH2 in of ΐ^2 piperidine) - 2H at2.70 ppm (M, CH2 in o< of piperidine) - 6Hat 2,40 ppm (M, CH2-ΐ-- 0 and CH2 C00) - 6Hbetweenl.5 and 2.2 ppm ” CO ■ ~ CH2-. (M, t- 0 , CHI CHg C02 , 3H piperidine) - lHat 1.20 ppm (M, H piperidine) CO NMR n° 89 - (b) : lHat 8.80 ppm (D, J = 9 Hz, CO NH) - 2H at 8.30 ppm (2 Se., NH®piperidine) 2H at 7,40 ppm (Se., NHg thiazol ) - 1H at6,78 ppm (S, H thiazol ) - lHat 5.92 ppm (D of 0, Jj = 9 Hz, J2 = 4 Hz, H?) - lHat 5.14 ppm (D, J = 13 Hz, CH2 0 CO) - lHat 4,96 ppm (D, J = 4 Hz, Hg) - lHat 4.60 ppm (D, J = 13 Hz, CH2 0 CO) - lHat 3.89 ppm (D, J = 17 Hz, CHg SO) - lHat 3.58.ppm (D, 0 = 17 Hz, CH2 SO) - 2H at 3,18 ppm (M, H N®k2 piperidine) - 2H at 2.81 ppm (M, H «< CH N H2 piperidine) - 4Hat 2.40 ppm (M, CH2- 0) - 2H at 2.28 ppm (0, J = 7 Hz, CO CH. CH2 CO - 0) - 5Hat 1.90 ppm (M, ΐl 0, CH CH2 COO, 2H β piperidine) CO 2H at 1.30 ppm (M, 2H piperidine) 1H at8 .45 ppm (D, J = 9 Hz, CO NH) - 1H at 8,50 ppm (Se., NH? piperidine) - , © - lHat8,20 ppm (Se., piperidine) - 2H at 7.30 ppm (Se., NH2 thiazol ) - 1H atδ.77 ppm (S, H thiazol ) - 1H 5.95 ppm (D of 0, J1 = 9 Hz, J2 = 4 Hz, 5 H?) - 1Hat 5.11 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at4.95 ppm (D, J = 4 Hz, Hg) - 1Hat 4.51 ppm (D, J = 13 Hz, CH2 0 CO) - lHat 3.89 ppm (D, J = 17 Hz, CH2 SO) - 1H at 3.58 ppm (D, J = 17 Hz, CH2 SO) - 2Hat 3.21 ppm (M, CHgancKX N^2 piperidine) - 2Hat2.81 ppm (M, CH2 in lf®H2 piperidine) - 2Hat 2.27 ppm (D, 0 = 7 Hz, CH2 COO) - lHat 1.95ppm (M, CH CH2 COO) - 2H at 1.75 ppm 10 (M, CH2 2H at 1,40 ppm (M, CH2 NMR n° 91 - (b) : 2H at 8.70 ppm (Se., CHgl^CH-j") - 1H at 8.50 ppm (D, J = 9 Hz, CONH) - 1H at 8.10 ppm (Se., H Ar 2 ' ) - 1H at 7.96 ppm (D, J = 8 Hz, Ji ar 6' ) - 15 1H at7.75 ppm (D, J ≈ 8 Hz, H Ar 4' ) - 1H at 7.56 ppm (T, J = 8 Hz, H ar 5') 1H at6,92 ppm (S, H thiazol ) - 1H cit6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H?) - lHat 5.45 ppm (0, ϋ ≈ 13 Hz, CH2 0 CO) - lHats.oo ppm (D, J = 4 Hz, Hg) 1H at4.87 ppm (D, J = 13 Hz, CH2 0 CO) - 2H at 4.16 ppm (M, Ar CHgAgCHg) 1H at4.05 ppm (D, J = 17 Hz, CHg 'SO) - lHat 3.75 ppm (D, J = 17 Hz, CH2 SO) 20 3H at 2.50 ppm (M, CH3 N^2 CH℮) - 6H at 1.45 ppm (2 S, (CH3)2 C) NMR n° 92 - (b) : 2H at8.70 ppm (Se., CHg ^ CH2CH3) - 1H at8.60 ppm (0, J = 9 Hz, CO NH) 1H atδ.10 ppm (Se., H Ar 2') - 1H at7.96 ppm (D, J = 8 Hz, H Ar 6') - 1H at 7,75 ppm (D, J = 8 Hz, H Ar 4') - 1H at7.56 ppm (T, J = 8 Hz, H Ar 5’) 25 1H at 6,92 ppm (S, H_ thiazol ) - lHat 5.02 ppm (D of D, = 9 Hz, J2 ≈ 4 Hz, Hy) lHat 5.45 ppm (0, J * 13 Hz, CH2 0 CO) -‘lHat 5.00 ppm (D, J = 4 Hz, Hg) lHat 4.87 ppm (0, J = 13 Hz, CH2 0 CO) - 2H at 4.17 ppm (Se., Ar, CH2 Et) 1H at4.05 ppm (D, J = 17 Hz, CH2 SO) - 1H at3.75 ppm (D, J » 17 Hz, CH2 SO) 2H at2.95 ppm (M, CH3CH2 l^2) - 6H atl.45 ppm (2 S, (CH3)2 C) - .30 3H at 1.15 ppm (T, J ≈ 7 Hz, CH^rPk,) NMR n° 93 (b) ; 1H at8.75 ppm (D, J ≈ 9 Hz, CO NH) - 2H ate.70 ppm (Se., CH2 ^-i Pr) 1H at8.10 ppm (Se., H Ar 2') - 7.95 ppm (D, J = 8 Hz, 1Hat7.75 ppm (D, J = 8 Hz, H_ Ar 4') - lHat 7.58 ppm (T, J = 8 Hz, _H Ar 5 5' ) - 1H at7.00 ppm (S, H thiazol ) - lHat 6.00 ppm (D of D, Jχ= 9 Hz, J2 = 4 Hz, H7) - 1H at 5.46 ppm (D, J = 13 Hz, CH2 0 CO) - lHatδ.OO ppm (D, 0 = 4 Hz, Hg) - lHat4.87 ppm (D, J = 13 Hz, CH2 0 CO) - 2Hat4.19 ppm (M, Ar CH2 #h2 i Pr) - lHat 4.05 ppm (D, J = 17 Hz, CH2 SO) - 1H at3.79 ppm (D, 0 ≈ 17 Hz, CH2 SO) - lHat 3.31 ppm (M, (CH3)2“CH) - 10 6H atl.45 ppm (2S, (CH3)2 C) - 6Hnt 1.22 ppm (D, J = 7 Hz, (CH3)2 CH ^H℮) - 15 20 NMK ∩° 94 - (b) : 1Hat8.90 pprn (D, J =* 9 Hz, CO NH) - 3Hat 8.10 ppm (Se., CH2 N®H3) - 1H at7.66 ppm (D, J = 8 Hz, H Ar 6') - lHat 7.55 ppm (D, J = 8 Hz, H Ar 4') - 1H at7.45 ppm (T, J = 8 Hz, H Ar 5') - lHat 6.95 ppm (S, H thiazol) 1H at6.00 ppm (0 of D, = 9 Hz, J2 ≈ 4 Hz, Hy) - 1H at5.40 ppm (D, J » 13 Hz, CH2 0 CO) - lHat 5.00 ppm (D, J = 4 Hz, Hg) - 1H at4.86 ppm (D, 0 * 13 Hz, CH2 0 CO) - 3H at 4.07 ppm (M, Ar CH℮ ^and CH2 SO) - 1H at3.67 ppm (D, J = 17 Hz^ CH2 SO) - 3Hat 2.40 ppm (S, CH3 Ar) - 4H at2.50 ppm (M, CH -CH. ) - 2H at 1.90 ppm (M,Clj12 -0 ) - CO CO 1H at 8.90 pprn (D, J = 9 Hz, CO NH) - 3Hat 8.05 ppm (Se., CH2 iN®h3) - 1H at 7,40 ppm (D, J = 8 Hz, H A r 4') - lHat7.20 ppm (D, J = 8 Hz, H Ar 51 ) - lHat 6.95 ppm (S, H thiazol ) - lHat 6.00 ppm (D of D, J1 = 9 Hz, J2 = 4 Hz, H?) - 1H at5.30 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at 5.00 ppm (D, J = 4 Hz, Hg) - lHat 4.95 ppm (D, J = 13 Hz, CH2 0 CO) 3H at 4.00 ppm (Ar CH2 N®^3 et CH2S0) - lHat3.63 ppm (D, 0 = 17 Hz, CH2 S0) 4Hat2.40 ppm (M, _CH 2 ) - 6H at2.20 ppm (S, CH3 Ar) - CH 2H at 1.90 ppm (M,CH2' il C0 C0 NMR∩° 96 - (b) : 1H at8.90 ppm (D, 0 = 9 Hz, C0 MH) - 3Hat7.90 ppm (Se., CH2 ^3) - 1H at7.00 ppm (S, H_ Ar) - 1H a.t6.9 ppm (S, H_ thiazol ) - lHat6.00 ppm (D of D, J1 = 9 Hz, J2 = 4 Hz, H?) - lHat 5.30 ppm (D, J = 13 Hz, CH2 0 C0) 1H at5.00 ppm (D, 0 = 4 Hz, Hg) - lHat4.94 ppm (D, J = 13Hz, CH2 0 C0) 3H at4.00 ppm (M, Ar CH2 et CH2 S0) - lHat 3.62 ppm (0, J = 17 Hz, ] ™2 CH2 SO) - 4H at 2.50 ppm (M, CHg- 3H at2.2 ppm (S, CH3 Ar) ~ 3H at2.1β ppm (S, CH3Ar) - 2Hat 1.90 ppm NM R ∩° 97 - (b) : lHat 10.30 ppm (S, Ar NH CO) - 1H at8.70 ppm ( D, J = 9 Hz, CO NH) - lHat 8.30 pprn (Se., H Ar 2') - 3H at8.05 ppm (M, CH2 N®H3) - 2Hai 7.70 ppm (M, H Ar 5' , 6' ) - 1H atδ.95 ppm (S, H_ thiazol ) - 5 1Hat 6.00 ppm (Dof 0, J1 = 9 Hz, J2 = 4 Hz, H?) - 1H at5.45 ppm (D, J = 13 Hz, CH2 0 CO) - lHat 4.97 ppm (D, J = 4 Hz, Hg) - lHat4.80 ppm (D, J ≈ 13 Hz, CH2 0 CO) - 1H aΐ4.03 ppm (D, J = 17 Hz, CH2 SO) - 2H at 3.85 ppm (M, CH2 îβ^) - lHat3.75 ppm (D, J ≈ 17 Hz, CH2 SO) - 5H at 1.47 ppm (2S, (CH3)2 C) - NMR π° 98 - (b) : 10 lHat 9.90 ppm (S, Ar NH CO) - lHat8.65 ppm (D, 0 ≈ 9 Hz, CO NH) - lHat 8.28 ppm (S, H Ar 2') - 5Hat 7.70 ppm (M, H Ar 5' , 5' at CH2 iPh3) lHat 6.95 ppm (S, H thiazol ) '− lHat 6. 00 ppm (D of D, ≈ 9 Hz, J2 = 4 Hz, H?) - 1H at5,45 ppm (0, J ≈ 13 Hz, CHλ, 0 C0) - lHat5.00 ppm (D, J = 4 Hz, H℮) - 1H at4.84 ppm (D, J ≈ 13 Hz, CH2 0 C0) - lHat4.03 ppm (0, J = 17 Hz, 15 CH? SO) - 1H at3.68 ppm (D, 0 = 17 Hz, CH? SO) - 2H at3.05 ppm (M, - C - CH? - 6Hat 1.46 ppm (2 S, (CH3)2 C) NMRπ° 99 - (b) : lHat 10.5 ppm (S, Ar NH CO) - lHat8.56 ppm (D, J = 9 Hz, CO NH) - 20 2Hat 7.89 ppm (D, 0 = 8 Hz, H Ar 21, 6’) - 2Hat7.70 ppm (D, J = 8 Hz, H Ar 3’, 5') - 3H at7.70 ppm (Se., (CH2)2 lφf3) - lHat6.95 ppm (S, H thiazol ) - 1Hat5.98 ppm (D of D, = 9 Hz, J2 = 4 Hz, H^) - 1H at5.40 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at4.98 ppm (D, 0 = 4 Hz, Hg) 1H at4.79 ppm (D, J ≈ 13 Hz, CH2 0 CO) - lHat4.05 ppm (D, J = 17 Hz, CH2 SO) - 25 1H at3.75 ppm (D, J = 17 Hz, CH2 SO) - 2H at3.06 ppm (M, -C-CHg CH£ f^3) (! 2Hat 2.70 ppm (M, -C-CH2 CH℮ fβi3) - 6Hatl.45 ppm (2S, (CH3)2 C) 0 NM R ∩° 100 - (b) : 1H at 12 ,75 ppm (Se., thiazol NH CO) - lHat8.90 ppm (D, 0 = 9 Hz, CO NH) 4Hat8.15 ppm (M, CH^ NH^andjl thiazol in 3) - lHat6,96 ppm (S, _H thiazol ) 1Hat 5.00 ppm (D of D, = 9 Hz, J2 ≈ 4 Hz, H?) - lHat5.40 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at 4,98 ppm (D, J = 4 Hz, Hg) - 1H at4,81 ppm (D, J ≈ 13 Hz, CH2 0 CO) - 1Hat4.0 ppm (D, J = 17 Hz, CH2 SO) - 2Hat3.86 ppm (M, CH℮ N^3) - CH, 1H at3.66 ppm (D, J = 17 Hz, CH℮ SO) - 4Hat2.5 ppm (M, CHg. CH„- .0) - 2H at 1.90 ppm (M, Ll. CO .0) CO NM R n° 101 - (b) : 1H at 10.8 ppm (S, Ar NH CO) - lHat 8.95 ppm (D, J = 9 Hz, CO NH) - 3H at8.15 ppm (Se., C»2 1^3) - 2Hat7.90 ppm (0, J ≈ 8 Hz, H Ar 2’, 5') - 2H at 7 .70 ppm (D, J = 8 Hz, H_ Ar 3', 5' ) - 1H at6.97 ppm (S, H_ thiazol ) lHat 6.00 ppm (D of D, ≈ 9 Hz, J2 = 4 Hz, H-,) - lHat5.36 ppm (D, J = 13 Hz, CH2 0 CO) - lHatδ.OO ppm (D, J = 4 Hz, Hg) - 1H at4.82 ppm (D, J = 13 Hz, CH2 0 CO) - lHat4.05 ppm (D, J = 17 Hz, CH2 SO) - 3H at3.80 ppm (M, CH2 #k3 CH antlCHg SO) - 4H at2.40 ppm (M, CHg .0) - 2H at 1.90 ppm (M, ,0) CO CO NMR∩° 102 - (b) : lHat 8,45 ppm (0, J = 9 Hz, CO NH) - 3Hat8.0 ppm (Se., CH2 ^3) - 1H at6.79 ppm (S, 1H at4,97 ppm (0, J = 4 Hz, Hg) - 11^62 ppm (D, J = 13 Hz, CHg 0 CO) - 1H at4.15 ppm (De., J = 12 Hz, H^Eq piperidine) - 3H at 3.84 ppm (M, CH2.1^3 andCH2 SO) - 2Hat 3.58 ppm (M, CH2 SO andHg Eq piperidine) - 1Hat3.05 ppm (Te., J = 12 Hz. H,, 4x piperidine) - 1H at2,Sl ppm (Te., J ≈ 12 Hz, Hg Ax piperidine) - lHat2.50 ppm (M, CH C02) - 2H atl.84 ppm (M, H3andHg piperidine) 2Hatl.50 ppm (M, H3 and Hg piperidine) - 6Hat 1.45 ppm (2 0, (CH3)2 C) NMR∩° 103 - (b) : 1H at 8.72 ppm (D J = 9 Hz, CO NH) - 3Hat8.25 ppm (Se., CH2 N®H3) - 3H at 7.75 ppm (M, _H Ar) - 1H at 6,97 ppm (S, H thiazol ) - 1H at6.00 ppm (D of D, ^ = 9 Hz, J2 » 4 Hz, H?) - lHat5.45 ppm (D, J = 13 Hz, CH2 0 CO) - 1Hat5.00 ppm (D, J = 4 Hz, Hg) - 1H at4.84 ppm (D, J ≈ 13 Hz, CH2 0 CO) - 3Hat4.05 ppm (M, CH2 N^and CH2 SO) - 1H at3.75 ppm (D, J ≈ 17 Hz, CH2 SO) - 6Hatl.45 ppm (2S, (ch3)2 C) - NMR n° 104 - (b) : 2H at8,80 ppm (Se., CHg ^2 GH3) - lHat8.77 ppm (D, J = 9 Hz, CO NH) - 3H at7.75 ppm (M, H Ar) - lHat6.95 ppm (S, H thiazo.l ) - lHatβ.OO ppm (D of D, = 9 Hz, J2 = 4 Hz, H?) - 1Hat5.45 ppm (D, J = 13 Hz, CH2 0 CO) 1H at5,00 ppm (D, J ≈ 4 Hz, Hg) - 1H at4.8δ ppm (D, J ≈ 13 Hz, CH℮ 0 CO) 2H at4.25 ppm (M, CH2 I'ftlg CH3) - 1H at4.10 ppm (D, J = 17 Hz, CH2 SO) - 1H at3,74 ppm (D, J ≈ 17 Hz, CH2 SO) - 3Hat2.58 ppm (M, CH2 ^H2 - CH3) 6H at 1.45 ppm (2 S, (CH3)2 C) NMRn° 105 - (b) : 1H at 10.70 ppm (S, Ar NH CO) - 2Hat8.70 ppm (Se., CH2 #k2 CH3) - 1H at8.68 ppm '(0, J ≈ 9 Hz, CO NH) - 1H at8.16 ppm (S, H Ar 2’) - 1H at7,92 ppm (D, J = 8 Hz, H Ar 6') - lHat7.66 ppm (D, J = 8 Hz, H Ar 4') 1H at7.50 ppm (T, 0 = 8 Hz, H Ar 51 ) - lHat6.95 ppm (S, H thiazol ) lHatβ.OO ppm (Dof D, NMR∩° 106 - (b) : 1H at 10,80 ppm (S, A r NH CO) - 3Hat8.70 ppm (M, CHg N^gtCHj et CO NH) 2Hat7.92 ppm (0, J = 8 Hz, H Ar 2', 6') - 2H at7.69 ppm (D, J = 8 Hz, H. Ar 3' , 5' ) - 1Hat6.95 ppm (S, H_ thiazol ) - lHat 6.00 ppm (D of D, = 9 Hz, 02 ≈ 4 Hz, H?) - 1H at5,42 ppm (D, J = 13 Hz, CH℮ 0 CO) - lHat 5.00 ppm (D, J = 4 Hz, Hg) - 1H at4.81 ppm (D, J = 13 Hz, CH2 0 CO) lHat 4.05 ppm (D, J = 17 Hz, CH2 SO) - 2H at3.95 ppm (M, CH2 N®H2 CH3) lHat 3.75 ppm (D, J = 17 Hz, CH2 SO) - 3H at 2.62 ppm (M, CH2 ^ CH3) 6Hat 1.45 ppm (2S, (CH3)2 C) - NMRn0 107 - (b) : 1H atg.95 ppm (S, Ar NH CO) - 1H ate.75 ppm (D, J = 9 Hz, CO NH) - 3H at8.05 ppm (Se., CH2 N%3)'- lHat 7.61 ppm (D, J = 8 Hz, H Ar 6‘ ) - 1H at7.52 ppm (D, J = 8 Hz, H_ Ar 4‘ ) - 1H at7.31 ppm (T, J = 8 Hz, H_ Ar 61 )-1H at6.96 ppm (S, H_ thiazol ) ~ lHaΐδ.OO ppm (Dof D, = 9 Hz, J2 = 4 Hz, H7) - lHat 5.40 ppm (0, J ≈ 13 Hz, CH2 0 CO) - lHat 5.00 ppm (D, J = 4 Hz, H℮) - lHat4.81 ppm (D, J ≈ 13 Hz, CH2 0 CO) - lHat 4.05 ppm (D, J = 17 Hz, CH2 SO) - 2H at3,81 ppm (M, CHg iβy - 1H at3.72 ppm (D, 0 ≈ 17 Hz, CH2 SO) 3H at2.28 ppm (S, Ar CH3) - 6H at 1.45 ppm (2S, (CH3)2 C) - NMRΠ° 108 - (b) : lHat9.75 ppm (S, Ar NH_ CO) - lHat8.70 ppm (D, J =9 Hz, CO NH_) - 3H at7,70 ppm (Se., CH2 CH2 !^H3) - lHat7.60 ppm (D, J = 8 Hz, _H Ar 6’) 1H at7.50 ppm (D, J = 8 Hz, H. Ar 41 ) - 1H at7.25 ppm (I, J = 8 Hz, JH Ar 51 ) 1H at6.95 ppm (S, H_ thiazol ) - 1H at6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H?) - 1H at5.39 ppm (0, 0 = 13 Hz, CHg 0 CO) - 1H at5.00 ppm (D, J = 4 Hz, Hg) - lHat4.82 ppm (D, J = 13 Hz, CH℮ 0 CO) - lHat 4.05 ppm (D, J = 17 Hz, CH2·S0) - 1H at3.72 ppm (D, J = 17 Hz, CH2 SO) - 2H at3.02 ppm (M, CH℮ CH2 ^3) - 2H at2.69 .ppm (T, J ≈ 7, CH2 CHg ^H3) - 3H at2.29 ppm (S, Ar CH3) 6H atl.45 ppm (2S, (CH3)2 C) - NM R n° 109 - (b) : 5 10 15 20 25 30 1H at 12.7 ppm (Se., NJH CO thiazol ) - lHat8,79 ppm (D, J = 9 Hz, CO NJH) - 1H atδ.03 ppm (S, JH thiazol in 3) - 3H at7.75 ppm (Se., CH? I'Ph.,) ~ ppm lHat.6,98 ppm (S, H thiazol ) - lHat6.00v(0 of D, = 9 Hz, J2 = 4 Hz, Hy) - lHat5.37 ppm (D, J = 13 Hz CH^ 0 CO) - 1H atδ.OO ppm (D, J = 4 Hz, Hg) - 1H at 4.81 ppm (D, J = 13 Hz, CHg 0 CO) - lHat4.03 ppm (D, J = 17 Hz, CH2 SO) - 1Hat3.68 ppm (D, J ≈ 17 Hz, CH, SO) - 2Hat3.06 ppm (M, CH2 CH2 i#H3) - 2Hat 2,77 ppm (T, J = 7 Hz, CH2 CH2 N®k3) - 6Hatl.45 ppm (2S't (CH3)2 C) 1Hat8.70 ppm (D, J ≈ 9 Hz, CO NH_) - 5Hat7.96 ppm (M, H Ar 2', 6' and CH2 γ!®H3) - 2H at7.55 ppm (D, J = 8 Hz, H Ar 3' , 5') - 1H at6.95 ppm (S, JH thiazol )*- 1H atβ.OO ppm (D of C, vh≈ 9 Hz, Jg = 4 Hz, H7) - 1H at5.46 ppm (D, J = 13 Hz, CH2 0 CO) - 1Hat 4.99 ppm (D, j"≈ 4 Hz, Hg) - 1H at4,84 ppm (0, J = 13 Hz, CH2 0 CO) - lHat4.06 ppm (D, J = 17 Hz, CH2 SO) - IHat 3.74 ppm (D, J = 17 Hz, CH2 SO) - 2H at3.55 ppm (Se., CH2 ^l3) - 3H at 3.25 ppm (Se., N Ch'3) - 6Hatl.45 ppm (2S, (CH3)2 C) NMR n° 111 - (b) : IHat 10.5 ppm (Se:, Ar NJH CO) - IHat 8.95 ppm (D, J = 9 Hz, CO NJH) - 2H at 7.89 ppm (D, J = 8 Hz, H Ar 2', 6') - 2Hat7.71 ppm (D, J ≈ 8 Hz, JH Ar 5' , 5' ) - 1H at6.96 ppm (S, JH thiazo ) - 1H at 5.98 ppm (D of D, Jχ = 9 Hz, 02 * 4 Hz, H?) - 1H at5.42 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at5.00 ppm (D, J = 4 Hz, Hg) - 1H at4.80 ppm (D, J ≈ 13 Hz, CH2 0 CO) 1H at4.05 ppm (D, J ≈ 17 Hz, CH2 SO) - lHat3.75 ppm (D, J = 17 Hz, CH2 SO) 2H at3.05 ppm (M, CH2 CH2 ^H3) - 2H at2.70 ppm (T, J = 7 Hz, CH2 CH2 ) I-^2 4H at 2.40 ppm (M, CH2 -0 ) CO CH. -0 ) CO 2H at 1.90 ppm (M, NM R n° 112 - (b) : 1H at 8,80 ppm (D, J = 9 Hz, CO NH) - 3Hat7,go ppm (Se., CH2 |φ)3) - 1H at6.80 ppm (S, H thiazol ) - lHat5.95 ppm (D of d, J1 = 9 Hz, J2 = 4 Hz,h7) - 1H at5-17 ppm (2 D, J = 13 Hz, CH2 0 CO) - lHat4.96 ppm (D, J = 4 Hz, Hg) ~ lHa-t4.60 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at4.18 ppm (M, H2℮ piperidine) 3H at3.90 ppm (M, CH2 I^H3andCH2 S0) - 2Hat3.58 ppm (M, CH2 S0 et H^e piperidine) - 1Hat3.06 ppm (M, H2a piperidine) - 1Hat 2.75 ppm (M, H,a piperidine) - lHat2.60 ppm (M, H^ piperidine) - 4H at2.40 ppm 0 (M, CH, CH2 CO) - 4H at 1.80 ppm et 2H 1.50 ppm ( ch2-i -CO et h3 et h5 piperidine) lHat8.75 ppm (D, J ≈ 9 Hz, CO NH) - 3Hat8.40 ppm (Se., CH f^3) - 1H at8.13 ppm (S, H Ar 6') - lHatβ.OO ppm (D, J ≈ 8 Hz, H Ar 2') - 1H aΐ7.64 ppm (D, J = 8 Hz, H_ Ar 3') - 1H aΐ6.97 ppm (S, H_ thiazol ) lHatβ.OO ppm (D ofO, ^ ≈ 9 Hz, J2 => 4 Hz, H?) - 1H at5.45 ppm (D, J » 13 Hz, CH2 0 CO) - 1H at 5.00 ppm (D, J == 4 Hz, Hg) - 1H at4.86 ppm (D, J = 13 Hz, CH2 0 CO) - 2H at4.19 ppm (M, CH2 ^H3) - lHat4.10 ppm (D, J = 17 Hz, CH℮ SO) 1H at3.76 ppm (D, J = 17 Hz, CH2 SO) - 6Hatl.45 ppm (2 S, (CH3)2 C) NM R n° 114 - (b) : 1H at8.72 ppm (D, J = 9 Hz, CO NH) - 3Hat8.40 ppm (Se., CH2 lΦi3) - 2H at8.ll ppm (M, H Ar 2', 6’) - 1H at7.86 ppm (M, H Ar 3') - 1Hat6.99 ppm ( S, H thiazol ) - 1H atβ.Ol ppm (D ofO, = 9 Hz, J2 = 4 Hz, H?) - 1H at5.46 ppm (D, J = 13 Hz, CH2 0 CO) - lHat 5.00 ppm (D, J = 4 Hz, Hg) - lHat4.89 ppm (D, J = 13 Hz, CH2 0 CO) 2Hat4.18 ppm (M, CH2 tpHj) - lHat 4.06 ppm (D, J = 17 Hz, CH2 SO) lHat3.78 ppm (D, J = 17 Hz, CH2 SO) -,6Hatl.45 ppm (2S, (CH3)2 C) - NMR ∩° 115 - (b) : lHat 10.20 ppm (Se., Ar NH CO) - lHat8.70 ppm (D, J = 9 Hz, CO NH) - 1Hat 8.16 ppm (Se. , H Ar 2') - 1H at7.84 ppm (D, J = 8 Hz, H Ar 6') - 3Hat 7.66 ppm (Se. , CH2 rf^3) - lHat 7.60 ppm (D, J = 8 Hz, H Ar 4') - S 1H at7,45 ppm (I, J = 8 Hz, _H Ar 5') - 1H at6.97 ppm (S, H thiazol ) - lHat 6.00 ppm (D of D, = 9 Hz, = 4 Hz, Hy) - lHat5.45 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at5,00 ppm (D, J = 4 Hz, Hg) - lHat 4.84 ppm (D, J ≈ 13 Hz, CH2 0 CO) - 1Hat4,05 ppm (D, J = 17 Hz, CH2 SO) - 1H at3.75 ppm (D, J = 17 Hz, CH2 SO) - 2H at2.81 ppm (M, CH2 - f^3) - 2H at2.40 ppm (T, J = 7 Hz, 10 CH2 C02) - 2H at 1.82 ppm (M, CH2 CH2 C02) - 6H at 1.45 ppm (2 S, (CH3)2 C) NMR ∩° 116 - (b) : lHat 10.3 ppm (Se., Ar NH CO) - lHat8.70 ppm (D, J = 9 Hz, CO NH) - 2Hat 7.90 ppm (D, J = 8 Hz, H ·Ar 2', 6') - 1H at7.67 ppm (D, J = 8 Hz, H Ar 3', 5') - 3H at 7.60 ppm (Se., CH2 #H3) - lHat 6.95 ppm (S, H thiazol.) - 15 1H atδ.OO ppm (D of D, = 9 Hz, J2 = 4 Hz, Hy) - lHat5.42 ppm (D, J = 13 Hz CH2 0 CO) - 1H at4,98 ppm (D, J = 4 Hz, Hg) - 1H at4.79 ppm (D, J = 13 Hz, CH, 0 CO) - 1H at4.06 ppm (D, J = 17 Hz, CH2 SO) - 1H at3.75 ppm (D, J ≈ 17 Hz, CH2 SO) - 2Hat 2.79 ppm (M, CH2 20 NMRn° 117 - (b) ; lHat 10.30 ppm (Se., Ar NH CO) - lHat8',75 ppm (D, J = 9 Hz, NH CO) - 2H at 7.84 ppm (0,0 = 8 Hz, H Ar 2’, 6') - 2H at7.72 ppm (D, J = 8 Hz, H Ar 3', 51) - 3Hat7.60 ppm (Se., CH2 ^3) - lHat6,97 ppm (S, _H thiazol ) 1H atδ.OO ppm (D of D, Jχ ≈ 9 Hz, J2 = 4 Hz, Hy) - lHat 5.40pprn (ds j = 13 Hz, 25 CH2 0 CO) - lHat4.90 ppm (D, 0 = 4 Hz, Hg) - lHat4.78 ppm (D, J ≈ 13 Hz, CH2 0 CO) - lHat 4.05 ppm (D, J = 17 Hz, CH℮ SO) - lHat 3.75 ppm (D, J = 17 Hz, CHg.'SO) - 2Hat2.75 ppm (M, CH2 N^3) - 2H at2.36 ppm (M, CH2 CONH Ar) - 4H at 1,58 ppm (M, -CO CH2 (CH2)9 CH2^3) - 6H atl.45 ppm (2 S, (CH3)2 C) 1H at 12.7 ppm (Se, NH CO thiazol) - 1H at 8.65 ppm (D, J = 9 Hz, CO NH) - 3H at 8.20 ppm (Se, CH2 t$k3) - 1H at 5 6.93 ppm (S, H thiazol) - 1H at 6.00 ppm (D of~D, = 9 Hz, J2 = 4 Hz, Hy) - 1H at 5.45 ppm (D, J = 13 Hz, CH2 O CO) - 1H at 5.02 ppm (D, J = 4 Hz, H6) - 1H at 4.75 ppm (D, J = 13 Hz, CH2 O CO) - 1H at 4.02 ppm (D, J = 17 Hz, CH2 SO) - 2H at 3.90 ppm (M, CH2 Gly) - 1H at 3.70 10 ppm (DT J = 17 Hz, CH2 SO) - 3H at 2.50 ppm (S, CH3 thiazol) - 6H at 1.45 ppm (2S, (CH3)2 C) . NMR n· 119 - fbΐ: 1H at 8.45 ppm (D, J = 9 Hz, CO NH) - 3H at 7.80 ppm (Se., CH-I$H3) - 1H at 6.80 ppm (S, H thiazol) - 1H at 15 6.00 ppm (D of D, ^ = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.10 ppm (D, J = 13 HZ, CH2 O CO) - 1H at 4.95 ppm (D, J = 4 Hz, H6) - 1H at 4.58 ppm (D, J = 13 Hz, CH2 O CO) - 1H at 3.90 ppm (D, J = 17 Hz, CH2 SO) - 1H at 3.56 ppm (D, J = 17 Hz, CH2 SO) - 1H at 3.00 ppm (2M CH 1<%3) - 1H at 20 2.25 ppm (M, Cg C02) - 4H at 1.80 ppm and 4H at 1.40 ppm (M, CH2 cyclohexane) - 6H at 1.44 ppm (2S, (CH3)2 C). MMR Π.°~12!0 - (b) ; 1H at 8.75 ppm (D, J = 9 Hz, CO Njg) - 2H at 7.80 ppm (Se., ϋ Ar 2', 6') - 3H at 7.65 ppm (Se., CH2 *Φh3) - 1H 25 at 7.57 ppm (D, J => 8 Hz H Ar 4') - 1H at 7.47 ppm (T, J = 8 Hz, H Ar 5') - 1H at 7.00 ppm (S, H thiazol) - 1H at 6.00 ppm (D Of D, Jχ => 9 HZ, J2 = 4 Hz, Hy) - 1H at 5.45 pprn (D, J ≈ 13 HZ, CH2 O CO) - 1H at 4.98 ppm (D, J ≈ 4 Hz, H6) - 1H at 4.82 ppm (D, J = 13 Hz, CH2 O CO) - 1H 30 at 4.05 ppm (D, J = 17 Hz, CH2 SO) - 1H at 3.75 ppm (D, J = 17 Hz, CH2 SO) - 3H at 3.00 ppm (M, CH CH2 ch3 iΦh3) - 6H at 1.50 ppm (2S, (CH3)2 C) - 3H at 1.20 ppm (D, J ≈ 7 Hz, CH CH2 K®H3) 35 CH3 NMR ∩° 121 - (b) : 1H at 10.0 ppm (Se., Ar NH CO) - 1H atδ.85 ppm (D, J = 9 Hz, CO NH) 3Hat8.05 ppm (Se., CH2 l^3) - 1H at 7.45 ppm (S, H Ar 6' ) - lHat7.30 ppm (S,. H Ar 41 ) - 1Hat 7.00 ppm (S, thiazol ) - 1H at6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, Hy) - 1H at5.43 ppm (D, J = 13 Hz, CH2 0 CO) - lHatδ.OO ppm (D, J = 4 Hz, Hg) - 1H at4.78 ppm (D, J = 13 Hz, CHg 0 CO) - lHat4.05 ppm (D, J = 17 Hz, CH℮ SO) - 2H at 3.80 ppm (M, CH2 Gly) - lHat3.75 ppm (D, J = 17 Hz, CH2 SO) - 6Hat 2.25 ppm (2 S, CH3 Ar) - 6H at 1.50 ppm (2 S, (CH3)2 C) NMR ri° 12 2 - (b) : 1H atlθ.45 ppm (Se., Ar NH CO) - 1Hat8.70 ppm (D, J = 9 Hz, CO NH) lHat8.50 ppm (Se., ΐFllg, piperidine) - lHat8.20 ppm (Se. , Filg, piperidine) 2H at7.84 ppm (D, J = 8 Hz, H Ar 21, 6' ) - 2Hat 7.70 ppm (D, J = 8 Hz, H Ar 3', 5') - 1H atβ,98 ppm (S, _H thiazol ) - lHatδ.OO ppm (D of 0, = 9 Hz, J2 = 4 Hz, H?) - 1H at5,42 ppm (D, J = 13 Hz, CH2 0 CO) - lHat4.98 ppm (D, J = 4 Hz, Hg ) - 1H at4.78 ppm (D, J » 13 Hz, CHg 0 CO) - lHat4.05 ppm (D, J = 17 Hz, CH2 SO) - 1H at3.75 ppm (D, J ≈ 17 Hz, CH2 SO) - 2H at3.30 ppm (M, CH2 in !^®Hg piperidine) - 2Hat2.9Q ppm (M, CH2 in rPπ2 piperidine) - lHal2.66 ppm (M, CH CO NH) - 4H at 1.80 ppm (M, CH2 in NMR n° 123 - (b) : 1H at 10.25 ppm (Se., Ar NH CO) - lHat8.70 ppm (D, J = 9 Hz, CO NH) lHat8.50 ppm (Se., iFkg, piperidine) - lHat8,25 ppm (Se, N®Hg, piperidine) 1Hat8.19 ppm (Se, H Ar 2') - 1H at7.85 ppm (D, J = 8 Hz, Hr 5') - IHat 7.60 ppm (D, J = 8 Hz, H Ar 4') - lHat7.42 ppm (T, J = 8 Hz, H Ar 5') 1H at6.95 ppm (S, H thiazol ) - IHat 6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H7) - IHat 5.45 ppm (D, J ≈ 13 Hz, CHg 0 CO) - lHatδ.OO ppm (D, J = 4 Hz, Hg) - IHat 4.81 ppm (D, J IHat 2.66 ppm (M, CH CO NH) - 4H at 1.80 ppm (M, CHg in NMR n° 124 - (b) : 5 1H at6,00 ppm (D ofD, = 9 Hz, J2 ≈ 4 Hz, Hyj - 1H at5.45 ppm (D, J = 13 Hz, CH2 0 CO) - 1Hat 5,00 ppm (D, J ≈ 4 Hz, Hg) - lHat4,80 ppm (D, J = 13 Hz, CH2 0 CO) - 2Hat 4,00 ppm (M, Hx AlaandCHg SO) - 1H at3.75 ppm (D, J = 17 Hz, CH2 SO) - 6H at 1,50 ppm (2S, (CH3)2 C) - 3Hatl.42 ppm (D, J ≈ 7 Hz, CH3 Ala) - 10 1H atlO,80 ppm (Se., Ar NH CO) - 1H at9,00 ppm (D, J = 9 Hz, CO NH) - IS CH2 0 CO) - 2H at4.00 ppm (M, H o( Ala and CH℮ SO) - 1H at3.75 ppm (D, J = 17 Hz, 20 NMRn° 126 -(b) : 1H at 6,00 ppm (Oof 0» Oj = 9 Hz, J2 ≈ 4 Hz, Hy) - lHat 5,20 ppm (M, CH2 0 CO) 1H at4,95 ppm (D, ϋ = 4 Hz, Hg) - lHat 4.50 ppm (0, CH2 0 rθ) - lHat 3.15 ppm 25 (M, H℮a piperidine) - lHat2,80 ppm (M, Hga piperidine) - lHat 2,60 ppm NMR n° 127 - (b) : 1H at8.43 ppm (D, J = 9 Hz, CO NH) - 6H at7.50 ppm (Se., - 1H at 6.80 ppm (S, H thiazol) - lHatβ.OO ppm (D of D, = 9 Hz, J2 = 4 Hz/H?) - 1Hat 5.16 ppm (2D, J ≈ 13 Hz, CH2 0 CO) - 1H at 4.95 ppm (D, J ≈ 4 Hz, Hg) - 1H at4.58 ppm (D, J = 13 Hz, CH2 0 CO) 1Hat4.20 ppm (M, Hgθ piperidine) - IHat^O ppm (D, J = 17 Hz CH2 SO) 1H at3.64 ppm (M, Hge piperidine) - lHat3.57 ppm (D, J ≈ 17 Hz, CH2 SO) lHat3.07 ppm (M, H2a piperidine) - 2Hat2.96 ppm (M, CH2 N®H3) - 1H at 2.75 ppm (M, Hga piperidine) - 3H at2.65 ppm (M, CH C02andCH2 CO N) 2H at 1,80 ppm et 2Hatl,50 ppm (H^anclHζ piperidine) -6Hatl,45 ppm (2S, (ch3)2 C) - NMRn° 128 - (b) : 1H at 8.45 ppm (D, J = 9 Hz, CO NH) - 6H at7,70 ppm (Se., NΦH3) lHat6,80 ppm (S, J2 ≈ 4 Hz, H?) - 1H at5.20 ppm (2 C, J = 13 Hz, CHg 0 CO) - 1H at4,96 ppm (D, J = 4 Hz, Hg) - lHat4.58 ppm (D, J = 13 Hz, CH2 0 CO) lHat4.18 ppm (H2℮ piperidine) - lHat3.90 ppm (D, J = 17 Hz, CH2 SO) lHat3.75 ppm (M, Hge piperidine) - lHat3·.55 ppm (D, J ≈ 17 Hz, CH2 SO) lHat3.00 ppm (M, H2a piperidine) - 4Hat 2.65 ppm (M, CH2 I^Hg, Hga ℮t H4 piperidine) - 2Hat2,40 ppm (T, CH2 CO N) - 4H at 1.70 ppm (M, CH CH2 Λ **** CH2 λvH3, HjandH- piperidine) - -Hat 1.50 ppm (M, H^andHg piperidine) 6H at 1.44 ppm (2S, (CH3)2 C) - lHaΐ8.50 ppm (Se., N$H2 piperidinium) - 1H at8.45 ppm (D, J = 9 Hz, CO NH) - 1H at8,25 ppm (Se., NΦH2 piperidinium) - 3Hat7,40 ppm (Se., N®H3 thiazol ) - lHatβ.80 ppm (S, H thiazol ) - lHatβ.OO ppm (D of D, 5 Jj = 9 Hz, J2 = 4 Hz, H?) - 1H atδ.16 ppm (D, J ≈ 13 Hz, CH2 0 CO) - lHat4 15 ppm (M, H2℮ piperidine) - 2H at 3 .90 ppm (M, Hg℮ piperidine and CH2 SO) - 1Hat 3.55 ppm (D, J = 17 Hz, CH2 SO) - 2Hat 3.25 ppm (M, Hgβ andHδe piperidinium) - lHat3.15 ppm (M, H2a piperidine) - 3Hat2.85 ppm (M, Hga piperidine and H2a and Hga piperidinium) - 2Hat2.70 ppm (M, H^ 10 piperidineandH^ piperidinium) - 6H atl.75 ppm and 2H at 1.50 ppm (2M, H^andHg piperidinium H^andHg piperidine) - 6Hatl.44 ppm (2S, (CH3)2 C) - lHat8.75 ppm (D, J 9 Hz, CO NH) - 3H at 8.20 ppm (Se., CH2 N®H3) - 1H at7.80 ppm (D, J = 8 Hz, H Ar 6') - 2H at7.45 ppm (M, H Ar 3', 5') 15 1H at7,00 ppm (S, H thiazol ) - lHatβ.OO ppm (D ofD, = 9 Hz, 02 = 4 Hz, H7) - 1H aΐ5.42 ppm (D, J => 13 Hz, CH2 0 CO) - 1H at 5.00 ppm (D, 0 = 4 Hz, Hg) -1Hat 4.80 ppm (D, J a ‘13 Hz, CH2 0 CO) - 3Hat4.00 ppm (M, CH2 l^gβndCHg SO) - 1H aΐ3.75 ppm (D, 0 = 17 Hz, CH2 SO) - 3Hat2.45 ppm (S, CH3 Ar) - 6Hatl.45 ppm (2S, (CH3)2 C) - 20 NM Rn° 131 - (b) : NM Rn° 131 - (b) : lHat8.85 ppm (D, J ≈ 9 Hz, CO NH) - 3Hat 8.20 ppm (Se., CH2 NΦH3) - 1H at7,80 ppm (D, J = 8 Hz, H Ar 5') - 2Hat7 45 ppm (M, H Ar 3', 5') lHat6.95 ppm (S, H_ thiazol ) - lHatβ.OO ppm (D of D, = 9 Hz, J2 = 4 Hz, Hy) - 1H at5.45 ppm (D, J ≈ 13 Hz, CH2 0 CO) - lHats.OO ppm 25 CD, J = 4 Hz, Hg) - lHat4.80 ppm (D, J ≈ 13 Hz, CH2 0 CO) - CD, J = 4 Hz, Hg) - lHat4.80 ppm (D, J ≈ 13 Hz, CH2 0 CO) - 3H at4.00 ppm (M, CH2 NΦH3 et CH2 SO) - 1H at3.73 ppm (D, J a 17 Hz, CH2 SO) - 3H at2.50 ppm (S, CH3 Ar) - 4Hat2.40 ppm (M, CO ) 2H at 1.80 ppm (M, 0 ) - CH, ) - CH, -CO -CH, -CH, 30 CH, CH, NMR∩° 132 - (b) : 1H at8.80 ppm (D, J = 9 Hz, CO NH) -3H atδ.10 ppm (Se., CH2 N^3) - 1H at7.55 ppm (S, ji Ar) - 1H at7,45 ppm (S, H_ Ar) - 1H at7.00 ppm (S, H thiazol ) - 1Hat6.00 ppm (D of D, Jj ≈ 9 Hz, J2 = 4 Hz, H?) - 1H at5,40 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at 5.00 ppm (D, J = 4 Hz, Hfi) lHat4,83 ppm (D, J = 13 Hz, CH2 0 CO) - 3Hat3.70 ppm (M, CH2 N®H3 et CH2 SO) - 1Hat 3.70 ppm (D, J = 17 Hz, CH2 SO) - 3H at2.4θ ppm (S, CH3 Ar) - 3H at2,34 ppm (S, CH3 Ar) - 6Hatl.45 ppm (2S, (CH3)2 C) - NMR n° 133 - (b) : 1Hat 12.5 ppm (Se., Ar NH CO) - lHat8.78 ppm. (D, J = 9 Hz, CO NH) - 3H at 8.30 ppm (Se., - CH - N®H3) - 1H at 8.20 ppm (S, H thiazol in 3) - ch3 " 1H at 7,00 ppm (S, H thiazol) - 1H at 6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H7) - 1Hat 5.42 ppm (2 D, J = 13 Hz, CHg 0 CO) - lHatδ.OO ppm (D, J = 4 Hz, Hg) - 1Hat4.90 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at4.15 ppm (M, CH ^3) “ ~ ch3 1H at4.00 ppm (D, J = 17 Hz, CH2 SO) - lHat3.76 ppm (D, J = 17 Hz, CH2 SO) 6H at 1.44 ppm (2 S, (CH3)2 C) - 3Hat 1.40 ppm (D, 0 = 7 Hz, CH3 CH) NMRn° 134 - (b) : 1H at8,85 ppm (D, J = 9 Hz, CO NH) - 1H at8.50 ppm (S, H thiazol in 3) 3Hat 7.90 ppm (Se., CH2 1^3) ~ lHat7.00 ppm (S, H_ thiazol ) - lHat 6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H?) - 1H at5.42 ppm (D, J = 13 Hz CH2 0 CO) - 1H at4.99 ppm (D, J = 4 Hz, Hg) - lHat 4.84 ppm (D, J ≈ 13 Hz, CH2.0 CO) - lHat4.00. ppm (D, J ≈ 17 Hz, CH2 SO) - lHat3.75 ppm (D, J = 17 Hz CH2 SO) - 4H at3,20 ppm (M, CH2 CH2 l^3) - 6H at 1.45 ppm (2 S, (CH3)2 C) NM R n° 135 ~ (b) : lHaΐ8.80 ppm (D, J ≈ 9 Hz, CO NH) - 1H at8,57 ppm (S, _H thiazol in 3) 3Hat8.50 ppm (Se., CH2 ^3) - 1H at 7.00 ppm (S, H_ thiazol ) - lHatδ.OO ppm (D of D, Jχ = 9 Hz, J2 = 4 Hz, H7) - 1H at5.40 ppm (D, J = 13 Hz, CH2 0C0) - 5 lHatδ.OO ppm (D, J = 4 Hz, Hβ) - 1H at4.90 ppm (D, J = 13 Hz, CH℮ 0 CO) 2Hat4.45 ppm (M, CH2 N®H3) - lHat4.00 ppm (D, J ≈ 17 Hz, CH2 SO) - 1H at 3.72 ppm (D, J ≈ 17 Hz, CH2 SO) - 6Hatl,45 ppm (2 S, (CH3)2 C) 10 15 NMR n° 136 - (b) : lHat 8.90 ppm (D, J = 9 Hz, CO NH) - 1H at 8.60 ppm (S, H_ thiazol in 3) lHat 8.50 ppm (Se., CH2 N®H3) - 1H at6.98 ppm (S, H_ thiazol ) - lHatδ.OO ppm (D ofD, = 9 Hz, Jg ≈ 4 Hz, Hy) - lHat5.42 ppm (D, J = 13 Hz, CH2 0 CO) - lHatδ.OO ppm (D, J = 4 Hz, Hg) - lHat4.84 ppm (D, J = 13 Hz, CH2 0 CO) - 2Hat 4.45 ppm (M, CH2 f^H3) - lHat4.00 ppm (D, 0 = 17 Hz, CH2 SO) -lHat 3.72 ppm (D, 0 ≈ 17 Hz, CHg SO) - 0 0 4H at2.40 ppm (M, CH2 -CO) - 2Hatl.86 ppm (M, -CO) ■■CH, CH, NMR n° 137 - (b) : lHat8.90 ppm (T, J = 8 Hz, C NH CH?) - lHat8.75 ppm (D, J = 9 Hz, CO NH) - 20 3H 3.58.00 ppm (Se., CH2 N®k3) - 2H at7. 88 ppm (D, 0 = 8 Hz, H 4r 2', 6') - 2H at^.40 ppm (D, J = 8 Hz, ' 1H Ar 3', 5' ) - 1H at6 .96 ppm (S, HI thiazol ) 1H at6.00 ppm (D of 0, Jj_ = 9 Hz, J2 = 4 Hz, Hy) - 1H atδ.44 ppm (0, J = 13 Hz,rH2 0 CO) - 1Hat4.98 ppm (D, J = 4 Hz', Hg) - 1H at4.80 ppm (D, 0 = 13 Hz, CH2 0 CO) - 2Hat4,40 ppm (D, J = 8 Hz, Ar CHg NH) - 1H at4.06 ppm lHat3.70 ppm (D, J = 17 Hz, CH2 S -> 0) - 2H at3.57 ppm (M, OC CH2 N^3) 2Hatl.47 ppm (2 S, (CH3)2 C) 25 By operating as in Example 2 of Example 3, the compounds according to the invention are obtained, in the form of trifluoroacetates described in Table n 5 below. These compounds are identified by a reference number and for each of them are given the values of Rl7 15 R2, n and B and the NMR spectrum. The chromatography eluant is also given which serves to isolate (V) : the last intermediate product before deblocking of the acid and amine functions of the molecule. This intermediate V is characterized by its 20 infra-red spectrum, the wavelengths indicated in cm-1 correspond in order to the elongation vibration frequencies of the carbonyl at the 8 position of the beta lactam, the tertiobutylic esters and the thioester at the 3 position, the amide at the 7 position and the 25 protective carbonate of the amine. When 2 wavelengths only are indicated the second corresponds to a wide band which covers the elongation vibration frequecies both of the esters, the amide and the protective carbonate of the amine and the thioester. 30 It happens for certain products that the vibration frequency of the thioester is at the same wavelength as that of the tertiobutylic esters. This is indicated in the table by + COS opposite the corresponding vibration frequency. / TABLE II / 78 NMR Spectra The spectra are recorded at 60 MHz, indicated by (a) or at 250 Mllz, indicated by (b); when two steroisomers exist in the molecule, the split signals are indicated by *. NMR n° 1 - fa): 8H between 6 and 9 ppm (wide signal, CH2, TFA, C02H)1H at 8.40 ppm (D, J=9 Hz, CONH) - 1H at~6.86 ppm (S, H 5 thiazol) - 1H at 6.00 ppm (D of D, J3=9 Hz, J2=4 Hz, H7) - 1H at 4.97 ppm (D, J=4 Hz, Hg) - 1H at 4.20 ppm (AB, JAB=13 Hz, CH2 SCO) - 3H at 3.70 ppm (M, CH^ SCO and CH2SO) - 4H at 2.75 ppm (M, CH2NH2 and CH2COS) - 2H at 1.77 ppm (M, CH2CH2CH2) - 6H at~1.45 ppm (s’, (CH3)2C). 10 NMR n· 2 - 8H between 6.5 and 9 ppm (wide signal, C02H, TFA, NH2)1H at 8.40 ppm (D, J=9 Hz, CONH) - 1H at 6.88 ppm -1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.20 ppm (A of 15 AB, J=13 Hz, CH2SCO) - 3H at 3.80 ppm (M, CHgSO and CH^SCO) - 4H at 2.65 ppm (M, CH2NH2 and CH^COS) - 10H at 1.45 ppm (S.e., (CH3)2C and CH2 (CH^j·CH^. NMR n° 3 - fa^ ; 8H between 6.5 and 8.7 ppm (wide signal (NH2, C02H, TFA) 20 - 1H at 8.40 ppm (D, J=9 Hz, CONH) - 1H at~6.87 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, J^=9 Hz, J2=4 Hz, H7) - 1H at 5.0 ppm (D, J]_=4 Hz, Hg) - 1H at 4.20 ppm (A of AB, J≈13 Hz, CH2SO) - 3H at 3.70 ppm (M, CH2SCO and CH2SO) - 4H at 2.80 ppm (M, CH2NH2 and CH2C0) - 12H at 25 1.45 ppm (S.e., (CH3)2 c and CH2 (CH2)3 CH2). NMRn· 4 - (a)i ~ ~ 7H between 6.5 and 9.5 ppm (wide signal, NH2, NH, co2H, TFA) - 1H at 8.40 ppm (D, J=9 Hz, CONH) - lF at 6.90 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jx=9 Hz, J2=4 30 Hz, H7) - 1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.20 ppm (A Of AB, JAB=13 Hz, CH2SCO) - 3H at 3.70 ppm (M, CH2SCO and CH2SO) - 5H at 3.0 ppm (M, CH2N and CHCOS) - 4H at 1.90ppm (M, CH2CH2N) - 6H at 1.45 ppm (S, (CH3)2C). NMR n' 5 - (bΐ: 35 5H between 7 and 9 ppm (wide signal, NH2, TFA, NH) - 1H at 8.34 ppm (2D, J=9 Hz, CONH)* ~ 1H at 6.8 ppm (S, H thiazol) - 1H at 5.97 ppm (D of D, J3=9 Hz, J2=4 Hz, H7) - 1H at 4.95 ppm (D, J=4 Hz, H6) - 1H at 4.16 ppm (2D, J=13 HZ, CH2SCO)* - 1H at 3.76 ppm (D, J=13 Hz, CH2SCO) - 2H at 3.66 ppm (S, CH2SO) - 1H at 3.4 ppm, 1H at 3.16 ppm and 2H at 2.95 ppm (M, CH2N) - 1H at 2.80 ppm (M, 5 CHCOS) - 4H between 1.5 and 2.1 ppm (M, CH2CH2CH2N) - 6H at 1.44 ppm (S, (CH3)2C). NMR n' 6 - (a^: 3H at 8.50 ppm (S.e., CONH, NH2) - 3H at 7.80 ppm (S.e., NH3) - 1H at 6.85 ppm (S, H thiazol) - 1H at 6.00 ppm (D 10 of D, J-l≈Θ Hz, J2=4 Hz, H7) - 1H at 5.00 ppm (D, J==4 Hz, Hg) -1H at 4.15 ppm (A of AB, JAB=13Hz/ CH2SCO) - 1H at 3.80 ppm (B of AB, Jab=13 Hz / CH2SCO) ~ 2H at 3.70 ppm (S.e., CH2SO) - 7H at 2.50 ppm (M, CH3NH, CH2NH, CH2 C ~ ~ 0 15 S) - 2H at 1.80 ppm (M, CH2CH2CH2NH) - 6H at 1.45 ppm (2S, (CH3)2C). NMR n· 7 - 1H at 8.35 ppm (D, J=9 Hz, CONH) - 8H between 6.5 and 10 ppm (C02H, NH2, TFA) - 1H at 6.82 ppm (S, H thiazol)20 1H at 6.00 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7) - 1H at 5.00 ppm (D, J≈4 Hz, Hg) - 1H at 4.15 ppm (A of AB, Jab≈13 Hz, CH2SC0) - 3H~"at 3.66 ppm (M, CH2S0 and B of AB, CH2SCO) - 4H at 2.65 ppm (M, CH2C0 and~CH2NH2) - 6H at 1.42 ppm (S, (CH3)2C) - 10H at l725 ppm (sTe., (013)5 25 CH2 NH2). ~ NMR n” 8 - (b); 1H at 8.34 ppm (D, J≈9 Hz, CONH) - 3H at 7.80 ppm (S.e., &Hτ,) - 3H at 7.40 ppm (S.e., fobj) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.94 ppm (D of D, Jx=9 Hz, J2≈4 Hz, NMR n1 9 - fbΐ ; 5 10 15 20 25 30 35 CH2 (M, CH COS and NH) - 2H at 1.95 ppm and 2H atCHJ.^ CH2 1.70 ppm (M, SC h/ ) - 3H at 1.45 ppm (D, J=7 Hz, oXch2 CH3CH). NMR n· 13 - (b): 2H at 8.70 ppm (M, CONH and NH^) - 1H at 8.40 ppm (M, NH2) - 3H at 7.40 ppm (S.e·, NH3) - 1H at 6.79 ppm (S, H thiazol) - 1H at 5.90 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7) - 1H at 4.94 ppm (D, J=4 Hz, H6) - 1H at 4.16 ppm (D, J=13 Hz, CH2 SCO) - 1H at 3.74 ppm (D, J≈13 Hz, CH2 SCO) 2H at 3.70 ppm (S, CH2S0) - 2H at 3.25 ppm (M, CH2NH) 3H at 2.90 ppm (M, CH2NH and CH COS) - 4H at 2.40 ppm (M, CH2 and SCO O -j C02H) - 6H at 1.80 ppm (M, CH2 ch2 ch2 ,ch2 )• 0 co2h ch2 ch2 MR n" 14 - (b) : 1H at 8.65 ppm (D, J=9 Hz, CONfl) - 3H at 8.20 ppm (S.e., NH3) - 2H at 7.92 ppm (D, J≈8 Hz, H ortho CO) - 2H at 7.56 ppm (D, J=8 Hz, H meta CO) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.82 ppm (S, H thiazol) ~ 1H at 5.88 ppm (D of D, Jχ=9 HZ, J2≈4 Hz, H7) - 1H at 4.92 ppm (D, J=4 Hz, H$) - 2H at 4.55 ppm (S, CH^ON) - 1H at 4.37 ppm (D, J=13 Hz, CHjSCO) - 2H at 4.13 ppm (M, CH2NH2) - 1H at 4.42 ppm (D, J=13 Hz, CHgSCO) - 2H at~ 3.74 ppm (S, CHjSO). NMR n‘ 15 - (bΐ: 1H at 8.60 ppm (2D, J=9 Hz, CONH)* - 3H at 8.20 ppm (S.e., $113) - 2H at 7.92 ppm (D, NMR n' 16 - i 1H at 8.61 ppm (D, J=9 Hz, CONH) - 5H at 8.40 ppm (S.e., NH3, C02H) - 2H at 7.95 ppm (D, J=8 Hz, S ortho CO) - 2H 10 at 7.61 ppm (D, j+8 Hz, H meta CO) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.76 ppm (S, H thiazol) - 1H at 5.92 ppm (D of D, Ji=9 Hz, J2=4 Hz, H7) - 1H at 4.93 ppm (D, J=4 Hz, H6) - 1H at 4.42 ppm (D, J=13 Hz, CH2SCO) - 2H at 4.10 ppm (S.e., CH2NH2) - 1H at 3.92 ppm (D, J=13 Hz, 15 CH^SCO) - 2H at 3.74"ppm (S, CH2 SO) - 4H at 2.35 ppm 0 ^ch20 (M, CH2 ) C02H) - 2H at 1.85 ppm (M, CHg ch2 ch2 co2h NMR n* 17 - ~7b^ : 20 1H at 8.62 ppm (D, J => 9 Hz, CO Nϋ) - 3H at 8.20 ppm (Se., CH2 l^j) - 1H at 8.00 ppm (Se., g Ar 2') - 1H at 7.90 ppm (D, J = 8 Hz, g Ar 6') - 1H at 7.72 ppm (D, J ≈ 8 Hz, g Ar 4') - 1H at 7.55 ppm (T, J = 8 Hz, H Ar 5')1H at 6.93 ppm (S, H thiazol) - 1H at 5.95 ppm (D of D, 25 Jx => 9 Hz, J2 => 4 Hz, Hj) - 1H at 4.93 ppm (D, J = 4 Hz H6) - 1H at 4.43 ppm (D, J ≈ 13 Hz, CH2SC0) - 2H at 4.10 ppm (Q, J = 7 Hz, CH2 N®H3) - 1H at 3*794 ppm (D, J = 13 HZ, CH2 SCO) - 2H at 3.75 ppm (Se., CHg SO) - 6H at 1.45 ppm (2S, (013)3 C). 30 NMR n‘ 18 - 1H at 8.80 ppm (D, J = 9 Hz, CO NH) - 3H at 8.20 ppm (Se., CH2 #ÎH3) - 1H at 8.00 ppm (Se., H Ar 2') - 1H at 7.90 ppm (D, J = 8 Hz, HAr 6') - 1H at 7.72 ppm (D, J = 8 Hz, H Ar 4') - 1H at 7.55 ppm (T, J = 8 Hz, HAr 5')35 1H at 6.92 ppm (S, H thiazol) - 1H at 5.94 ppm (D of D, Jx = 9 Hz, J2 = 4 Hz, H7) - 1H at 4.96 ppm (D, J = 4 Hz, H6) - 1H at 4.44 ppm (D, J = 13 Hz, CH2 SCO) - 2H at 4.10 ppm (Q, J = 7 Hz, CH2 lΦï3) - 1H at 3.94 ppm (D, J «,ï Lλλ 10 15 20 25 30 35 = 13 Hz, CH2 SCO) at 2.40 ppm (M, CH2 84 2H at 3.77 ppm (Se. -CH2 ) O CH2 SO) - 4H CO 2H at 1.90 ppm (M, ch21 CO NMR n‘ 19 JM: J = 2', 2H at 8.80 ppm (Se., ï$^2 CH3) - 1H at 8.60 ppm (D, 9 Hz, CO NH ) - 2H at 7.95 ppm (D, J = 8 Hz, H Ar 6') - 2H at 7.60 ppm (D, J = 8 Hz, Ar 3', 5') - 1H at 6.94 ppm (S, H thiazol) - 1H at 5.95 ppm (D of D, J3 = 9 Hz, J2 = 4 Hz, H7) - 1H at 4.95 ppm (D, J = 4 Hz, H6)1H at 4.42 ppm (D, J ≈ 13 Hz, CH2 SCO) - 2H at 4.16 ppm (T, J ≈ 7 Hz, CH2 iΦh2 CH3) - 1H at 3.92 ppm (D, J ≈ 13 Hz, CH2 SCO) - 2H at 3.75 ppm (Se., CH2 SO) - 3H at 2.55 ppm (T^ J ≈ 7 Hz, CH2 iΦh2 CH3) - 6H at 1.45 ppm (2S, (CH3)2 C). NMR n° 20 - (b): 1H at 8.84 ppm (D, J = 9 Hz, CO NH ) - 2H at 8.80 ppm (Se., #H2 - CH3) - 2H at 7.95 ppm (D, J ≈ 8 Hz, H Ar, 2', 6') 2H at 7.60 ppm (D, J ≈ 8 Hz, H_ Ar 3', 5')1H at 6.95 ppm (S, H thiazol) - 1H at 5.94 ppm (D of D, Jχ ≈ 9 Hz, J2 ≈ 4 Hz, H7) - 1H at 4.95 ppm (D, J ≈ 4 Hz, Hg) - 1H at 4.45 ppm (D, J ≈ 13 Hz, CH2 S CO) - 2H at 4.16 ppm (T, J ≈ 7 Hz, CH2 N®H2 CH3) - 1H at 3.92 ppm (D, J ≈ 13 HZ, CH2 S CO ) - 2H at 3.75 ppm (Se., CH2 SO) - 3H at 2.55 ppm (T, J = 7 Hz, CH2 b®H2 - CH3) - 4H~at I ∞2 2.40 ppm (M, CH2 (M, CH, tz_ -O) - 2H at 1.90 ppm CO •O) CO NMR n· 21 - (bΐ: 1H at 8.66 ppm (D, J = 9 Hz, CO NH) (Se., CH2 - 2H at 7.55 ppm (M, 5 at 7.37 ppm (T, J = 8 HZ, HAr 5') H thiazol) - 1H at 5.96 ppm (D of D, Hz, H7) - 1H at 4.96 ppm (D, J = 4 Hz ppm (D, J = 13 Hz, CH2 S CO) - 2H at 4 H©H3) - 1H at 3.90 ppm (D, J = 13 Hz, 10 3.78 ppm (S, CH2s°) - 3H at 2.26 ppm at 1.45 ppm (2 S, (CH3)2 C). - 3H at 8.10 ppm H Ar 4', 6') - 1H 1H at 6.95 ppm (S, = 9 Hz, J2 = 4 , H℮) - 1H at 4.39 .07 ppm (M, Ar CH2 CHg S CO) - 2H at (S, CH3 Ar ) - 6H NMR ∩° 22 - (b) : 5 10 15 20 25 1H at 8.89 ppm (D, J = 9 Hz, CO NH) - 3H at 8.10 ppm (Se., CH2 |^3) - 2H at 7.55 ppm (M, H Ar 4', 5') - 1H at 7.37 ppm (T, J = 8 Hz, H Ar 5’) 1H at 6.95 ppm (S, H thiazol ) - 1H at5.95 ppm (D of D, = 9 Hz, J2 = 4 Hz, H7) - 1H at 5,0 ppm (D, 0 = 4 Hz, Hg) - 1H at 4.40 ppm (0, J = 13 Hz, CH2 S CO) 2Hat4.05 ppm (M, Ar CH2 ,^3) - 1H at 3.90 ppm (D, J ≈ 13 Hz, CH2 S CO) - 2H at 3.79 ppm (S, CH2 SO) - 4H at 2.40 ppm (M, CIL- CO) - 3H at 2.25 ppm ~ TL- ch„ CH, (S, CH- Ar) - 2Hat'1.90 ppm (M, tz_ .0) CO NMR n° 23 - (b) : 1H at 8.64 ppm (D, J = 9 Hz, CO NH) - 3Hat8.14 ppm (Se., CH2 fpH-j) - 1H at 7.95 ppm (S, H Ar 2') - 1H at 7,60 ppm (D, J = 8 Hz, H_ Ar 6' ) - 1H at 7.39 ppm (D, 0= 8 Hz, H_ Ar 5' ) - 1Hat 6.95 ppm (S, H. thiazol ) lHat5.95 ppm (D of D, = 9 Hz, J2 = 4 Hz, H^) - 1H at4.96 ppm (D, J ≈ 4 Hz, Hg) - 1Hat 4.37 ppm (D, J = 13 Hz, CH2 SCO) - 2H at4,08 ppm (M, CHg iftg) - 1H at3.94'ppm (D, J ≈ 13 Hz, CH2 SCO) - 2H at3,74 ppm (Se., CH2 SO) - 3Hat2.37 ppm (S, Ar CH3) - 6H at 1.45 ppm (2S, (CH3)2 C) - NMRn° 24 - (b) : 1H at 8.80 ppm (2D, J ≈ 9 Hz CO NH) - 3H at 8.20 ppm (Se., CHg ^H3) - 1H at 7.94 ppm (S, H Ar 2') - 1H at 7.80 ppm (D, J = 8 Hz, H Ar 61) - 1H at 7,39 ppm (D, J ≈ 8 Hz, H_ Ar 5' ) - 1Hat 6,95 ppm (2S, H_ thiazol ) 1H at 5 ,94 ppm (Dof D, = 9 Hz, J2 = 4 Hz, Hy) - 1H at 4.95 ppm (2D, J = 4 Hz, Hg) - 1H at 4.70 ppm (M, CH3 .CH ON) - 1H at 4.37 ppm (2D, 0 = 13 Hz, CH2 SCO) - 2H at4.08 ppm (M, CH2 ^H3) - lHat3.94 ppm (D, J = 13 Hz, CH2 SCO) - 2H at 3.73 ppm (Se., CHg·SO) - 3Hat2.36 ppm (S, Ar CH3) - 3H atl',42 ppm (D, J = 7 Hz, CH3 CH ON) - 30 'NMR n° 25 - (b) : 1H at 8.66 ppm (D, J = 9 Hz, CO NH) - 3H atβ,17 ppm (Se., CH2 1^H3) - 2H at7.80 ppm (M, H Ar 2' , 6') - 1H at7.50 ppm (D, J = 8 Hz, H Ar 5') - 1H at6,95 ppm (S, H_ thiazol) - 1H- 5.95 ppm (D °fD, J1 = 9 Hz, 02 = 4 Hz, 5 Hy) - 1H at 4.95 ppm (D, J = 4 Hz, H℮) - lHat 4,40 ppm (D, J ≈ 13 Hz, CH2 S CO) 2H at 4.06 ppm (M, CH2 i^3) - 1H at 3.90 ppm (D, J = 13 Hz, CH2 S CO) - 2H at 3.74 ppm (S, CH2 SO) - 3H at 2,46 ppm (S, Ar CH3) - 6H at 1.46 ppm (2 S, (CH3)2 C) NM R n° 26 - (b) : 10 1H at 8.80 ppm (2D, J = 9 Hz, CO NH) - 3H at8.20 ppm (Se., CH2 N^U) - 2H at 7.80 ppm (M, H Ar 2', 6') - 1H at 7.46 ppm (D, J ≈ 8 Hz, H Ar 5') - 1H at6,95 ppm (2S, IH thiazol ) - lHaΐ5.94 ppm (D ofD, 0^ = 9 Hz, J2 = 4 Hz, Hy) - 1H at4 ,95 ppm (2D, J ≈ 4 Hz, Hg) - 1H at4.66 ppm (M, CHg CH- ON) - 1H aΐ4.40 ppm (2D, J ≈ 13 Hz, CH2 SCO) - 15 2H at4.06 ppm (M, CH2 Λj) - lHat3.90 ppm (D, J ≈ 13 Hz, CH2 SCO) - 2H at 3.76 ppm (Se., CH2 SO) - 3H at 2.40 ppm (S, Ar CHg) - 3H at 1.44 pm (D, 0 = 7 Hz, CH3 CH ON) NMRπ0 27 - (b) : 1H at8.66 ppm (D, J = 9 Hz, CO NH) - 3H at7.80 ppm (Se., CH2 N3^) - 20 1H at6,95 ppm (S, _H thiazol ) - lHàt5.98 ppm (D of D, J1 = 9 Hz, ^2= ^ ^7) " 1H at 4.95 ppm (D, J ≈ 4 Hz, Hg) - lHat4.18 ppm (D, J = 13 Hz, CH2 S CO) - 1H at 3.78 ppm (D, J = 13 Hz, CH2 SO) - 2H at3.69 ppm (Se., CH2 SO) - 2H at 2.95 ppm (M, CH2 ^ ) - 6H at 1.45 ppm (2S, (CH3)2-C-0) - 6Hatl,22 ppm (S, (CH3)2 C COS) - NMR n° 28 - (b) : 1H at 10,80 ppm (S, Ar NH CO) - 1H at 8.66 ppm (D, J = 9 Hz, CO NH) - 3H at 8.05 ppm (Se., CH2 f^) - 2H at7,89 ppm (D, J = 8 Hz H Ar 2', 6') 2H at7.74 ppm (D, J = 8 Hz H_ Ar 3' , 5' ) - 1H at 6,96 ppm (S, thiazol) 5 1H at 5.95 ppm (D of D, = 9 Hz, = 4 Hz, H^) ~ 1H at 4.95 ppm (D, J = 4 Hz, Hg) - 1H at 4.42 ppm (D, J = 13 Hz, CH℮ S CO) - lHat3.88 ppm (D, J ≈ 13 Hz, CH2 S CO) - 4H at 3.80 ppm (M, CH2 SO and CH2 ^H3) - 6H atl .45 ppm (2S, (CH3)2 C) 10 15 NMR n° 29 - (b) : 1H atlθ.83 ppm (S, Ar NH CO) - 1H at8.89 ppm (D, 0 = 9 Hz, CO NH) - 3H at 8.10 ppm (Se., CH2 γPh^) - 2H at 7,90 ppm iQ , J = 8 Hz, H Ar 21, 6‘) 2H at 7.71 ppm (D, J ≈ 8 Hz, H_ Ar 3' , 51 ) - 1H at 6,95 ppm (S, H_ thiazol ) 1H at5.94 ppm (D of D, Jχ = 9 Hz, J2 * 4 Hz, H?) - lHat4.95 ppm (D, J = 4 Hz, H ) - lHatT745 ppm (D, J = 13 Hz, CH? S CO) -6. 1H àt3.87 ppm (D, 0 = 13 Hz, CHg S CO) - 4H at 3.80 ppm (M, CH2 S0andCH2 ^3) CHr 4H at2,40 ppm (M, CHg- 0) - 2H at 1.90 ppm (M, CH9- t£ L-0) CO Co NMRn° 30 (b) : 20 1H at 8.50 ppm (Se., N®H2 piperidine) - 1H at 8.20 ppm (Se., N®ll2 piperidine) 1 H at 8,36 ppm (D, J = 9 Hz, CO NH_) - 1H at 6.76 ppm (S, H_ thiazol ) - 1 H at 5.95 ppm ( C of D, = 9 Hz, J2 = 4 Hz, H?) - IHat 4.92 ppm (D, 0 ≈ 4 Hz, Hg) - IHat 4.16 ppm (D, J = 13 Hz, CH2 S CO) - IHat 3.72 ppm (D, J = 13 Hz, CH2 S CO) - 2H at 3.14 ppm (S, CH2 SO) - 2H at 3.17 ppm 25 2H at 2.80 ppm (M, CHg in≈< fpHg) - 2H at 2.55 ppm (D, J = 7 Hz CH2 CO S) - 1H at2.00 ppm (M,. CH CH2 CO S) - 2H at 1.75 ppmand2H 1.30 ppm (M, CH2 injβ N®H2) - 6H at 1.45 ppm (2S, (CH3)2 C) - NMR ∩° 31 - (b) : 1Hat 8.34 ppm 3H at 7 .30 ppm 1H at 5 .95 ppm 1H at4,92 ppm 1H at 4.15 ppm lHat3.72 ppm piperidine) - 1Hat 2.87 ppm 2H at 1,86 ppm 5 piperidine) (D, J = 9 Hz, CO NH) - 3H at7.92 ppm (Se., CH2 l^kg) - (Se., I^3 thiazol ) - lHat6,76 ppm (S, H, thiazol ) - (D of 0, J1 = 9 Hz, J2 = 4 Hz, H?) - (D, J = 4 Hz, Hg) - 1H at 4.26 ppm (DE, J = 12 Hz, H^piperidine) (D, J = 13 Hz, CH2 SCO) - 2H at 3.84 ppm (M, CH2 |φ*3) - (D, J = 13 Hz, CH2 SCO) - 3H at 3.60 ppm (M, CH2 SO + Hβ Eq lHat3.05 ppm (TE, J = 12 Hz, H2 Ax piperidine) - (TE, CH COS) -· 1H at2.74 ppm (TE, J = 12 Hz, Hg Ax piperidine) (M, H en 3 in 5 piperidine) - 2H at 1.45 ppm (M, H en 3 and - 6H at 1.45 ppm (2S, (CH3)2 C) - NMR∩° 32 - (b) ; 1H at8,66 ppm (D, 0 ≈ 9 Hz, CO NH) - 3H at7.90 ppm (Se., CH℮ ^3) - 3Hat7.30 ppm (Se., - NΦH3 thiazol ) - lHat6.78 ppm (S, H thiazol ) - 1H at 5,90 ppm (D of D, ≈ 9 Hz, J2 ≈ 4 Hz, Hy) - 1H at 4.94 ppm (0, J = 4 Hz, Hg) - 1H at 4.26 ppm (De., J =» 12 Hz, H2 Eq piperidine) - lHat4.16 (D, 0 » 13 Hz, CH2 S CO) - 2Hat 3.82 ppm (M, CH2 Gly) - 1H at 3.74 ppm (D, J = 13 Hz, CHg SO) 3Hat3.63 ppm (Se., CH2 SO Hg Eq piperidine) - lHat3.05 ppm (Te., 0 = 13 Hz, H? Ax piperidine) - lHat2.87 ppm (Te., 0 = 12 Hz, S - C CH ) -lHat2.75 ppm - ΰ (Te., J = 12 Hz, Hfi Ax piperidine) - 4Hat2.44 ppm (M, CH,- ti ■CO) 4H at 1.90 ppm (M, CH2t CH, -0 andH3 EqandHg Eq piperidine) - CO 2H at 1.50 ppm (M, H3 AxandHg Ax piperidine) NMRπ° 33 - (b) : 1H at 10.70 ppm (S, Ar NH CO) - 1H at 8.70 ppm (D, J = 9 Hz, CONH) - 1H at 8 .30 ppm (S, H Ar 2') - 3Hat8.10 ppm (Se., CH2 f^3) - lHat7.75 ppm (D, J = 8 Hz, H Ar 6') - 1H at 7.60 ppm (0, J = 8 Hz, H Ar 4') - 1H at 7.50 ppm 5 (T, J = 8 Hz, H Ar 5’) - 1H at6.95 ppm (S, H_ thiazol ) - lHat 5.95 ppm (Dof D, J1 = 9 Hz, 02 = 4 Hz, H?) - lHat4.95 ppm (D, J = 4 Hz, Hβ) - 1H at 4 .45 ppm (D, J ≈ 13 Hz, CH2 S CO) - 1H at 3.90 ppm (D, J ≈ 13 Hz, CH2 S CO) 4H at 3 .75 ppm (M, CH2 S0andCH2 Gly) - 6H at 1.45 ppm (2 S, (CH3)2 C) 10 IS 20 25 NMRn° 34 - (b) : 1H at 10.65 ppm (Se., Ar NH CO) - lHat8.80 ppm (D, J = 9 Hz, NH CO) - 1H at8 .25 ppm (Se. , H Ar 2' ) - 3Hat 8.05 ppm (Se., CH2 I^3) - 1H at 7 .75 ppm (D, J = 8 Hz, H Ar 6') - 1H at 7.58 ppm (0, J = 8 Hz, H Ar 4') - 1H at 7.50 ppm (T, J = 8 Hz, H Ar 5' ) - 1H at 6.95 ppm (S, H_ thiazol ) - 1 IIat5.95 ppm (D of D, J1 = 9 Hz, J2 = 4 Hz, Hy) - 1 Hat 4.95 ppm (D, J = 4 Hz, Hg) - 1H at 4.45 ppm (D, J = 13 Hz, CH2 S CO) - lHat 3.90 ppm (D, J = 13 Hz, CH2 S CO) 4H at 3,75 ppm (M, CHg SOandCHg Gly) - I 4H at2.40 ppm (M, CH,,· •CH CH, ■0) - 2H at 1.90 ppm (M, +L 0) CO CO NMRn0 35 - (b) : 1H at 8.40 ppm (D, J = 9 Hz, CO NH) - 6H at7.60 ppm (Se., N®H3) - 1H at6.80 ppm (S, H_ thiazol ) - 1H at 5,95 ppm (D de D, = 9 Hz, J2 = 4 Hz, Hy) - lHat 4.95 ppm (D, J = 4 Hz, Hg) - lHat 4.30 ppm (M, H2℮ piperidine) lHat4.16 ppm (D, J = 13 Hz, CH2 S CO) - lHat 3,75 ppm (D, J ≈ 13 Hz, CH2 S CO) 2H at 3.60 ppm (S, CH2 SO) - 1H at3.55 ppm (M, Hg℮ piperidine) - 4H at 2.90 ppm (Mi CH2 ^3 et H2aandH5a piperidine) - 3Hat 2.60 ppm (M, CH2 CH2 N^i3 H^-piperidine) - 2H at1.80 ppm et 2H at 1,50 ppm (2 M, H3 at Hg piperidine) 6H at 1.45 ppm (2 S, (CH3)2 C) NMRΠ0 36 - (b) : 5 10 15 lrl at 8.70 ppm (D, 0 = 9 Hz, CO NH) - 3H at 8.20 ppm. (Se., CH2 A3) - 1H at 7.75 ppm (0, J = 8 Hz, H Ar 6') ~ 2H at 7.43 ppm (M, H Ar 3', 5') - 1H at6.98 ppm (Se., H thiazol ) - 1H at 6.00 ppm (D of D, 0j = 9 Hz, J2 = 4 Hz, H7) - 1H at4.97 ppm (D, J = 4 Hz, Hg) - 1H at 4.34 ppm (D, 0 = 13 Hz, CH2 S CO) - 2H at4.00 ppm (M, CH2 A3) - 1H at 3.90 ppm (D, 0 = 13 Hz, CH2 S CO) 2H at 3.77 ppm (Se., CH2 SO) - 1H at 2.34 ppm (S, CH3 Ar) - 6Hat 1.46 ppm (2 S, (CH3)2 C) NMRΠ° 37 - (b) : 1H at 8.80 ppm (D, J = 9 Hz, CO NH) - 3Hat8.15 ppm (Se., CHg N®H3) - 1Hat7.72 ppm (D, J = 8 Hz, H; Ar 6') - 2H at7.40 ppm (M, H Ar 3', 5') - 1H at 6.95 ppm (S, H_ thi azol ) - 1H at 5.95 ppm (0 of D, 9 Hz, J2 = 4 Hz, Hy) - 1H at 4,93 ppm (D, J ≈ 4 Hz, Hβ) - 1H at 4.34 ppm (D, J = 13 Hz, CH2 S CO) - 2H at 4.00 ppm (M, CH2 A3) -lHat3.90 ppm (D, 0 ≈ 13 Hz, CH2 S CO) - 2H at 3,78 ppm (Se., CH2S0) - 2Hat2.34 ppm (S, CH3 Ar) - 0 0 4H at2.30 ppm (M, CH0· t: -CO) - 2H at 1.80 ppm (M, CHg- ■C0 -CH, NMRn° 38 - (b) : 20 1H at8.60 ppm (D, J = 9 Hz, CO NH) - 7H at 7.70 ppm (M, H Ar et CH2 A3) - 1H at 6.98 ppm (S, H thi azol ) - 1H at5.9S ppm (D of D, = 9 Hz, J2 ≈ 4 Hz, H7) - lHat4.96 ppm (D, J = 4 Hz, H5) - lHat4.38 ppm (D, J = 13 Hz, CH2 S CO) 1H at 3 .94 ppm (0, J » 13 Hz, CH2 S CO) - 2H at 3.75 ppm (Se., CH2 SO) - 3H at 3.00 ppm (M, CH CH2 NΦH3) - 6H at 1.47 ppm (2 S, (CH3)2 C) - 25 3H at 1,19 ppm (D, J = 7 Hz, CH3 CH) 5 10 lH·at3.80 ppm (D, J = 9 Hz, CO NH) -7Hat7.80 ppm (M, H Ar et N®H3 CH2) 1Hat6.95 ppm (S, H thiazol ) - 1H at 5.95 ppm (D de 0, ≈ 9 Hz, J2 = 4 Hz, Hy) - 1H at 4.97 ppm (D, J = 4 Hz, Hg) - lHat 4.40 ppm (D, J = 13 Hz, CH2 S CO) - 1H at3.93 ppm (D, J = 13 Hz CH2 S CO) - 2Hat3.75 ppm (Se., CH2 SO) - 3H at 3.00 ppm (M, CH CH2 N®H3) - 0 0 4Hat2.40 ppm (M, CHg- • CO) - 2H at i ,85 ppm (M, CH CH, CO 3H at 1.25 ppm (D, 0 = 7 Hz, CH-j CH.) NMR∩° 40 - (b) : 1H at 12.5 ppm (Se., Ar NH CO) - 1H et 8.75 ppm (D, 0 = 9 Hz, CO NH) lHatδ.OO ppm (S, JH thiazol in 3) - 3Hat7.75 ppm (Se., CH2 ff^H·j) - 1H at7.00 ppm (S, H thiazol ) - 1H at 5.98 ppm (D of D, => 9 Hz, J2 ≈ 4 Hz, 15 H7) - lHat4.95 ppm (D, J » 4 Hz, Hg) ~ 1H at 4 .40 ppm (D, J = 13 Hz, CH2 S CO)1H at3.78 ppm (D, J ≈ 13 Hz, CHg S CO) - 2Hat3.75 ppm (Se., CH2 SO) - 2H at3.50 ppm (M, CHg N®H3) - 2H at2.80 ppm (M, CH2 CHg ^3) - 6H at 1.45 ppm (2 S, (CH3)2 C) NM R n° 41 - (b) : 20 1H atl2.8 ppm (Se., NH CO CHg) - lHat8.80 ppm (D, J = 9 Hz, CO NH) 3Hat8.25 ppm (Se., CH2 N^H^) - lHat8.16 ppm (S, JH thiazol i∩ 3) lHat7.00 ppm (S, JH thiazol) - lHat5.96 ppm (D of D, = 9 Hz, J2 = 4 Hz, H7) - 1H at4 .97 ppm (D, J = 4 Hz, Hg) - lHat4.40 ppm (D, J ≈ 13 Hz, CH2 S CO) 3H at 3.90 ppm (M, CH2 f^3 et CH2 S CO) - 2Hat3.75 ppm (Se., CH2 SO) - 25 5H atl .44 ppm (2 S, (CH3)2 C) IH at8.75 ppm (0, J = 9 Hz, CO NIH) - lHat8.55 ppm (D, H_ thiazol in 3) 3Hat8.50 ppm (Se., CH^ N%3) “ lHat7.00 ppm (S, H_ thiazol) - 1H at 5.95 ppm (D of D ≈ 9 Hz, J2 = 4 Hz, H^) - lHat4.96 ppm (0,0=4 Hz, Hg) - 5 2H at 4.46 ppm (M, CH2 i^H3) - lHat4.30 ppm (D, J = 13 Hz, CH2 S CO) - IH at 3 .90 ppm (0, J = 13 Hz, CH2 S CO) - 2H at 3.73 ppm (Se., CH2 S0) - 6H at 1.44 ppm (2 S, (CH3)2 C) NMR∩° 46 - (b) : IH at 8.87 ppm (T, J = 8 Hz, NH CH? Ar) -lHat8.64 ppm (0, J = 9 Hz, NH CO) 10 3H at 8.00 ppm (Se., H3 N® CH£·) - 2H at 7.84 ppm (D, J = 8 Hz, H Ar 2', 6') 2H at 7.42 ppm (0. 0 = 8 Hz, HI Ar 3' , 5' ) - 1H at 6.94 ppm (S, IH thiazol ) 1Hat 5.95 ppm (D ofQ, = 9 Hz, J2 = 4 Hz, H?) - IH at4.95 ppm (D of 0, 0 = 4 Hz, Hg) - 3H at 4.40 ppm (M, Ar CH2 NH et CHg S C0) - IH at 3.88 ppm D, J ≈ 13 Hz, CH2 S CO) - 2H at3.74 ppm (Se., CH2 S->0) - 2H at 3.58 ppm 15 (M, 0C CH2 N®H3) - 6H at 1.47 ppm (2 S, (CH3)2 C) The products of the invention have been studied as regards their pharmacological properties and, more especially, bacteriostatic action. This has been determined in vitro by the dilution method, and the study was on. 20 Gram negative strains. Results, expressed in minimum inhibiting concentrations (MIC - ^μg/ml ) , are collected in the following table (Table III). .Mic_(^giπii2 25_9!Eperent_strains -{=» H= cn vD cr> i w £Π ω I ro cπ RODUCT SR No. 42 535 42 536 42 537 42 538 42 540 42 541 42 542 42 546 42 547 42 548 42 549 42 581 42 582 42 583 42 584 42 585 42 586 42 587 42 657 STRAINS J№ CΠ 42 658 42 661 42 663 42 664 42 665 42 674 42 675 42 676 42 685 -42 686 42 687 42 688 42 689 42 690 42 781 42 782 42 783 42 811 42 814 STRAINS tn «J ςn The results presented in Table III show good activity on Gram negative bacteria of the products according to the invention. To evaluate the stability of these products towards beta-lactamases, their MIC was determined on isogenic strains producing and not producing beta- 5 lactamases. The results are expressed in μg/ml in Table IV. TABLE IV 10 MIC (μg/ml) ON STRAINS PRODUCING BETA-LACTAMASES AND NOT PRODUCING (indicated by *) as According to the results of Table IV, the products according to the invention have an equal or comparable activity on strains producing or not producing beta-lactamases, which shows the good stability towards beta-lactamases. The therapeutic effectiveness of the products was determined on the septicemic model of the mouse. The septicemia was initiated by the intraperitoneal 5 innoculation of 0.5 ml of a suitable dilution of a suspension of the Escherichia coli SOL 90 strain. The products were administered in solution in a phosphate buffer pH 7.0 in a volume of 0.2 ml sub-cutaneously to batches of 10 mice, 1 to 5 hours after innoculation of 10 the microorganism. After 4 days of observation in the course of which the mortality was noted, the 50% effective doses (DE 50) were calculated by the Muench and Reed method. The results obtained are shown in Table V. 15 TABLE V DES0 (mg/kg) IN THE SEPTICEMIC MODEL IN THE MOUSE ND = not determined According to the results of Table V, the products, according to the invention, show good IN VIVO therapeutic activity. In addition, according to tests carried out up till now on animals, the toxicity of the products according to the invention has appeared to be sufficiently low to enable their use in therapeutics. The products of the invention can hence be employed as antibiotics in human or veterinarian medicine. They have a wide spectrum on Gram negative organisms and can be used in all germ sensitive bacterial infections. The products can be administered by the general route (parenteral, oral or topically). The pharmaceutical compositions are produced from the compounds (I) in soluble form obtained by salification of one of the acid functions of the molecule or of one of the amine functions of the B chain. The pharmaceutical compositions can be solid or liquid and be presented, for example, in the form of injectable preparations, tablets, gelules, granules, pommades, creams, gels or suppositories. The posology can vary within wide proportions, in particular according to the type and seriousness of the infection to be treated and according to the mode of administration. Mostly, in the adult, by the injectable route, it is comprised between 0.250 g and 4 g per day. 5 To a solution of 3 g of dihydrochloride of SR 41 973 in 25 ml of water, is added drop by drop a saturated solution of sodium bicarbonate. When the pH is 3, the solution is filtered. The pH is then adjusted to 3.6 by the addition of some drops of saturated 10 solution of sodium bicarbonate. The solution is cooled to + 4°C and the SR 41 973 starts to crystalline. 75 ml of acetone are added slowly drop by drop. After 1.25 g of the SR 41 973 so obtained is suspended in 15 ml of water at + 4°C. A solution of 20 0.168 g of sodium bicarbonate in 3 ml of water is added drop by drop. The clear solution thus obtained is frozen and freeze-dried, after sterile filtration, to obtain the sodium salt of 41 973 ready for injection. The present invention relates to a process for producing antibiotic compounds derived from cephalosporins having formula ; <IMG> (I) in which: . The COOA group at the 4 position is an acid radical, or an alkaline or alkaline-earth salt or an amino acid or amine salt, for example triethylamine or ethanolamines, or an easily hydrolyzable or metabolically labile and pharmaceutically acceptable ester radical. X denotes an oxygen atom or a sulfur atom n is zero or 1. R1 and R2 each denote independently hydrogen or a lower alkyl group, preferably a methyl group, or R1 and R2 taken together with the carbon atom to which they are linked form a cyclobutyl or cyclopentyl nucleus. B is the residue of a primary or secondary amine, said process consists of acylating 4-tertiobutyl-l-S-oxide 7-amino-3-bromomethyl 3-cepheme carboxylate (II) with the acid(IlI) to obtain the compound (IV) described in European patent application 60745 and of adding to compound (IV) an acid B-(CH2)n-COOH or B(CH2)nCOSH. 1. Derivatives of the family of cephalosporins of the formula in which : 15 - the C00A group in the 4 position is an acid radical or an alkali or alkaline-earth salt, or an amino acid or amine salt, or an easily hydrolyzable or meΐabαlically labile and pharmaceutically acceptable ester radical ; - X denotes an oxygen atom or a sulfur atom ; 20 - n is zero or 1 ; - R^ and Rg each denote independently hydrogen or a lower alkyl group, or . R^ and Rg taken together with the carbon atom to which they are linked form a cyclobutyl or cyclopentyl nucleus;, ' 25 , B is the residue of a primary or secondary amine selected by the following groups : - Z-NH-R where Z is a straight or branched chain alkylene group having from 2 to 7 carbon atoms, optionally interrupted by a sulfur atom and optionally substituted by a hydroxyl, thiol, 30 methylthio, amino, acetamido, carbamoyl, phenyl, hydroxyphenyl or imidazolyl group, Z can also be a cyclopentylidene or cyclohexylidene groυp^and R represents a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms^ 35 - Z'-Alk-NH-R where Aik represents a straight or branched alkyl group having from 1 to 3 carbon atoms, R is as defined above or is aminoacetyl, -Z'-N-CO-Y-NH-R" where Z' is as defined above, Y denotes an alkyl (CH2)in group in which m = 1, 2, 3 or 4, a branched alkyl group having 2 or 3 carbon atoms or again Y with NH-R" constitutes a ring R' and R", identical or different, represent a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms, -Z"-NH-R where Z" is a 1,3-cyclohexylene or 1,4 cyclohexylene group and R represents a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms, hydrogen atom or a methyl group, n = 0 or 1 and Aik is as previously defined and R represents a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms, Aik is as previously defined and R represents a hydrogen atom or alkyl group having from 1 to 3 carbon atoms, - a 2-piperidyl, 3-piperidyl or 4-piperidyl group optionally substituted on the nitrogen atom by a -C0- Alk-NH2 or a -CO NH group where Aik is as previously defined, and the salts of said compounds with pharmaceutically acceptable acids, said derivatives being in one of the syn and anti forms. 2. Derivatives of the family of cephalosporins according to claim 1 of formula (I) in which: and R2 each denote independently hydrogen or a methyl group. 3. Derivatives of the family of cephalosporins according to claim 1 of formula (I) in which the COOA group is a triethylamine or ethanolamine salt. 4. Derivatives according to claim 1, wherein R^ and R2 are each a methyl group; X = oxygen; n = 0 and B is selected from the group consisting of: -(CH2)4NH2; ΛO CH2NH2; Λ0 )~CH2NH2; 'I CH. u -<(θ^)-NH--C-CH2-HN2; and 0 y-N-C~CH2-NH2 5.A derivative according to claim 1, wherein R^ and R2 are each a methyl group, X ≈ oxygen, n ≈ 1 and B is the group 6.Derivatives according to claim 1, wherein R^ and R2 are each a methyl group; X ≈ sulfur, n = 0 and B is selected from the group consisting of: 7. Process for the preparation of derivatives of the family of cephalosporins according to claim 1 which comprises : 1) acylating 4-tertiobutyl 7-amino 3-bromomethyl· 3-cepheme carboxylate 1-S-oxide of formula II 15 0 20 CΠ) by the acid of formula III NH-Tr 25 S M C - COOH ii N R, I I1 COOΐSu (III) 30 in which Tp is the trityl group, tBu the tertiobutyl group, and are as defined above, to obtain the compound of formula IV 35 NH-Tr R? C00ΐ3u 2)adding to said compound of formula IV an acid B-(CH2)n-C00H or a thioacid B-(CH2)n COSH, in which B is the 10 residue of a primary or secondary amine as defined above, the amine function of said acid having been previously protected, to form the compound of formula V 15 20 in which Tr, R^, Rg, n are as previously defined and 8' represents 25 the group B in which the amine function is protected,, 3) removing the protective groups on the amine and carboxy functions to obtain the compound of formula I in which A is hydrogen. 4) optionally converting said compound obtained into a 30 compound of formula I in which A is other than H by acting on said compound with an inorganic or organic base or by esterification. 5)optionally converting said compound of formula I into one of its salts by reaction with a pharmaceutically acceptable acid. 35 8. Process according to claim 7, wherein the addition of the Ill acid B-ζCHgJη-COOH is carried out through the intermediate by using the sodium or potassium salt of said acid, said addition being carried out in an aprotic polar solvent. 9. Process according to claim 7 , wherein the addition of the 05 thioacid B’-ζCh^^-COSH is carried out by using the sodium or potassium salt of said acid, said addition being carried out in an apolar solvent. 10. Pharmaceutical compositions containing as active ingredient a derivative according to claim 1 in combination with a 10 pharmaceutically acceptable vehicle. 15 20 25 30 35PROCESS FOR PRODUCING ANTIBIOTIC COMPOUNDS DERIVED FROM CEPHALOSPORINS
/ TA3LEAÜ I / SR nα n A -c B Chroma t off rnphy eluant from intermediate V vol/vol IR uCO cm"* intermediate V NMR no. 41 730 0 Λ ch3 ch3 (CH2)2 NHj CH2 Cl2 85 Ac 0 εt 15 1805 1725 1590 i 41 731 " " -CH - NH2 © CH2 Cl2 92.5 Ac 0 Εt 7.5 1805 1723 2 41 732 11 * -CH - NH2 © kN^0H CH2 Cl2 90 Ac 0 Εt 10 1305 1725 3 41 733 " " -CH - NH2 © ch3 m o o 1305 1725 4 ■ 41836 • " CH2 Cl2 95 Ac 0 εt 5 1805 1730 5 Chromatography IK A -C B eluant from inteπnedi ato V OCO cm'1 NiMR no. V vol/vol intermcdi ate *2 V “pH* nh2 © ch2 - CH - CH3 £h3 -CH - NH, © CH - CH,CH, ch3 Chromatography IR niuant from NMR no. 5R no, ∩ -C B intermediate V intermediate Nr2 vol/vol V 41885 0 A -ÇH - NH2 © CH - OH CH2 Cl2 85 ■ 1305 15 ch3 ch3 i», Ac 0 εt 15 1720 -CH - NH, © CH2 Cl2 100 1805 41885 " 12 1720 16 ch2 co mh2 Ma OH 1.5 1680 -CH - NH, © CH, Cl, 95 1805 41387 l 2 2 2 17 ch2 - ch2 s ch3 . Ac 0 Et 5 1725 41888 „ “CH - NH2 φ CH, Cl2 100 1805 18 (ch2)4 - NH2 Me OH 1 1720 41889 -ÇH - ,NH2 © CH, Cl, 80 1805 1 u 19 !Yj HN Ac 0 Et 20 1755 1720 CH2 Cl2 90 1805 . 20 41891 <■ 1* i CH 3 Ac 0 Et 10 1725 CH, Cl, 90 1805 41967 il (CH2)4 nh2 r 1725 1690 21 41975 „ V~1 1 1805 22 Ac 0 Et 7.5 1725 . H2N '- 41 976 - >0 HjN CH2 Cl2 92.5 Ac 0 Et 7.5 1805 1730 23 T R. Πiromatography IR SR no. /i ?luant from NMR no. n - C *2 B intermediate V intermediate vol/vol V 42031 0 -CH - NH2 CH2 ci2 35 1805 34 CH - OH 1725 ch3 ® Ac 0 εt 15 1675 42042 " " -(θ)- CHjNHg CH2 C12 90 Ac o εt io 1310 17301690 ' cci4 35 CHj -C -CH-.NHl 2 2 CH- Cl-' 90 1805 42 073 H " 1725 36 Ac o εt io 1690 ch3 42 117 ■■ » CH2 Cl2 100 Me OH 1 1810 17251585 cci4 37 CH- Cl- 90 1805 42 120 It » 4 4 38 Ac o εt io 1725 CD CH- Cl- ·90 1805 39 42 121 H, " -ch-ch2ch2nh2 4 4 1730 • ch3 Ac o εt io 1690 42 139 -CH - NH2 CH - CH3 CH2 Cl2 95 1805 1725 40 ‘ ® Ac 0 εt 5 1690 CH- Cl- 90 1805 42 140 -ch2 ch2 nh ch3 4 4 1730 41 Ac o εt io 1690 CH- Cl, 100 1305 42 131 M -(CH2)3NH CH, CH3 4 4 1730 42 Me OH 1 1635 CH2 Cl2 42 182 » c 2 I 3 CH2 Cl2 90 1805 1735 43 CH3 (D Ac o εt 10 1685 SR no. n Λ -c β Chromatography eluant from intermediate V vol/vol IR ΐ) CO cm intermediate V NMR no. 42 133 0 X ch3 ch3 -(CH2)5MH ch3 CH2C12 100 Me OH 1 1310 17351690 CCI4 44 42 191 h - CH2 o CH2 Cl2 35 Ac 0 εt 15 1805 1730 1690 . 45 42 192 n ~0 o ■ CH2 Cl2 90 Ac o εt io 1805 1730 1690 46 42 193 U -ch2 -<^Ô)-ch2nh2 CH2 Cl2 90 Ac 0 Εt 10 1805 1720 47 42 194 u -0 CH2NH2 CH2 Cl2 90 Ac o εt io 1805 1725 48 42 19S 11 - ch2 ,-(ch2)3 nh2 CHj Clj 35 Ac 0 εt 15 1805 1730 1690 49 42 196 11 " CH2 Cl 2 90 Ac o εt io 1305 1725. 1685 50 42 197 . 11 - CH2 -(CH2)4 nh2 CH2 Cl2 85 Ac 0 Εt' 15 1805 1725 1690 51 42 198 ■o “ CHZ Cl2 90 Ac 0 Εt 10 1805 1725 1595 52 /R1 -0 Chromatography 1R SR nrv n B eluant from intermediate V t)C0 cm * intermed iate NMR no. vol/vol V 42 200 0 © o o 1805 1725 53 42 201 " -CH-CH,NH1 2 2 /-s ch3 ® CH2 Cl2 90 Ac o εt 1805 1725 1590 54 CH, 13 CH- Cl. 92.5 1805 4 2 208 " -C - CH-NH- 55 i»32 ! Ac 0 Εt 7.5 1725 - CH - CH2CH2NH2 CH- Cl- 90 1805 55 42 209 II 11 CH3 ® d d 1725 Ac o εt . io 1690 1 1805 57 42 210 " " d d h2n ^ Ac 0 εt 7.5 1725 42 211 " ■ ^ n.ÇHgHHg CH2 Cl2 85 Ac o εt 1805 1725 1590 58 1805 59 42 212 II » d 1725 Ac o εt io 1590 -CH CH- Cl- 85 1805 60 42 213 » ch3 -(CH2)3HH2 d · * 1730 Ac 0 εt 15 1590 CH- Cl- 85 1305 42 214 » » „(ch2)4nh2 6 d 1730 61 Ac 0 εt 15 1590 42 215 ■ ■ ■CX CH2 Cl2 90 Ac o εt io 1305 1735 1590 62 1 Λ -c \ Chromatography IR SR no. n β rluant from intermediate V ()CO cm'1 intermediate NMR no. R2 VO1/vol V - CH - CH2 Cl2 90 1810 63 42 215 0 1CH3 -%%DESCRIPTION%%)-CH2NH2 Ac 0 Et 10 1725 cα4 42 2 1 7 " ■ ^ ^)"»CH2NH2 CH2 Cl2 90 Ac 0 Et 10 1810 1725 1690 64 42 320 A CH2 Cl2 . 95 1805 65 ch3 ch3 CH2NH2 Ac 0 Et 5 1725 42 321 o ch2 Cl2 100 1805 1730 66 ℮'h2NH2 Me OH 1 1690 42 371 1 « -o Nh ch2 Clj 100 67 Me OH 0.7 42 372 „ -o ch2 ci2 100 68 N NH Me OH 0.7 / Æ) o CH- Cl- 100 1805 42 374 0 \ / « 1725 69 NHC CH2NH2 Me CH 1 1690 42 379 I. II -(θVCH3 CH2 Cl2 90 1805 70 \ Ac 0 Et 10 1725 ÆVcHgNHj CH- Cl- 95 1805 42 380 • " 2 2 Ac 0 Et 5 1725 71 ' CH3 42 395 " " -<Ô)-ch2nh ch3 CH2 Cl 2 90 Ac 0 Et 10 1805 1725 1685 72 SR no. ∩ Λ B ‘Chromatography eluant from \ntermediate V vol/vol IR Î CO cm1 intermediate V MMR no. 42 463 0 -/θVCH2NH2 "-ch3 CH2 Cl2 100 Me OH 1 1805 1720 82 42 464 ■ « -(5)-CH2NHCH3 CH2 Cl2 100 Me OH 1 1805 1720 1690 83 42 465 " A ch3 ch3 ■@ΐ ^NHC(CH2)2MH2 CH2 Cl2 100 Me OH 1.5 1805 1725 1690 84 42 466 '■ » ?n"nhc' ch2nh2 CH2 Cl 2 100 Me OH 1.5 1805 1720 85 42 467 • » / \ 0 ■\θ)"NH^CH2NH2 CH2 Clj 100 Me OH 2 1805 1720 86 42 471 1 6 -o N- ch2ci2 100 Me OH 0,5 1805 C Cl, 1720 ^ 1675 87 42 472 - - -o NNH CH2 Cl2 95 Ac 0 Et 5 1805 C Cl, 1725 * 1675 88 42 473 " 'o CHj Clj 100 Me OH 0.5 1805 C Cl. 17254 1685 89 42 474 " a\ ch3 ch3 CH2 Cl g 95 Ac 0 Et 5 1805 · C Cl, 1725H 1685 90 42 537 0 » '-C-CH2NH CH3 CH2 Cl2 100 Me OH 1 1805 ' 1725 1690 91 5R no. n -C B Chromatography rlua∩t from intermediate V vol/vol IR NMR no. 42 538 0 A ch3 ch3 CH2 Cl2 100 Me OH 1 1805 1725 1590 92 42 539 » CH2 Cl2 100 île 0H 0.8 1805 1725 1585 93 42 540 “ <> A CH3^ CH2!IH2 CH2 Cl2 100 Me 0H 0.7 1805 1720 94 42 541 ■ “ A ch3x CH2flH2 CH2 Cl2 100 Me 0H 0.7 1805 1720 95 42 542 “ ■ ch7 CH2NH2 CH2 Cl2 100 Me 0H 0.5 1805 1720 96 42544 Λ CH3 CHj -<oV Cl ^ nhcoch2nh2 CH2 Cl2 100 Me. OH 1 1802 1720 97 42545 " « ^-d NHCO(CH2)2NH2 CH2 Cl2 100 Me OH 1 1803 1720 98 42545 ■ " <§>Nhco(ch2)Λ CH2 Clj 100 Me OH 1 1805 1720 99 42547 ch2 ci2 100 Me OH 1.5 1805 1720 100 * 5R no, n R, / 1 -C \- B Chromatography eluant from intermediate V IR 0 CO cm"1 intermediate NMR no. R2 vol/vol V 42 548 0 ∂ -^O^-NHC0 CH,NH2 CH2 Cl2 Me OH 100 2 1802 1720 101 42 549 „ / v 0 / \ " ch2 ci2 100 1805 102 ch3 ch3 -/N-C-CH^NH2 Me OH 1 1720 <5)-CH2NH2 CH- C1-, 100 1805 42 581 " 103 F He OH 0,8 1725 CH? Cl- 100 1805 42 582 11 " 1725 104 \ Me OH 0,8 1590 42 583 " II CH2 Cl2 100 1805 1720 105 nhcoch2nhch3 Me OH 0.5 1685 /γ\ CH- Cl- 100 1802 ' 42 584 w « <0 )-NHCOCH,MHCH, 106 \ Me OH 1 1720 CH- Cl- 100 1805 42 585 « « 1720 107 ch3 nhcoch2nh2 Me OH 0.8 1690 H® CH- Cl- 100 1805 42 585 11 >-( 1725 108 CH3 NHC0(CH2)2NH2 Me OH 1 1690 CH2 Cl2 100 1805 42 537 Me OH 1.5 1720 1690 109 42 6 5 7 _ CH2 Cl2 Me OH 100 0,7 1805 1725 1675 110 3R no. Π 8 Chromatography yluant from intermediate V vol/vol IR 9 CO cm * intermediate V NMR no. 42 653 0 6 ■ •^O^ÎtHC0(CH2)2NH2 CH2 Cl2 100 Me OH 1 1805 1720 in 42 675 ■ - y- t û CH2 Cl2 90 Ac 0 Et 10 1805 1725 112 42 676 - X ch3 ch3 Br ch2nh2 CH2 Cl2 100 Me 0H 0.5 1805 1720 113 42 677 " " CH-NH, CH2 Cl2 100 Me OH 0.5 1805 1720 114 42 6 8 7 ° - φ . NHCO(CH2)3NH2 CH2 Cl2 100 Me OH 0.9 1805 1725 1690 115 42 688 " » <^ÔyNHC0(CH2)3NH2 ch2 ci2 100 Me OH 0.8 1805 1720 116 42 689 « <[θyNHC0tCH2)4NH2 ch2 ci2 100 Me OH 0.8 1805 • 1720 117 42 690 " II CH, X^^JLNHCOCHjîlHj CH2 Cl2 100 Me OH 1 1805 1715 118 42811 " II CIs Trans -O* CH2 Cl2 100 Me OH 0,5 1805 CH2C1 1725 119 42 812 “ « S,CBΛ CH2 Cl2 92.5 Ac 0 ET 7.5 1805 1725 120 ?R no. n Λ -c 8 Chromatography eluant from intermediate V vol/vol IR *∂C0 cm * intermediate V NMR no. 12 811 0 A ch3 ch3 CHj. JIHCOCHjjflHj -<o)CH3 CH2 Cl2 100 He OH 1 1805 1725 1690 121 12 815 - 0 AV NHC·/~\H ch2 ci2 100 He OH 0.7 1805 1725 1690 12 815 ■ . <0^ CH2 Cl2 100 Me OH 0.7 1805 1725 1590 123 42 817 " 1» 0 /O/-NH-C-CH NHgW ch3 ch2 ci2 100 Me OH 0.9 1805 1720 124 42 818 ■ ό " CH2 Cl2 100 Me OH 0.9 1805 1720 125 42 731 " A CHj CBj - 0 -/ ;n-c-ch-nh, AiHj * CH2 Cl2 100 Me OH 1 1805 CH,CU 1725 126 42 782 « " -\ S -/Jn-C(CH2)2NH2 ch2 ci2 100 Me OH 1.5' 1805 1725 127 42 733 " " ch2 ci2 100 Me OH 1 128 42 845 - " OK> CH2 Cl2 100 Me OH 1 1805 CH-Cl, 1725 129 42 848 " " -<^0)-ch2nh2 ch3 CH2 Cl2 100 Me OH 0.7 1805 1720 130 SR no ∩ R. % 3 Chromatography eluant from intermediate V vol/vol IK ∂CO cm'1 i ntermedΐ ate V NMR no. 42 849 0 £ -^θy~CH2NH2 ch3 o o o 1805 1720 131 42852 " ch3 ch3 CH2 Cl2 100 Me OH 0.5 1805 1725 132 42357 " " ^-NH-COCH-NHj N CH3' CH2 Cl2 100 Me OH 1.5 1805 1725 133 42852 " ■ s Vch2ch2nh2 tr CH2 Cl2 100 Me OH 1 1805 1725 134 42869 - - CH2 Cl2 85 Ac 0 εt 15 1805 1725 135 42870 " >-CH2NH2 N CH2 Cl2 80 Ac 0 Εt 20 1805 1720 136 42901 » A ch3 ch3 -^Q^-ch2nhcoch2»h2 CH2 Cl2 100 Me OH 1 1805 1720 1680 137 NMR n° 95 - (b) :
NMR ∩° 110 - (b) :
NMR n° 113 - (b) :
NM R n° 130 - (b) :
SR ne n -c \Rκ2 B Chromatography eluant from intermediate V vol/vol IR t>CO cm * intermediate V NMR no. 41970 0 X CH3 ch3 - (CH2)3 nh2 CH2 Cl2 90 Ac 0 Et 10 1800 1720 1590 i 41971 » " - (ch2)4 nh2 CH2 Cl2 90 Ac 0 Et 10 1300 1715 1590 2 41972 " " - <cVsNH2 CH2 Cl2' 92 Ac 0 Et a ooo 3 41973 ■' « O CH2 Cl2 90 Ac 0 Et 10 laoo 1725 1690 4 42074 " " -O ® '-NH CH2 Cl2 90 , Ac o εt' io 1800 1725 1690 5 42076 " " - {CHj }3 NH CH3 CH2 Cl2 90 Ac 0 Εt 10 1300 1725 1550 6 42077 " ■ - (CH2>7NH2 CH2 Cl2 . 95 Ac 0 Εt 5 1800 1720 1690 7 ∩ Λ -Cn*2 3 Chromât opera ph\ rlπant from ΐ ntormocli ate V vol/vol IR t) CO cm * intermediate V NMK no. 42118 0 > CHj CH3 ^“■»℮h2nh2' CH2 Cl2 95 Ac 0 εt 5 iao3 1720 1690 8 42119 ~^Q^- ch2 nh2 CHjClj 92.5 Ac 0 Εt ' 7.5 13Q5 1720 9 42187 ■ " «/O ' CH2 Cl2 95 Ac 0 Εt 5 1805 1725 10 42199 " - C«2 - O CH2 Cl2 90 Ac 0 Εt 10 1300 1725 1690 11 42218 " -a, " CH2 Cl2 92.5 Ac 0 Εt 7.5 1305 1725 1690 12 42219 -O’ CH2 Cl2 · 92.5 Ac 0 Εt 7.5 1805 1725 1690 13 42229 • - CH2 -<0>ch2 nh2 CH2 Cl2 95 Ac 0 Εt 5 1800 1720 14 · 42221 iH CHj « CH2 Cl2 95 Ac 0 Εt 5 1800 1720 15 42222 " CH, Cl2 95 Ac 0 Εt 5 1805 1720 16 SR no n A -C A B Chromatography eluant from intermediate V vo1/vol IR t> CO cm'1 intermediate V NMR no. 42 531 0 Λ CH3 ch3 X '"CHgNHg CH2 Cl2 100 Me OH 0.5 1800 1720 17 42 532 - A ^ CH2NH2 CH2 Cl2 100 Me OH 0.5 1800 1720 18 42533 - ch3 ch3 h(Ô)-ch2nhch3 CH2 Cl2 100 Me OH 0.5 1800 1720 1690 19 42 534 » CH2 Cl2 100 Me OH 0.5 1800 1720 1690 20 42 535 - A ch3 ch3 A ch3 ch2nh2 CH2 Cl2 95 Ac 0 Et 5 1800 1720 21 42 535 " 6 A ch3 ch2nh2 CH2 Cl2 95 Ac 0 Et 5 1800 1720 22 42 659 - A ch3 ch3 -{q)-CH3 CH2 Cl2 100 Me OH 0.4 1802 1720 23 42 650 - % ch3 CHjNH2 CH2 Cl2 100 Me OH 0.5 1802 1720 24 42661 " A ch3 ch3 -/θV ch2nh2 ch3 CH2 Cl2 95 Ac 0 Et 5 1802 1720 25 SR ncv n /S1 -C 8 Chromatography eluant from intermediate V vol/vol IR ΰCO cm1 intermediate V NMR no. 42662 0 H O- CH3" -<o)-ch2nh2 ^ch3 CH2 Cl2 95 Ac 0 Et 5 1802 1720 26 42663 " X ch3 ch3 CH, 1 3 - c -ch2nh2 ch3 CH2 Cl2 100 Me OH 0,4 1802 1720 1680 27 42664 " II -NHCOCHgHH^ CH2 Cl2 95 Ac 0 Et 5 1802 1720 28 42665 « -^Ôy-NHC0CH2NH2 CH2 Cl2 95 Ac 0 Et 5 1802 1720 29 42672 1 Λ ch3 ch3 γ.C℅-QnΠ CH2 Cl 2 90 Ac 0 Et 1C 1802 CHpCl0 1720 30 42673 0 " -y^N-C-C^NHg ch2 ci2 100 Me OH 1 1802 CHoClp 1715 “ i690 31 42674 " -/ Vc-ch2nh2 ch2 Cl 2 100 Me OH 1 1802 CH-Cl, 1715 32 42635 « Λ ch3 ch3 NHCQCH2NH2 CH2 Clj 95 Ac 0 Et 5 1805 ' 1725 1695 33 42686 - 6 nhcoch2nh2 CH2 Cl 2 95 Ac 0 Et 5 1805 1725 1695 34 42847 Λ ■ch3 ch3 0 ^N-C(CH2)2NH2 ch2 Cl 2 100 Me OH 1 1800 CHjCl 1710 35 SR no. ∩ -c δ Chromatography *lua∩t from intermediate V vol/vol IR NMR no. 42850 0 A ch3 ch3 -<5>:h2nh2 ch3 CH2 Cl2 100 Me OH 0.7 1805 1720 36 42851 » -{o}“CH2nh2 / CH3 ch2 ci2 100 Me OH 0.7 1805 1720 37 42853 - Λ ch3 ch3 A ^■CH-CH2NH2 ch3 CH2 Cl2 95 Ac 0 Et 5 1802 1720 38 42854 « iH32 2 ch2 Cl, 100 Me OH 0.4 1802 1720 39 42855 " Λ ch3 ch3 /À J-'NHC0CH2CH2NH2 (T CH2 Cl2 85 Ac 0 Et 15 1803 1720 1685 40 42858 - « -y ^-NHC0CH2NH2 N ch2 ci2 100 Me OH 1 1802 1725 1590 41 42859 - " -<^)-NHCOCH2CH2NH2 CH2 Cl2 70 Ac 0 Et 30 1802 1720 1690 42 42850 " à ■<(θ^-NHC0CH2CH2NH2 CH2 Cl2 70 Ac 0 Et 30 1302 1720 43 1 SR nα n /R1 _ : 8 Chromatography eluant from intermediate V voi/VOÎ IR CO cm"1 intermediate V N'MR no. 42 863 0 /\ ch3 ch3 -^Ôy-NHCOCHjNHCHj CH2 Cl2 90 Ac 0 Et 10 1800 1720 1690 44 42 868 " ■ //)-ch2nh2 NX ch2 Cl, 100 He OH 0.7. 1802 1720 45 42 902 " ■ <^0ycH2NHC0CH2NH2 CH2 Cl2 100 He OH 1 1802 1720 1670 46 NMR n° 39 - (b) :
NMR ∩° 45 - (b) :
TABLE III
( ( { ( PRODUCTS ( SR No. ( ( s r R A I N s Escherichia coli SOL RL 90 Ci trobacter 49 Proteus vulqaris RL 99 bis Serratia RL 72 Klebsiella R0 30 Enterobacter RO 154 Pseudomonas RL 112 ! { 41 730 0,5 · : 0.25 4 0.12 1 0.25 0.25 4 j 41 733 ( 41 806 2 2 0.5 8 1 1 8 1 1 0.5 4 0.5 8 8 j 41 854 0.25 0.5 ^ 0.12 0.5 0.25 2 4 i 41 855 0.25 1 ^ 0.12 0.5 0,25 2 8 i 41 856 0.5 2 ^ 0.12 2 0.25 4 16 ( 41 858 2 1 0.5 4 0.5 8 8 ( 41 859 / 41 860 1 2 0.25 4 0.5 8 16 2 1 0.5 4 0.5 8 16 ( 41 862 0.25 0.25 4 0.12 0.5 0.25 1 4 1 4 0.5 4 0.5 8 8 2 4 0.25 4 0.5 8 8 2 2 1 8 1 8 8 1 1 0.5 4 1 8 8 f 41 891 0.5 0.5 0.5 4 0.5 8 8 S T RAINS ( f PRODUCTS SR No. Escherichi a col i SOL RL 90 Citrobacter 49 RcΩtëüi volants RL 99 bis Serratia Rl72 Klebsiella RQ"3θ Enterobacter R0 154 Pseudomonas ( { { ( { 41 967 0.25 0,5 4 0.12 0.5 r 0.25 2 4 41 975 0.25 0.5 0.5 4 0.5 8 8 41 976 1 0.5 0.25 8 0.5 8 8 ( ( ( 42 022 0.5 0.25 4 0.12 0.5 0.25 2 4 42 024 0.5 0.5 0.25 LO o 0.25 2 4 ( { { 42 025 0.5 0.5 0.25 1 0.5 4 4 42 026 0,5 0.25 4 0.12 1 0.25 4 8 ( . 42 027 0.25 0.25 4 0.12 0.5 0.25 2 4 i 42 028 0.25 0.5 ^ 0.12 L∩ o 0.25 2 4 * c ( 5 42 029 0.25 0.25 4 0.12 . 0.5 0.25 2 8 42 042 4 0.12 4 0.12 4 0.12 2 4 0.12 1 4 42 073 1 0.5 0.5 2 0.5 4 4 ( / 42 074 1 0.5 0.5 4 0.5 8 8 ! ( ( ( 42 117 0.25 0.25 4 0.12 0.5 4 0.12 1 4 42 118 1 . 0.5 0.25 4 0.5 16 8 42 119 0.5 0.25 4 0.12 4 0,5 8 8 ( ( ( 42 208 0.5 0.5 4 0.12 1 0,5 0.25 4 42 209 0.25 4.0.12 4 0-12 0,5 0,25 4 0,12 4 ( < 42 210 1 0.5 0.25 1 0.5 0.25 4 PRODUCTS SR No. S TRAINS > Escherichia col 1 SOL RL 90 Citrobacter 49 P-Tflteüi vulgaris RL Serratia RL Klebsiella : RO 3Ô Enterobacter RO 154 Pseudomonas ( RL ff2 j 42 211 4 0.12 4 0.12 4 0.12 4 0.12 ; 4 0.12 4 0.12 64 42 212 4 0.12 4 0.12 4 0.12 0.25 4 0.12 4 0.12 4 ( 32 213 0.25 4 0.12 4 0.12 0.5 0.25 4 0.12 15 1 42 214 4 0-12 4 0.12 4 0.12 0,5 4 0.12 4 0.12 16 42 215 4 0.12 4 0.12 4 0.12 0.25 4 0.12 4 0.12 8 1 42 216 4 0.12 4 0.12 4 0.12 0.5 4 0.12 4 0.12 8 \ 42 217 4 0.12 -4 0.12 4 0.12 0.25 . 4 0.12 4- 0.12 16 i 42 218 0.5 0.25 0.5 2 0.5 0.5 64 J 42 219 0.5 4 0.12 4 0.12 1 0.5 0.5 4 Î 42 221 0.25 4 0.12 4 0.12 - 2 £ 0.12 0.25 64 J 42 222 0.5 4 0,12 . 4 0.12 1 0.5 0.5 8 ( 42 320 4 0,125 4 0.125 4 0.125 0.5 4 0.125 4 0.125 4 1 42 321 0.5 0.5 4 0.125 1 0.5 0.25 8 42 371 0.5 0.25 4 0.125 0.5 0.25 0.25 8 / 42 372 0.25 4 0.125 4 0.125 0.25 . 0.25 4 0.125 4 ! 42 374 0,5 0.25 4 0.125 1 0.25 0.25 4 42 379 0.25 4 0.125 4 0.125 0.5 4 0.125 4 0.125 8 42 380 4 0.125 € 0.125 4 0.125 1 4 0.125 4 0.125 4 i 42 395 4 0.125 4 0.125 4 0.125 0.5 4 0.125 4 0.125 4 i Escherichia col i SOL RL 90 Citrobacter 49 Prateu? vulqaris RL 99 bis Serratia RL Klebsiella ROS Enterobacter RÛ 154 Pseudomonas RL 112 0.5 0.25 4 0.125 1 0.25 0.5 8 0.5 0.25 4 0.125 0.5 0.25 0.5 8 0.25 0.25 4 °·125 l∩ o 0.25 0,25 8 0.5 0.25 4 0.125 0.5 0.25 0.25 8 0.25 0.125 4 0.125 0.25 4 0.125 4 0.125 4 0.5 0.25 4 0.125 0.5 4 0.125 0.25 4 0.5 0.5 4 0.125 to o 4 0.25 0.5 8 0.25 0.25 4 0.125 1 0.25 0.25 4 0.5 0.25 4 0.125 0.5 0.25 0.5 4 0.25 4 0.125 4 0.125 - 0.5 0.125 0.25 2 0.25 4 0.125 4 0.125 0.5 0.25 0.25 4 0.125 0.125 2 4 0.25 0.25 2 8 1 0.5 4 8 0.25 0.25 2 4 0.25 0.25 8 4 0.25 0.25 16 4 0.25 0.25 8 4 0.25 • 0.25 4 8 Escherichia coli SOL RL 90 Citrobacter 49 Prstgϋi vulgaris RL 99 bis Serratia RL 72 " Klebsiella RO Enterobacter RÛ~Ï54 Pseudomonas RL 112 0.125 0.125 8 4 0.5 0.25 1 8 4 1 4 8 1 4 0.5 4 8 0.5 0.5 2 8 1 0.5 2 8 0.125 0.125 1 4 0.25 0.25 2 8 2 1 2 8 2 1 2 8 2 1 4 8 0.125 0.25 4 4 0.125 0.25 4 4 0.5 0.5 8 4 0.25 0.125 2 4 0.25 0.125 2 4 0.25 0.125 2 8 0.125 0.125 2 4 0.5 0.25 8 8 f PRODUCTS { SR No. ( ( Escheri chia coli SOL RL 90 Citrobacter 49 Prateus YMloarU RL 99 bis Serratia RL 72 “ Klebsiella R0 3Ô Enterobacter R0 154 Pseudomonas ' RL 112 ' i ( ( 42 815 j 42 817 0.125 0.25 8 8 0.125 0.25 4 4! 0.125 0.125 4 4 | | 42 848 ( 42 849 0.125 0.125 2 4 j 0.125 . 0.125 2 4 j ( 42 850 [ 42 851 0.5 0.25 2 8 « 0.5 0.25 1 8 ( 42 852 0.25 0.125 1 8 j 42 857 0.5 1 8 8 ! ( PRODUCTS SR no. S T R VINS Escherichia coli Serratΐa · Proteus vulgaris 255 255/1.7 * SI/326 A SI 1326 S * GN 75/C.l GN 76/C.1/3 * 41 730 0.25 <0,12 0,5 <0.12 0.25 0.25 41 854 <0,12 <0,12 0.25 <0.12 0.25 0.25 41 855 <0.12 <0.12 0.25 <0.12 <0.12 <0.12 41 362 <0.12 0.12 <0.12 <0.12 <0.12 <0.12 41 967 <0.12 <0,12 0.25 <0.12 <0.12 <0.12 41 973 0.25 0.25 0,25 <0.12 0.5 0.5 41 975 0.5 0.5 0,25 <0.12 0.5 0.5 42 022 0.25 0.25 <0.12 <0.12 <0.12 <0.12 42 024 0.25 ■ <0,12 0.25 0.06 0.25 0.25 42 027 0.12 0.06 0.25 <0.06 0.12 0.12 42 028 0.12 0.12 0.12 <0.06 0.25 0.25 42 042 <0.12 <0.12' 0,25 <0.12 <0.12 <0.12 42 073 0.5 0.25 0.25 <0,12 0.5 0.5 42 074 0.5 0.25 0.25 0.12 0.5 0.5 42 117 0,125 0.06 0,12 <0.06 <0.06 <0.06 CO 0.5 0.25 0.25 0 ; 12 0.5 0.5 42 119 0.25 0.12 0.25 <0.06 0.12 0.12 S T R A INS PRODUCTS SR no. Escherichia col 1 Serratia 1iςuefacie∩s Proteus vulαaris 255 255/1.7 * Sl/326 A SI 1325 S * GN 76/C.l GN 76/C.1/3 * 42 320 0.0625 0.0625 0.125 S< 0.0312 v< 0.0312 0.125 42 395 0.0625 0.0625 0.125 i 0.0312 0.0312 ^ 0.0312 42 456 0.0625 4 0.0312 0.25 0.0625 ^ 0.0312 0.125 42 457 0.125 <: 0.0312 0.0625 0.0625 0.0312 0.0625 42 466 0.125 0.125 1 4 0.0312 4 0.0312 0.0625 42 467 0,0625 ,< 0,0312 0.125 0.125 0.0312 0.0625 42 474 0.0625 0.0625 0.125 ^ 0.0312 0.0625 0.0625 42 531 0.125 0,0625 0,125 0.125 0.0625 0.0625 42 533 0.125 0,0625 0.125 v< 0.0312 0.0625 0.125 42 535 0.125 0,0312 0.0625 0.125 0.0625 0.125 42 546 0.0625 4 0.0312 0.25 4 0.0312 N< 0.0312 0.125 42 547 0.125 <• 0,0312 2 0,125 0.0625 0.25 42 548 0.625 0.0312 0.125 4 0.0312 0.0625 0.0625 42 549 0,125 0,0625 0.125 4 0.0312 4 0.0312 0.0625 42 664 0.25 0,0625 0.25 0.0625 0.125 0.25 42 673 0,25 0.25 0,25 0.0625 0.25 0.25 PRODUCTS SR no. S T RAINS Escherichia coli SOL 90 Klebsiella R0 30 41 730 1.4 0.79 41 854 0.23 0.19 41 855 0.16 0,17 41 862 0.13- 0.10 41 973 0.22 0.4 42 042 0.05 ND 42 073 0.33 ND 42 117 0,11 ND 42 119 0.16 ND Bv wav of example of pharmaceutical composition, there mav be prepared injectable solutions of the sodium salt of SR 41 973: